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2   General introduction 
 
I. Introduction  
 Soil-transmitted helminths (STH) refer to a cluster of four helminths, 
including Ascaris lumbricoides (roundworm), Trichuris trichiura (whipworm), 
Ancylostoma duodenale and Necator americanus (hookworms). These four 
helminths are clustered into one group because they share a number of 
features: they all (i) are nematodes, (ii) their adult worms dwell exclusively in 
the gastrointestinal tract of humans (iii), they have a direct lifecycle (no 
intermediate host is required to complete the lifecycle), and (iv) they produce 
eggs which are excreted through stool, but which are not immediately infectious. 
The infectious stages will develop outside the host in the soil (referring to their 
common name). In addition, they all (v) cause mainly mild chronic, rather than 
sever acute disorders in the human host, and (vi) can often be treated with the 
same anthelminthic drug (WHO, 2002a; Utzinger and Keiser, 2004; Bethony et 
al., 2006; WHO, 2012).  
 However, despite these common features important differences can be 
noted in their morphology, fecundity of the adult female worms, route of 
transmission, survival of infectious stages in the environment, and their location 
in the gastrointestinal tract. The most important differences are summarized in 
Table I. 
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Table I. Overview of the most important differences between the four soil-transmitted helminth species (Ascaris 
lumbricoides, Trichuris trichiura, Ancylostoma duodenale and Necator americanus). 
 
 A. lumbricoides T. trichiura A. duodenale N. americanus 
Illustration of lifecycle 
  
 
Morphology     
 Adults 15-35 cm 3-5 cm +/- 1 cm  
 Eggs: Size 
          Shape 
          Shell thickness 
          Color 
40-65 µm 
Oval to round                   
Thick shell 
Brown colour 
50-54 µm  
Barrel shaped  
Fairly thick shell  
Yellow brown  
 
40-65 µm 
Oval shaped 
Thin shell  
Pale gray/or 
Colourless 
 
Fecundity (eggs/day) +/- 200,000 2,000-10,000 25,000-30,000 9,000-10,000 
Infectious stage Egg containing L3 larva Egg containing L1 larva L3 larva 
Survival of infectious stage  >10 years in appropriate soil >10 years in appropriate soil 3-4 weeks in appropriate environment 
Route of transmission Oral Oral Percutaneous 
Oral 
Percutaneous 
 
Extra-intestinal migration Yes No Yes 
Location in gastrointestinal 
tract 
Small intestine Large intestine Small intestine 
Adult life span 1-2 years About 1 year 1-3 years 
Booth and Bundy,1992; Wakelin, 1996a,b; Geissler et al., 1998; Hotez et al., 2004; Guerrant, 2005; Bethony et al., 2006; Brooker and Bundy,2009; 
WHO, 2012; http://dpd.cdc.gov/dpdx/HTML/ImageLibrary/Ascariasis_il.htm; http://dpd.cdc.gov/dpdx/HTML/ImageLibrary/Trichuriasis_il.htm 
http://dpd.cdc.gov/dpdx/HTML/ImageLibrary/Hookworm_il.htm
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 Each of the STH has specific morphological features on which they can be 
identified, for both adult worms and eggs. Overall, adult worms can be 
differentiated based on the size. A. lumbricoides is the largest of all (up to 35 
cm), followed by T. trichiura (up to 5 cm). The hookworms are the smallest (+/- 
1 cm). In addition to this, adult T. trichiura worms are characterized by a thin 
anterior part and wide posterior part, resembling a whip (referring to its 
common name). The eggs can be differentiated microscopically based on their 
size (A. lumbricoides and hookworm: 40-65 µm; T. trichiura: 50-54 µm), shape 
(A. lumbricoides: oval to round; T. trichiura: barrel shaped; hookworm: oval), 
thickness of the shell (A. lumbricoides: thick; T. trichiura: fairly thick; 
hookworm: thin), colour (A. lumbricoides: brown; T. trichiura: yellow brown; 
hookworm: pale grey to colourless). Female A. lumbricoides worms are the most 
fecund, excreting approximately 200,000 eggs per day. Fecundity of the 
remaining STH species varies between 2,000 and 10,000 for T. trichiura and 
from 9,000 to 30,000 eggs per day for hookworms (Necator americanus excrete 
less eggs [9,000 to 10,000] compared to Ancylostoma duodenale [25,000 to 
30,000]). Both A. lumbricoides and T. trichiura are transmitted by the oral 
uptake of eggs containing an L3 (A. lumbricoides) L1 (T. trichiura) larva, 
whereas hookworm infections are transmitted by the L3 larva penetrating the 
skin. The eggs of both A. lumbricoides and T. trichiura will take 2-3 months to 
mature in the external environment before becoming infectious. These eggs can 
survive many years in an appropriate environment and remain infectious 
throughout (Muller and Wakelin, 2002). This is in contrast to hookworms, for 
which the infectious stage (L3) can only survive 3-4 weeks under tropical 
conditions; however, it may remain infective for several months if environmental 
conditions are optimal (Albonico and Savioli, 1997). The life cycle of both A. 
lumbricoides and hookworm is characterized by an extra-intestinal migration of 
the immature stadia. Adult worms, however, are found in the small intestine for 
both STH species. For T. trichiura, there is no extra intestinal migration and all 
stages are found in the large intestine.  
II. Epidemiology and burden of soil-transmitted helminthiasis   
 In 2010, it was estimated that 1,450 million people were infected with any 
STH species, of which A. lumbricoides infect 772–892 million, T. trichiura 430-
508 million, and hookworms 406-480 million people (Pullan et al., 2014). 
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Although STH infections are distributed worldwide, the highest prevalence's 
(Figure I) is reported in tropical and subtropical regions from Asia, Sub-Saharan 
Africa (SSA), the Americas, and East China (WHO, 2002; Hotez and Kamath, 
2009; WHO, 2012; Pullan et al., 2014). Their occurrence, transmission and 
diseases burden largely relate to factors like poor sanitation and hygiene, 
overcrowding, and limited access to clean water (Stephenson et al., 2000; WHO, 
2002b; de Silva et al., 2003; Ukpai et al., 2003; Bethony et al., 2006).  
 
Figure I. Global distribution of any soil-transmitted helminths in 2010. (A) The 
combined prevalence of any infection, based on geostatistical models for sub-Saharan 
Africa and available empirical information for all other regions by country. (B) The 
proportion of the global population covered by the endemic countries (Pullan et al., 
2014). 
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 It has been projected that annual deaths from STH infection ranges from 
12,000 to 135,000 (WHO, 2002a, 2004; Awasthi and Bundy, 2007). The causes 
of mortality are mainly due to anaemia associated to hookworm and T. trichiura 
infection, or are linked to intestinal and/or biliary obstruction by A. lumbricoides 
(de Silva et al., 1997; Stephenson et al., 2000; Wani et al., 2010). Given that 
their consequence is rather disability than death, the worldwide burden of STH 
infection is typically assessed by disability-adjusted life years (DALYs) lost, that 
is the number of healthy years lost to premature death or disability. For 
instance, recent data (2010) on the composition of global DALYs/100,000 
shows: 47 (25-83) for hookworms, 19 (10-34) for A. lumbricoides and 9 (5-15) 
for T. trichiura, which may appear low in comparison with 1200 (921-1,594) for 
malaria, 1,184 (1,089-1,283) for HIV/AIDS, 717 (581-814) for tuberculosis, but 
it is still significant (Brooker, 2010; Murray et al., 2012; Pullan et al., 2014).  
 Overall, the severity of the disease caused by STH has consistently been 
found to depend on the number of worms present per person (Anderson and 
May 1991; Crompton and Nesheim, 2002; WHO, 2002b). Preschool-aged 
(preSAC) and school-aged children (SAC), and pregnant women are the three 
groups of the population at highest risk of the morbididty caused by these 
infections (Hall et al., 2008; Brooker, 2010). SAC harbour the most intense 
infections and thus they suffer most from the morbidity like malnutrition, growth 
stunting, intellectual retardation, and cognitive and educational deficits (WHO, 
2005).  
III. Soil-transmitted helminth infections in Ethiopia 
 It is estimated that A. lumbricoides, T. trichiura and hookworms infect 26 
million, 21 million and 11 million of the 86 million Ethiopians, respectively. Of all 
SSA countries, Ethiopia is one of the countries that suffer the most of the burden 
caused by STH, representing 15% (the 2nd highest), 13% (the 4th highest) and 
6.5% (the 3rd highest) of all A. lumbricoides, T. trichiura and hookworm 
infections respectively, in SSA (Hotez and Kamath, 2009; Deribe et al., 2012).  
 Although the national average prevalence is estimated at 37% for A. 
lumbricoides, 30% for T. trichiura and at 16% for hookworms, different studies 
revealed a prevalence range of 0-100% in different parts of the country for all 
the three STH (Wondimagegnehu et al., 1992; Jemaneh 2000; Erosie et al., 
2002; Erko and Medhin, 2003; Tadesse et al., 2008; Fekadu et al., 2008; Yami 
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et al., 2011; Alemu et al., 2011; Pullan and Brooker, 2012; Deribe et al., 2012). 
 Generally, most regions of Ethiopia are suitable for the transmission of 
STH, except parts of the Somali and Afar areas where the annual mean 
temperature is too high for transmission (Figure II). Prevalence is lower in the 
low and dry areas of the country than in the more humid highlands, where a 
prevalence ranging 20 – 100% was recorded (Pullan and Brooker, 2012). In 
addition, there are important differences in methodology such as diagnostic 
techniques, sample sizes that may contribute to the variation in reported 
prevalence.   
 
                 
 
Figure II. Distribution of soil-transmitted helminths survey data and average 
district-level prevalence in Ethiopia. Source: Wormy world Project 
(http://www.thiswormyworld.org/maps/ethiopia) 
 A report by the Federal Ministry of Health of Ethiopia (FMoH) indicated 
that STH are a leading cause of morbidity among patients visiting the outpatient 
Proportion of children requiring 
preventive chemotherapy for 
STH and national coverage by 
the year 2009 
 
Requiring preventive 
 chemotherapy  
 12% of African region 
Coverage 
     SAC: 2% 
 preSAC: 78% 
Source: (WHO, 2012) 
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department of the health institutions (FMoH, 2004). As a result, STH infections 
cause serious public health problems such as malnutrition, anaemia and growth 
retardation as well as higher susceptibility to other infections (Tedla, 1986).   
 Most risk factors associated with STH infections and transmissions (e.g., 
low socio-economic status, poor personal hygiene and environmental sanitation, 
lack of access to safe water, faecal contamination of human environment, or 
inability to use foot wear) also apply for STH infections in Ethiopia (Birrie and 
Erko, 1995; Assefa et al., 1998; Jemaneh, 1998; Ali et al., 2001; Legesse and 
Gebere-Silasie, 2007). 
 Despite the estimated high prevalence of STH and posing enormous 
disease burdens, in Ethiopia the control measures against STH are at their 
infancy stage. At the time of this thesis project, disease burden estimations 
(prevalence and intensity), epidemiological survey and mapping are based on 
limited studies (not covering all regions). Moreover, these studies are often not 
up-to date and scattered. Furthermore, preventive chemotherapy (PC) was not 
yet fully implemented to SAC. Ethiopia launched a programme entitled 
‘Enhanced Outreach Strategy’ in 2004, and since then preSAC are dewormed 
every 6 months. Accordingly, more than 11 million children by 2009 with a 
national coverage of 78% (Negash, 2011; WHO, 2012) have received PC. In 
addition, deworming of SAC started in 2007 and 2008. However, these 
programmes were restricted to some parts of the country, resulting in a national 
coverage of only 2% in 2009 (WHO, 2012) (see figure II above for distribution of 
STH and the PC coverage of (pre-)SAC in Ethiopia). At present, however, there 
is an immense commitment from Ethiopia's government to combat NTD 
including STH. The Federal Ministry of Health (FMoH) has recently inaugurated 
the National Master Plan to control NTD in June 2013. According to this master 
plan, mapping of NTD was completed in April-May 2014 and the preliminary data 
of mapping was released in June 2014. Available and/or donated drugs will be 
distributed to different regions for PC that need to be followed by regular 
monitoring and evaluation programmes (National Symposium on NTD in 
Ethiopia, 12-14 June 2013, Addis Ababa, Ethiopia). 
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1.1 Introduction 
 Soil-transmitted helminthiasis (STH) refers to a group of parasitic diseases 
in humans caused by infestations with various species of intestinal worms –
collectively called soil-transmitted helminths (STHs). STH infections are 
now well recognized as a major health issue worldwide. The World Health 
Organization (WHO) considered control of STH one of the top five health 
priorities within the global ‘Massive Effort Against Poverty’ (WHO, 2000). This is 
because of their global distribution, high prevalence, and effects on the 
nutritional status and physical and mental development of children.  
 Strategies have been developed to target morbidity control by means of 
regular mass anthelminthic drug distribution, and these preventive 
chemotherapy (PC) programmes remain the mainstay. PC is the cheapest and 
fastest means compared to other control methods, such as improving 
environmental sanitation, provision of safe water, and raising standards of living.  
 Annual or biannual single-dose treatment with benzimidazole (BZ) drugs 
based on the prevalence of any STH infections leads to significant reduction in 
the morbidity caused by these parasitic infections (Molyneux, 2004; Molyneux et 
al., 2005; Fenwick et al., 2005; WHO, 2011). This has had major positive 
impacts on children's health, including progress in growth after treatment and 
replenishment of important nutrients such as iron stores (Hotez et al., 2004, 
2009), improvements in childhood intellectual and cognitive development, and 
decreases in school absenteeism (Bundy et al., 1990; Drake et al., 2000; Savioli 
et al., 2002; Hotez et al., 2004; Hotez et al., 2005).  
 Observations of these impacts have led to the implementation of large-
scale STH control programmes that target school-aged children (SAC) (Urbani 
and Palmer, 2001; WHO, 2002, 2006; Hotez et al., 2009; WHO, 2011) through 
increased pledges of drug donation for PC purposes. 
 However, as of 2012, only 36.0% of SAC and 24.7% of preschool-age 
children (preSAC) were being treated for STH (WHO, 2014; Table 1.1). This low 
coverage was too far below the WHO's expected coverage of 75% by 2020. As a 
result, new objectives were set, stating that all the countries where STH was 
considered a public health problem should start national STH control 
programmes by 2015, and reach 75% national coverage and 100% geographical 
coverage by 2020 (WHO, 2012: Figure 1.1)  
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 The objectives of this review are, therefore, to review current (i) control 
strategies for STH infections, (ii) WHO-recommended anthelminthic drugs for 
STH control, (iii) ways of monitoring drug efficacies, (iv) factors affecting the 
monitoring of drug efficacy, and (v) efficacy trials performed on schoolchildren in 
Africa.  
 
1.2 Current control strategies for soil-transmitted helminth infections  
 Currently, we have two broad STH control strategies, including (i) periodic 
administration of anthelminthic drugs, and (ii) improvement of sanitation, 
personal hygiene and health education.  
1.2.1 Administration of anthelminthic drugs 
 Depending on the purpose (curative vs. preventive) and target (individual 
vs. group), we can broadly classify drug administration programmes into two 
catagories: (1) selective (individual-based) treatment, and (2) mass treatment 
(PC). Further, PC can be administered in one of two main ways: (i) mass 
treatment of targeted groups (i.e. high-risk groups, such as SAC, preSAC, and 
pregnant women), or (ii) universal (population-based) treatment (WHO, 1996c; 
Gabrielli et al., 2011).  
1.2.1.1 Selective treatment 
 Selective treatment is based on individual applications of treatment with 
specific drugs and drug regimens. Selective treatment demands pre-confirmation 
of infections through various diagnostic methods to guide therapeutic choice, 
and aims at the relief of symptoms and complaints or a clinical radical cure. The 
selection is based on the intensity of current or past infection. The choice of drug 
will be based on specific efficacy irrespective of the mode and length of 
administration. WHO recommends individual treatment when the prevalence of 
any STH in a given population is lower than 20%. However, in practice, selective 
treatment is difficult to achieve. This is mainly because diagnosis is more 
expensive than treatment, and because of the shortage of health institutions and 
health professionals proportional to the population in the majority of developing 
countries where STH are endemic (WHO, 2002). 
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1.2.1.2  Mass drug administration to targeted groups 
 Group-based application (PC targeting a specific segment of the 
community) is one of the most common and widely applied strategies underway 
in many countries. A specific group can be defined based on age, sex, being at 
high risk to infection, or social characteristics. Usually, treatment of a particular 
group through PC aims at interrupting transmission or lowering prevalence to a 
level below the threshold (prevalence <1%) at which the targeted infections are 
no longer considered a public health problem and PC becomes unnecessary 
(WHO, 2012).  
 Among a range of strategies and target groups for control of STH using 
PC, the school-based approach has received due attention for the following 
reasons. First, STH are highly prevalent in children, accounting for the majority 
of STH infections in the entire population (Bundy et al., 1992). Second, (pre-
)SAC tend to comprise more than 30% of the population and school enrolment 
has increased in recent years (UNESCO, 2011). Third, it is relatively easy to 
reach SAC, because the school system is usually better established than the 
health infrastructure in most developing countries, where distant villages without 
health facilities often have primary schools. Fourth, because of the adverse 
effects that STH imposes on the physical and mental development of children, it 
can be taken as a major retarding influence on the economic progress of the 
developing world.  
 Thus, the current means of controlling STH infections primarily depends 
on PC programmes in which single-dose albendazole (ALB) or single-dose 
mebendazole (MEB) is administered to SAC as the main target group, basically 
without any prior individual diagnosis. Yet, it is important to note that the 
frequency of PC depends on the prevalence of any STH in a given 
population/region. 
 According to the 2001 World Health Assembly Resolution to eliminate STH 
as a public health problem in children (WHA54.19), at least 75%, and up to 
100%, of all (pre-)SAC at risk of morbidity from STH were targeted to receive PC 
by 2010 (WHO, 2002). However, recent reports across the world have revealed 
that coverage has been lagging far below this target. Up to 2012, only about one 
third (32.6%) of children at risk of STH and requiring PC received an 
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anthelminthic treatment (Table 1.1), despite all the intensified effort to eliminate 
STH as a public health problem (WHO, 2014).  
Table 1.1 Coverage of preventive chemotherapy among preschool-aged children 
and school-aged children against soil-transmitted helminths by World Health 
Organization region, 2012 (WHO, 2014). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
WHO region Estimated number 
in need of PC 
Coverage     
    (%) 
Africa 300, 608, 939 25.3 
preSAC 98, 193, 220 15.5 
SAC 202, 415, 719 30.1 
Americas  49, 312, 001 33.1 
preSAC 13, 929, 732 31.9 
SAC 35, 382, 269 33.6 
Southeast Asia 368, 922, 141 51.1 
preSAC 105, 878, 494 35.4 
SAC 263, 043, 647 51.1 
Europe 1, 775, 391 42.9 
preSAC 602, 826 5.2 
SAC 1, 172, 565 62.3 
Eastern Mediterranean 80, 544, 663 6.9 
preSAC 25, 481, 678 17.9 
SAC 55, 062, 985 1.8 
Western Pacific 74, 721, 699 19.5 
preSAC 22, 330, 519 18.2 
SAC 52, 391, 180 20.1 
Global 875, 884, 833 32.5 
preSAC 266, 416, 469 24.7 
SAC 609, 468, 364 36.0 
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 During the past few years, renewed recognition of the burden imposed by 
these infections has led to the strengthening of PC programmes for the control 
and possible elimination of the major human helminths (Molyneux et al., 2005; 
WHO, 2006; WHO, 2011; Gabrielli et al., 2011; NTD Partner Website, 2012). 
Moreover, WHO recommendations continue to encourage governments and 
policy makers to invest in helminth control by strengthening political 
commitment and coordination, building technical capacity, facilitating 
sustainability and improving monitoring capacities as assets for national 
development (WHO, 2005).  
 Figure 1.1 illustrates the recent and revised WHO strategic plans for 
eliminating morbidity from STH in children by 2020. The strategic approaches 
respond to each of the challenges identified in the past, and milestones have 
been set based on the situation in each WHO region. 
 
 
Figure 1.1 Flow chart showing the World Health Organization's (2011-2012) 
strategic plans to eliminate and control soil-transmitted helminths by 2020 
(WHO, 2012). 
  
 In addition, the availability of safe and relatively inexpensive drugs for 
STH, coupled with significant donations of anthelminthic medicines by 
GlaxoSmithKline (ALB) and Johnson & Johnson (MEB), and increased interest in 
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neglected tropical diseases (NTD) by many partners (scintific communities and 
non-governmental bodies) offer a unique opportunity to control STH in the next 
10 years. Altogether, this has made control through PC a potentially affordable 
option even in resource-poor countries (Handzel et al., 2003; WHO, 2011). 
Figure 1.2 shows countries where STH is a public health problem and the 
proportion of children aged 1 to 14 years requiring PC in each country. 
Furthermore, rather than aiming to achieve eradication, current control 
programmes are focused on reducing infection intensity and transmission 
potential, primarily to reduce morbidity and avoid mortality associated with the 
disease (Albonico et al., 2008).  
 
  
Figure 1.2 Proportion of children aged 1-14 years requiring preventive 
chemotherapy for soil-transmitted helminthiasis, by country, 2009 (WHO, 
2011). 
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 The current WHO strategy for PC and recommended frequency of PC re-
treatment for SAC depends on the prevalence data (Table 1.2).  
 
Table 1.2 Recommended frequency of re-treatment with preventive 
chemotherapy for soil-transmitted helminthiasis in school-age children, by 
category of risk 
 
Category of risk Prevalence of any 
STH among SAC 
Re-treatment schedule 
High-risk areas >50% Twice a year 
Moderate-risk areas >20% and <50% Once a year 
Low-risk areas <20% None (case-by-case treatment) 
Adapted from Preventive chemotherapy in human helminthiasis (WHO, 2002) 
Technical report Series No 912. 
  
 Yet, it might also be important to look into the risk of re-emergence in the 
event that the parasites maintain transmission capacity despite intense drug 
pressure-which would be predictive of a rapid return to high prevalence if 
intervention is interrupted. Thus, WHO has recently suggested (WHO, 2012) a 
change in frequency of drug administration after five to six years of de-worming 
(Figure 1.3). In addition, it might be worthwhile to assess the effect of seasonal 
variation on STH infections to determine the appropriate season to administer 
available drugs for maximum possible benefit. 
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Figure 1.3 World Health Organization decision tree to determine frequency of 
drug administration after five to six years of de-worming (WHO, 2012). 
  
 Generally, aiming at SAC has proved to be an extremely acceptable 
strategy. However, it would be worthwhile to consider focusing on regular de-
worming for not only SAC, but also, other risk groups, such as preSAC, pregnant 
women and occupationally-defined risk groups such as tea pickers or miners 
(Savioli et al., 2002; Albonico et al., 2008). Hookworm infections in particular 
are difficult to control when only SAC are targeted, as the prevalence of infection 
with this parasite increases with age, and adults (or adolescents) contribute the 
greatest share in propagating transmission (Anderson et al., 2012; Truscott et 
al., 2014). 
1.2.1.3 Mass drug administration to the population 
 In mass drug administration (MDA) to the population, also known as 
universal treatment, the whole population of a community is treated irrespective 
of age, sex, intensity of infection, or social characteristics. MDA depends on the 
estimated prevalence of particular geographic locations without prior individual 
diagnosis. With respect to other control efforts, universal treatment (targeting 
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the whole population)  is correspondingly effective and acceptable, although it is 
more expensive (requires more drugs, human power and other logistics). 
Furthermore, the delivery channels to reach the whole community may not be 
easy (WHO, 1996; Albonico et al., 1999), and thus its applicability is 
questionable. Moreover, it may increase the risk of anthelminthic drug resistance 
development. 
1.2.2 Water, sanitation, and hygiene and health education  
 Although it has been proven that PC is a key element in reducing the 
morbidity and spread of STH quickly and cost effectively, re-infection with these 
diseases will remain a problem if behaviours and the environment remain 
unchanged (Singer and Castro, 2007; Utzinger et al., 2009; Ziegelbauer et al., 
2012). The cycle of STH treatment and re-infection will likely persist until 
sanitation conditions and hygiene practices are improved. It is widely 
acknowledged that complementary interventions are indispensable to decrease 
frequency of re-infection (Bartram and Cairncross, 2010; Spiegel et al., 2010); 
that is, interventions to promote better living standards and socio-economic 
development that include improving sanitation and providing health education 
and information to the community to sustain long-term control of STH.  
 In particular, exploring ways to integrate water, sanitation, and hygiene 
(WASH)-through the provision of safe water, latrines, and improved 
environmental sanitation, as well as the promotion of hygiene and health 
education-is a vital component of control programmes. This is because access to 
improved sanitation is a key factor in integrated control programmes aimed at 
controlling transmission through the reduction of soil and water contamination 
(Utzinger et al., 2003; Mara et al., 2010). Meanwhile, health education and 
information campaigns are essential to reduce transmission through the practice 
of healthy behaviours, and through the augmentation of knowledge and skills 
regarding infection and re-infection in the public health system at central and 
peripheral levels (Albonico et al., 1999; WHO, 2002; Ziegelbauer et al., 2012). 
Additionally, each country should work in parallel to increase the accessibility of 
health care facilities to their populations as a further control measure.  
 However, since access to clean water, improved sanitation, and education 
for the wider population entail high costs, implementing this strategy is difficult 
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where resources are limited, and it may take several years before it becomes 
effective as a primary means of control. 
1.2.3. Other approaches 
 Another complimentary approach to controlling helminth infections could 
be the development of vaccines – a potential dream for the elimination of STH 
infections. More members of the scientific community are working on research 
and development in this area than ever before (Hotez et al., 2003), and existing 
hookworm vaccine initiatives could be of interest in this regard 
(http://www.sabin.org). However, despite progress made in recent years, 
including the discovery of some promising candidate vaccine antigens, there is 
still no vaccine against hookworm (Hotez et al., 2003, Loukas et al., 2006, Hotez 
et al., 2010). Yet it is clear that this type of initiative will be encouraged to 
continue and extend to other parasites as well.    
1.3 Anthelminthics recommended by the World Health Organization 
 According to the WHO Model List of Essential Drugs, four drugs are 
recommended for wide use in the control of STH (WHO, 1997): the 
aforementioned two benzimidazoles (BZ) – albendazole (ALB) and mebendazole 
(MEB), as well as levamisole (LEV) and pyrantel pamoate (PYR). Ivermectin 
(IVM) and oxantel (OX) also have an effect against human STH, and are 
considered in MDA for other neglected NTDs such as onchocerciasis, although 
they are not on the essential drug list recommended for control of STH. All of 
these anthelminthics were originally registered for use in veterinary medicine 
and are still used to treat ascarids, hookworms and whipworms in livestock, 
horses and pets. 
1.3.1 Benzimidazoles (ALB and MEB) 
1.3.1.1 Description  
 ALB and MEB are orally administered, broad-spectrum anthelminthic 
drugs. Figure 1.4 below illustrates the chemical structure of ALB, its initial 
oxidised metabolite (ALB sulphoxide) and MEB. 
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Figure 1.4 Chemical structures of albendazole (a), albendazole sulphoxide (b), 
and mebendazole (c)       
 
 As summarized in Table 1.3, both ALB and MEB are available in a 
pharmaceutical form of chewable tablets (200 or 400 mg ALB and 100 or 500 
mg MEB) as well as an oral suspension (100 mg/5 ml). While the initial 
metabolite of ALB (ALB sulphoxide) is generally considered the active metabolite 
responsible for the therapeutic activity of ALB, the MEB metabolites have no 
anthelminthic activity. 
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Table 1.3 Characteristics of albendazole and mebendazole: similarities and differences 
 
Characteristics Albendazole Mebendazole 
Chemical formula Methyl 5-(propylthio)-2-
benzimidazole carbamate 
 Methyl 5-benzoylbenzimidazole-2- 
carbamate 
Derivative  BZ-carbamate  
Pharmaceutical form Chewable tablet(200 or 400 
mg)(white to off-white, film-
coated); suspension(100 mg/5ml) 
 Chewable tablet(100 or 500 mg) (white 
to slightly yellow, powder-coated); 
suspension (100 mg/5ml) 
First Human use 1982  1995 
Administration  Orally  
Absorption  Poorly absorbed 
Increased 
with fatty meals 
 
Bioavailability Relatively=1%  22 %  
Solubility  Relative insolubility 
(aqueous solutions) 
 
    
Distribution 70% bound to plasma protein  95% bound to plasma protein 
Initial metabolite Has anthelminthic activity  Devoid of anthelminthic activity 
Metabolism Extensively metabolized, 
converted to active form(ALB-
sulphoxide) 
 Extensively metabolized, converted to 
inactive form 
Excretion In urine(<1% as active 
metabolite),or in bile and faeces  
 In urine and the bile within 24-48 hrs 
2% excreted unchanged in urine or 
faeces 
Maximum plasma 
Concentration 
Reach after 3 hrs  Reach within 2-7 hrs 
Plasma half life 4-15 hrs  3-9 hrs 
Mechanism of action  Inhibition of microtubule 
polymerization interferes 
with glucose uptake 
 
Safety  Well tolerated and safe 
(teratogenic in 
pregnancy) 
 
Sources: Horton, 2000; Rigter et al., 2004; Friedman et al., 2012;http://www.medicines.org.uk/emc/medicine/944/spc; 
(http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchType=Basic
Search&Search_Button=submit&searchTerm=Mebendazole
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1.3.1.2  Pharmacokinetics (absorption, metabolism, distribution) 
 Generally, both BZ drugs are poorly absorbed from the gastrointestinal 
tract. The main properties that influence their absorption and behaviour in the 
body are their low aqueous solubility (relative insolubility in water). In vitro 
analysis shows that both are poorly soluble in aqueous solutions. ALB is 
somewhat soluble in methanol, chloroform, ethyl acetate, and acetonitrile, and 
generally soluble in dimethylsulfoxide, strong acids, and strong bases, while MEB 
is less than 0.05% soluble in water, dilute mineral acid solutions, alcohol, ether 
and chloroform, but soluble in formic acid (Gottschall et al., 1990).   
 Oral absorption of ALB in other animals is higher: about 50% in cattle and 
20 to 30% in mice and rats as compared to humans, in whom it is only about 1 
to <5%. However, in humans, intake of fatty foods and perhaps bile salts may 
increase absorption as much as five-fold (Dayan, 2003). Moreover, there have 
been numerous attempts over the past few years to improve formulations and 
thereby increase absorption when treating systemic helminth infections. One 
example of such formulations includes the use of liposomes, which have been 
shown to be effective experimentally (in animal models) and clinically (in human 
use), suggesting that improved efficacy could be achieved using absorption 
enhancement (Hrckova and Velebny, 2001).  
 After the administration of a single oral dose (200 mg or 400 mg) of ALB, 
it is variably and intermittently absorbed. It cannot be detected in plasma 
because the drug is rapidly metabolized in the liver, and possibly, in the 
intestine, to ALB sulphoxide, which has potent anthelminthic activity (Redondo 
et al., 1999). It reaches variable maximum plasma concentrations about three 
hours after a single oral dose, and its plasma half-life is about nine hours on 
average but highly variable, ranging from 4 to 15 hours (Marriner et al., 1986; 
Gottschall et al., 1990; Marques et al., 1999). ALB sulphoxide is mostly protein-
bound (approximately 70%), distributes well to various tissues, and enters bile 
and cerebrospinal fluid – where it reaches a concentration of approximately 20% 
in plasma (Morris et al., 1987; Dayan, 2003).  
 Similarly, out of the small proportion of MEB that is absorbed (only 10%) 
approximately 95% is bound to plasma proteins and is extensively metabolized. 
A combination of poor absorption and rapid first-phase hepatic metabolism is the 
main reason for the low systemic bioavailability of MEB, which is about 22% 
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(Dayan, 2003). Moreover, MEB is rapidly metabolized, the products (conjugates 
of MEB and its metabolites) being excreted in urine and the bile within 24 to 48 
hours. In humans, approximately 2% of administered MEB is excreted 
unchanged in urine and the remainder in the faeces as unchanged drug or 
primary metabolite. 
 The activity of ALB sulphoxide and the bioavailability of the parent drug 
explain why ALB is more effective than MEB for the treatment of tissue-dwelling 
helminths. Generally, the high plasma levels of ALB sulphoxide make it effective 
against worms in adult and immature stages in various host tissues and organs 
outside the gastrointestinal tract. ALB metabolites are excreted mainly in the 
urine (<1% as active metabolite) or bile and faeces.  
1.3.1.3  Mechanism of action  
 As illustrated in Figure 1.5, both drugs have a more or less similar 
mechanism of action in the sense that they exert their action by selectively 
binding to the nematode tubulin and inhibiting the tubulin polymerase enzyme, 
which prevents the formation/assembly of microtubules and so, impedes cell 
division. The inhibition of microtubule polymerization is accomplished primarily 
by binding to free β-tubulin (Prichard, 1994; Colbourn et al., 1994). The fact 
that these two BZ drugs have higher affinity for parasite β-tubulin than for the 
same target in higher eukaryotes results in the selective toxicity of these agents 
against helminths. These drugs also impair the uptake of glucose, thereby 
increasing glycogen depletion, and hampering the formation of adenosine 
triphosphate (ATP), which is the energy source of the worms (Lacey, 1990). 
Moreover, inhibition of mitochondrial fumarate reductase (an enzyme involved in 
the energy management of the worm cells), and uncoupling of oxidative 
phosphorylation are some of the biochemical changes found in nematodes 
following exposure to BZ. 
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Figure 1.5 Flow chart describing mode of action of benzimidazoles 
1.3.1.4 Safety  
 Based on comprehensive reviews (Horton, 2000; Urbani and Albonico, 
2003) the incidence of side effects in the use of ALB for STH infections is low 
(around 1%), with only transient, mild gastrointestinal symptoms occurring. 
Similarly, MEB is also well tolerated, although abdominal discomfort and 
diarrhoea can occur in cases of severe infection where patients may complain of 
transient abdominal pain, diarrhoea, slight headache, fever, dizziness, 
Decreased uptake of nutrients 
 
 
Benzimidazoles 
 
Binding to the vacant end of β-tubulin 
 
Inhibition of polymerization of tubulin into microtubules on one side 
of microtubules while depolymerization is going on at the other side 
 
 
Loss of structure and length of microtubules 
 
Disruption of the function of microtubules 
 
Decreased intracellular transport 
of essential nutrients 
 
Breakdown of nematode cell metabolism  
Nematodes die due to lack of energy and are removed from the host 
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exanthema, urticaria, and angioedema. Moreover, MEB has low systemic toxic 
potential although high doses can cause anaemia and liver damage. As both 
drugs are extremely well tolerated, safe, and easy for paramedical and non-
medical personnel to administer in the treatment of both individuals and whole 
communities, they have an excellent safety profile.  
 However, it has been shown that BZ drugs are embryotoxic and 
teratogenic in pregnant rats, and they are not generally recommended for use 
during pregnancy (Bethony et al., 2006; Teruel et al., 2009a; Longo et al., 
2014). Although their safety for pregnant women and young children has not 
been fully established, due to ongoing and anticipated widespread use of BZ in 
global control programmes, there is a high level of interest in their use in young 
children and in the second and third trimesters of pregnancy. However, it is 
recommended that treatment should be avoided during the first trimester of 
pregnancy (Urbani and Albonico, 2003). 
1.3.1.5  Efficacy  
 Overall, ALB has broad-spectrum effect against a range of many intestinal 
nematodes and cestodes in both animals and humans. Because of the systemic 
bioavailability of its sulphoxide metabolite, it also has an effect against tissue-
dwelling nematodes and cestodes such as Echinococcus in animals (Venkatesan, 
1998). In general, for humans, a single dose of ALB (400 mg) is used in adults, 
but in children between the ages of 12 and 24 months, the WHO recommends a 
reduced dose of 200 mg. 
 ALB has high efficacy against the adult stages of Ascaris, hookworms and 
Enterobius. It is also effective against migrating larval stages (larvicidal) of 
Ascaris, hookworms and even larvae of cestodes –Taenia and Echinococcus 
(Cline et al., 1984; Horton, 1997; Garcia and Del Brutto, 2000). Finally, ALB has 
ovicidal effects on eggs of A. lumbricoides, hookworms and T. trichiura 
(Maisonneuve et al., 1985). In comparison with MEB, ALB is generally superior in 
curing hookworm infections, whereas MEB is superior to ALB for T. trichiura 
infections in children, especially when administered as a single-dose (Bennett 
and Guyatt, 2000; de Silva et al., 2003; Keiser and Utzinger, 2008). 
 A single-dose of MEB (500 mg) is effective against the adult stage of A. 
lumbricoides, but has shown low efficacy against hookworms and very low 
efficacy results against T. trichiura although still better than ALB. However, 
30   Chapter 1 
administration of 100 mg MEB on at least two consecutive days appears to be as 
effective as a single dose of ALB (400 mg) for hookworm infection and even 
better than single doses of either drug (ALB and/or MEB) against T. trichiura 
(Bennett and Guyatt, 2000; Horton, 2000). It has been suggested that heavy T. 
trichiura infection may require up to a three-day course of treatment (WHO, 
1995). 
 Currently, ALB and MEB are the two BZ drugs of choice comprising the 
mainstay of PC against A. lumbricoides, T. trichiura and hookworms. The choice 
rests on several criteria: they are both relatively efficacious, broad-spectrum, 
typically administered orally in a single dose, easy to administer, safe, and either 
cheap or available in huge amounts as donations through WHO by dedicated 
pharmaceutical companies (Montresor et al., 2002; WHO, 2008, 2010). During 
PC, different frequencies of re-treatment are selected based on the category of 
risk (prevalence) of STH in SAC, with single administration of one tablet of ALB 
(400mg) or MEB (500 mg) carried once or twice per child per year (see Table 
1.2). In short, ALB and MEB have very similar modes of action and very similar 
efficacies (measured as a reduction in faecal egg counts – FECR) after a single 
administration. Keiser and Utzinger (2008) have summarized the efficacy result 
of these two drugs as indicated in table 1.4:  
Table 1.4 Summary of efficacy results of albendazole and mebendazole against 
three soil-transmitted helminths 
 
 
 
 
 
FECR = Reduction in faecal egg count 
Sources: Bennett and Guyatt, 2000; Keiser and Utzinger, 2008 
1.3.2  Levamisole (LEV) 
1.3.2.1 Description  
 LEV is an anthelminthic compound belonging to the chemical class of the 
synthetic imidazothiazole derivatives (the laevorotatory isomer of tetramisole). 
It was first discovered at Janssen Pharmaceutica in Belgium in 1966. The 
chemical structure is shown in Figure 1.6. 
STH Species ALB (FECR%) MEB (FECR%) 
A. lumbricoides 95–100 96–99 
T. trichiura 53–89 81–90 
Hookworms 64–100 52–100 
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Figure 1.6 Chemical structure of levamisole 
 
 LEV is universally available in pharmaceutical form as chewable tablets 
(40 mg) and given at a dose of 2.5 mg/kg in a single administration. It is 
typically used in the form of chlorhydrate salts, and occasionally as a phosphate 
as well. 
1.3.2.2 Pharmacokinetics (absorption, metabolism, distribution) 
 LEV, being highly soluble in water, can be formulated for many delivery 
forms (mainly in animals) such as drenches, injectables, feed additives, tablets 
and pills. It is rapidly and almost completely absorbed from the gastrointestinal 
tract, and then quickly distributed through the whole body. In humans, peak 
plasma levels (about 0.7 µg/ml) are reached within one to two hours after oral 
administration of a single dose of 150 mg. The drug is quickly metabolized in the 
liver and has a plasma half-life of about four hours, and the metabolites are 
eliminated from the body in the urine in about two days (Kouassi et al., 1986). 
Only about 5% of the administered dose is excreted unchanged and 70% as 
metabolites through urine, and in small amounts through faeces.  
1.3.2.3 Mode of action 
 LEV acts as an acetyl-cholinesterase (AchE), an enzyme that hydrolyzes 
acetylcholine. Thus, it exerts its action through binding to the acetylcholine 
receptors of the autonomic ganglia, causing a spastic contraction followed by a 
tonic paralysis of the nematode. It thereby plays a key role in eliminating the 
helminths passively (Martin, 1993). Although it is certain that LEV primarily 
influences the neuromuscular system of nematodes, it also interferes with the 
fumarate reduction system in mitochondria, affecting the mitochondrial energy 
production, which contributes to the anthelminthic efficacy of LEV. It also 
interferes with the metabolism of carbohydrates in the helminths.  
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1.3.2.4 Efficacy 
 LEV is active against a broad spectrum of human and animal nematodes. 
It has good efficacy against Ascaris and hookworms, including A. duodenale and 
other Ancylostomidae, although N. americanus infection may require a second 
dose after one week (WHO, 1995). Generally, it is highly effective against adult 
gastrointestinal and respiratory roundworms and larvae of several species 
infecting ruminants. Besides anthelminthic activities, it also has a stimulating 
effect on cellular immune responses in humans. However, although LEV has 
been studied much less intensively than BZ in humans, the available data 
suggest that it is not markedly better than the other anthelminthics (Keiser and 
Utzinger, 2008).  
1.3.2.5 Safety 
 Generally, side effects due to LEV treatment include: nausea, vomiting, 
diarrhoea, abdominal pain, dizziness and headache, fever, influenza-like 
syndrome, arthralgia, muscle pain, rash, and cutaneous vasculitis. It is also 
contraindicated in pregnancy. Due to the occurrence of serious side effects in 
some people, it has been withdrawn in several countries, including the USA 
(2000) and Canada (2003)  
(Source: http://www.drugsupdate.com/generic/view/259 accessed on June 22, 
2013).   
1.3.3  Pyrantel (PYR) and oxantel (OX) 
1.3.3.1 Description 
 PYR is a narrow-spectrum nematicidal belonging to the 
tetrahydropyrimidines group of drugs, and is typically a pyrimidine derivative. It 
is mostly used in the form of salts (e.g., pamoate, citrate and tartrate). PYR 
pamoate, for instance, is a combination of PYR and pamoic acid. OX is the meta-
oxphenyl analogue of PYR (Figure 1.7), also belonging to the 
tetrahydropyrimidines group.       
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Figure 1.7 Chemical structure of pyrantel (a) and oxantel (b)                  
                             
 PYR is available in pharmaceutical form as chewable tablets (250 mg) and 
is given at a dose of 10 mg/kg in a single administration. OX can be 
administered at 10 mg/kg, either alone or in combination with other drugs such 
as PYR. 
1.3.3.2 Pharmacokinetics (absorption, metabolism, distribution) 
 After oral administration, PYR pamoate is poorly absorbed by the 
gastrointestinal tract (including in the gut in dogs, cats and horses) and PYR is 
insoluble in water. This allows high concentrations of unchanged drug to reach 
the large intestine. PYR tartrate is better absorbed into the bloodstream, 
especially in monogastric animals (e.g. dogs, cats, pigs and horses). This 
reduces the time it remains in the gastrointestinal system and reduces efficacy 
against gastrointestinal worms, especially those species in the large intestine 
(e.g. whipworms). For this reason, in non-ruminants the pamoate salt is 
preferred, as it is less absorbed and allows higher safety margins. Partially 
metabolized in the liver, peak plasma levels are reached in one to three hours. A 
small percentage is excreted in urine and a large amount (over half of the 
administered dose) is eliminated unchanged in faeces (Webster, 1991). Like PYR 
pamoate, after oral administration, OX pamoate is poorly absorbed, so that high 
concentrations are reached in the cecum and colon (Garcia, 1976). 
 
1.3.3.3 Mode of action 
 PYR is a cholinergic agonist that causes spastic paralysis of helminth 
muscle. That is, PYR, like any other member of the tetrahydropyrimidines group, 
acts on the nervous system of the helminths as acetylcholinesterase (AchE) 
inhibitors. Acetylcholine is a molecule involved in the transmission of nervous 
signals from nerves to muscles (known as neuromuscular junctions) and 
between neurons in the brain (known as cholinergic brain synapses). Thus, AchE 
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inhibition massively disturbs the normal movements of the parasites; it is 
followed by depolarization-induced paralysis, whereby the worms die more or 
less quickly or are expelled from the gut because they cannot keep themselves 
attached to the intestinal wall.  
 Similarly, OX exerts its anthelminthic action by paralyzing the nematodes 
(Aubry et al., 1970) and this paralytic effect is due its ability to cause a 
depolarizing type of neuromuscular block. That is, it acts as a potent agonist at 
the acetylcholine receptors on the muscle cells of nematodes, causing paralysis 
by targeting nicotinic acetylcholine receptor molecules.  
1.3.3.4  Efficacy 
 PYR is highly effective against adult gastrointestinal nematodes 
(particularly, those of dogs, cats and horses). It is also used in human medicines 
against various gastrointestinal roundworms. It has been shown to be highly 
effective and safe against human adult ascariasis (a single dose yields cure rates 
of 85 to 100%) and hookworm infections, but for heavy infections, especially 
with N. americanus, a three-day course might be necessary to reach 90% cure 
rates (Geerts and Gryseels, 2000;  Keiser and Utzinger, 2008). 
 However, PYR pamoate does not possess any significant efficacy in the 
treatment of T. trichiura despite the fact that high concentrations reach the large 
intestine (WHO, 1995). On the other hand, the OX analogue of PYR is especially 
active against Trichuris species. The two drugs, when combined, have shown 
broad-spectrum anthelminthic activity (Rim et al., 1975). 
 It has also been shown that a combination of PYR/OX (10 mg/kg) as a 
single dose offers a valuable alternative to mebendazole as a single-dose 
treatment for the control of intestinal nematodes, including Trichuris infections in 
children in endemic areas of sub-Saharan Africa, due to its comparable efficacy, 
its low cost and its suitability for use in young children (Albonico et al., 2002). 
1.3.3.5 Safety 
 PYR and/or OX are extremely well-tolerated drugs. In both, adverse 
effects are minor/infrequent, mild and transient, but include gastrointestinal 
distress/irritation, vomiting, nausea, headache, fever and dizziness. It is advised 
that they be used with caution in patients with hepatic dysfunction. They are not 
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recommended for pregnant women or for children under 12 months old. No 
adverse events have been reported after use (Albonico et al., 2002). 
1.3.4  Ivermectin (IVM) 
1.3.4.1 Description 
 IVM is a semi-synthetic analogue of avermectin B1a (abamectin), an 
insecticide developed for crop management in the mid 1970s (Figure 1.8). 
Currently, it is used extensively to control and treat a broad spectrum of 
infections caused by parasitic nematodes and arthropods (Campbell, 1993) in 
animals. In humans, it is mainly used in the treatment of onchocerciasis, but 
also effective against other worm infestations (such as strongyloidiasis, 
ascariasis, trichuriasis, filariasis, enterobiasis) and some epidermal parasitic skin 
diseases, including scabies.  
                                                                                       
     Figure 1.8 Chemical structure of ivermectin                         
 
 IVM is an odourless off-white powder available in pharmaceutical form as 
tablets or by injection and is given at a dose of 150 to 200 µg/kg in a single 
administration.  
1.3.4.2 Pharmacokinetics (absorption, metabolism, distribution) 
 IVM exhibits high lipid solubility but poor solubility in water and can be 
formulated for delivery either by mouth or injection. It does not readily cross 
the blood-brain barrier of mammals due to the presence of P-glycoprotein (Borst 
and Schinkel, 1996), although crossing may still become significant if it is given 
at high doses, in which case, brain levels peak two to five hours after 
administration (Guzzo et al., 2002). 
1.3.4.3 Mode of action 
 IVM induces a very long-lasting hyperpolarisation or depolarisation of the 
neurone or muscle cell of the nematodes through Glutamate-gated chloride 
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channels (GluCl-channels). IVM-activated channels open very slowly but 
essentially irreversibly thereby blocking further functions (Wolstenholme and 
Rogers (2005). Although it is clear that IVM do have effects on nematode γ-
Amino Butyric Acid (GABA) receptors (Feng et al., 2002), and believed to induce 
tonic paralysis and alter feeding behaviour of nematodes, current attention 
turned more to alternative GluCl-channels as the most likely molecular target for 
its action. In onchocerciasis, IVM is microfilaricidal. It does not effectively kill 
adult worms but blocks the release of microfilariae for some months after 
therapy (Arena et al., 1995; Cully et al., 1996). 
1.3.4.3 Efficacy 
 IVM, administered as a single oral dose (150 to 200 µg/kg) every 6 to 12 
months, is the drug of choice for treatment of onchocerciasis in adults and 
children five years of age and up (Goa et al., 1991). In lymphatic filariasis, a 
single annual dose of ivermectin (400 µg/kg) was both effective and safe for 
mass chemotherapy of infections with Wuchereria bancrofti and Brugia malayi 
(Ottesen and Ramachandran, 1995). It is the drug of choice for treatment of 
human strongyloidiasis at two daily doses of 150 to 200 µg/kg, (Marti et al., 
1996).  
 IVM treatment is also variably effective against other intestinal 
nematodes. It is more effective in ascariasis and enterobiasis than in trichuriasis 
or hookworm infection (Keiser and Utzinger, 2008). In the latter two infections, 
although it is not curative, it significantly reduces the intensity of infection. 
 
1.3.4.5 Safety  
 In general IVM is well tolerated by uninfected humans, but infrequent 
adverse effects due to its treatment may include fatigue, dizziness, nausea, 
vomiting, abdominal pain, and rashes. Moreover, IVM is not approved for use in 
children under five years of age or in pregnant women. Lactating women taking 
the drug secrete low levels in their milk; the consequences for nursing infants 
are unknown. Currently, the WHO recommends against IVM treatments in MDA 
campaigns for pregnant women, lactating women in the first week after birth, 
children less than 90 cm in height/15 kg in body weight, and the severely ill 
(WHO, 2006). 
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1.4 Anthelminthic resistance in humans and other challenges of 
continuous use of preventive chemotherapy 
 There are a number of concerns and challenges directly or indirectly 
related to the continuous implementation of PC programmes. One such concern 
is the possibility of emergence of anthelminthic resistance due to increasing use 
of only BZ. Others relate to safety, poor understanding of the pharmacology of 
BZ, frequency of re-treatment, low coverage of PC so far, lack of integration of 
PC with other control measures, and failure to target key risk groups. These 
issues are discussed in more detail below.  
 
1.4.1 Anthelminthic resistance in humans 
 The most pressing concern for the future in the era of PC programmes is 
the possible emergence of resistance against the administered anthelminthic 
drugs. Since anthelminthic drug resistance is already a severe problem in 
veterinary medicine, it is only a matter of time before it becomes a worldwide 
problem in human medicine. 
 It has been suggested that the major mechanism of BZ drug resistance in 
nematodes involves the selection of a naturally occurring ‘resistant’ genotype 
involving a Phenylalanine Tyrosine change at position 200 of β-tubulin 
(Sangster and Gill, 1999). Although some previous studies have shown low 
efficacy (treatment failures) of single-dose ALB and MEB for the treatment of 
hookworm and Trichuris infections (Albonico et al., 1994; Adams et al., 2004; 
Flohr et al., 2007), drug resistance has not been fully demonstrated for human 
STH. Evidence for a selection pressure on the β-tubulin gene at position 200 is 
indicated for T. trichiura possibly explaining the reduced efficacy of ALB against 
this parasite (Diawara et al., 2009). The availability of even such minimal 
evidence of widespread dissemination of resistant forms is already a warning 
signal. However, the empirical evidence of drug resistance in human STH is still 
poor (Vercruysse et al., 2011).  
 In addition to the issue of anthelminthic resistance; the fact that BZ 
efficacy is not optimal for all species of STH, the contraindication of BZ in early 
pregnancy, and the paucity of comprehensive data on the pharmacology of both 
drugs in humans (Dayan, 2003) are reasons enough to seek possible 
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alternatives, either to optimize the available anthelminthic drugs or discover new 
ones. 
 One such alternative could be the use of a combination of OX with either 
ALB or MEB. Recent work has confirmed the excellent trichuricidal properties of 
OX pamoate, although it has no effect on hookworms. On the other hand, OX-
ALB combination has shown a promising result, which calls for further in-depth 
studies on drug combinations such as OX-MEB, OX-ALB or others as alternatives, 
including dosing and regimens (Keiser et al., 2013; Speich et al., 2014). Earlier 
studies have also shown and recommended that a single-dose mixture of OX and 
PYR pamoate is a highly effective and acceptable treatment for multiple 
infections with STH (Rim et al., 1975; Albonico et al., 2002).  
 Moreover, taking advantage of the geographic overlap of STH with other 
NTDs, it is possible to target these conditions simultaneously by combining drugs 
in an integrated ‘rapid-impact package’ (Molyneux et al., 2005; Hotez et al., 
2006). It is also equally important to ensure access to good quality 
anthelminthic drugs at all levels of the health care system in endemic areas. 
 
1.4.2 Other issues regarding the continuous use of preventive chemotherapy 
 Apart from fear of the emergence of anthelminthic resistance, there are a 
number of other concerns and challenges related to the continuous use of PC, as 
follows:  
 (i) Safety: The introduction of drug distribution to target groups or 
populations raises the issue of drug safety. When treatment is not under health-
sector supervision, the community needs full assurance that treatment will be 
safe and provided to meet the intended use and level of acceptance.  
 (ii) Poor understanding: Many gaps remain in our understanding of the 
pharmacology of the BZ drugs, despite remarkable efforts of some researchers 
in reviewing the existing knowledge and forwarding their urgent 
recommendations (de Silva et al., 1997; Albonico et al., 1999; Horton, 2000; 
Dayan, 2003; Albonico et al., 2004; Utzinger and Keiser, 2004). These gaps, 
which have been noted in the review of the uses, effects and modes of action of 
the drugs in section 1.3 as well as in 1.4.1 above, represent a challenge to the 
continued successful use of these drugs, as they leave us poorly equipped to 
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understand or monitor the emergence of drug resistance, and constrain attempts 
to look for new treatment options. 
 (iii) Timing/frequency of re-treatment: There is a lack of practical 
modelling to resolve key questions about how often drugs should be 
administered in mass PC programmes, and preferred seasons for administration 
to optimize effectiveness, so these issues remain a challenge.  
 (iv) Low coverage: As previously noted in this review, only about 36.0% 
of SAC and 24.7% of preSAC in areas affected by STH have been receiving 
regular treatments with either ALB or MEB (WHO, 2014), indicating very low 
coverage until now.  
 (v) Lack of integration with other control measures: PC must be supported 
by political commitment and synergized with socio-economic development, since 
long-term success depends on the integration of other control measures such as 
WASH together with chemotherapy.  
 (vi) Failure to target key risk groups: The targeting of SAC only is another 
challenge, particularly when it comes to hookworm treatment, as infection 
prevalence increases with age and the consequences of this infection are also 
serious in other risk groups. Hence, it is of paramount importance to extend PC 
to other segments of the population at high risk to hookworm infection, or if 
possible, to target the whole community (Brooker et al., 2004; Christian et al., 
2004; Albonico et al., 2008).  
1.5 The monitoring of drug efficacy in preventive chemotherapy 
programmes  
 It is vital to monitor drug efficacy in large-scale interventions to reduce 
the incidence of infection and associated morbidity and mortality due to STH, not 
only to demonstrate health benefits, but also to assess cost-effectiveness and 
show that drugs and other logistics from donor agencies have been used wisely.  
 From the health standpoint, there is now ample evidence clearly 
demonstrating that regular treatment of STH infections produces immediate as 
well as long-term benefits, significantly contributing to the development of 
affected individuals, particularly children (Savioli et al., 1992; Crompton and 
Nesheim, 2002; WHO, 2005).  
 However, given the scarcity of suitable alternative anthelminthics it is 
crucial for monitoring programmes to be introduced to assess the progress and 
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effectiveness of interventions and to detect any changes in therapeutic efficacy 
that may arise from a parasite's potential to develop resistance (Albonico et al., 
2004).  
1.5.1. How to monitor drug efficacy 
 Monitoring the efficacy of drugs is not straightforward, as it is subject to 
many factors, either inherent or external. This may lead to significant variation 
in efficacy monitoring results. Hence, the factors at different levels should be 
considered well in advance to help exercise more caution in the interpretation of 
results and distinguish between reduced efficacy and drug resistance.  
1.5.1.1 Indicators of drug efficacy 
 Efficacy is determined by measuring the change in faecal helminth egg 
output in an individual pre-and post-treatment with a given drug at an optimal 
interval of time. In STH infections of humans, this can be done either through 
determination of the cure rate (CR), expressed as the percentage of subjects 
excreting no eggs after drug administration, or by measuring faecal egg count 
reductions (FECR). These are the two most commonly used efficacy indicators.
 However, the meaning and interpretation of these indicators varies 
according to different health viewpoints. Some researchers prefer the use of CR 
to FECR, while others suggest the use of FECR is better. Yet in the latter case, 
the application of different formulas to calculate FECR by different researchers 
produces different FECR results, making it difficult to use FECR as an accurate 
and good indicator of drug efficacy (Kopp et al., 2008; Montresor, 2011). 
 Furthermore, there is some controversy regarding the use of CR and FECR 
as indicators in monitoring drug efficacy against human STH. Although Bennett 
and Guyatt (2000) reported both CR and FECR in their analysis of published ALB 
and MEB efficacy monitoring data, they observed a noticeable variation when the 
CR is the analysed endpoint. Whereas Keiser and Utzinger (2008) were only able 
to use CR as the primary outcome measure in their systematic review and meta-
analysis of the efficacy of single-dose oral ALB and MEB, as there was an 
insufficient number of valid studies reporting FECR.  
 Generally, wide variations in efficacy results are found, even in trials in 
which the same drug is given at the same dosage. Different co-morbidities (such 
as gastrointestinal diseases, immunodeficiency, malnutrition, etc.) and several 
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other factors may influence the efficacy of anthelminthic drugs, thus hindering 
the comparison of efficacy results by different investigators. Further 
exacerbating the problem is that methods for detecting eggs and analysing data 
are not fully synchronized. Additionally, much of the CR and FECR data 
investigated by different studies cannot be directly compared as many of these 
studies are confounded by differing methodological considerations and study 
designs (Keiser and Utzinger, 2008). Those and other factors are described in 
more detail in the next section. 
1.5.1.2 Factors affecting drug efficacies 
 Among the many factors, the following are thought to be most important 
in accounting for the variations in efficacy and should be considered well in 
advance and minimized if it is not possible to avoid them: (i) lack of use of 
standardized parasitological techniques, (ii) different intervals of post-treatment 
follow-up, (iii) different intensity levels at baseline, (iv) sample size, (v) age 
group of study subjects, (vi) quality of the drug, (vii) treatment regimens and 
dosing, (viii) diverse statistical measurements of intensity, and (ix) possible 
presence of drug resistant parasites/variable parasite strains (Albonico et al., 
1999; Bennet and Guyatt, 2000).  
 i. Lack of use of standardized parasitological techniques: It is generally 
agreed that there is significant day-to-day and intra-specimen variation in 
helminth egg output. Parasitological techniques used to examine the eggs also 
vary, mainly in their sensitivity, particularly for low-infection intensities 
(Utzinger, 2003; Goodman et al., 2007). The majority of investigators have 
overlooked the effect of the sensitivity of the methods they used as one factor. 
Moreover, with regard to diagnostic approach, different trials have evaluated 
drug efficacy based on either a single stool sample per individual, examined 
before and after treatment employing only one diagnostic test, or two samples 
over consecutive days, resulting in different efficacy results based on CR (Keiser 
and Utzinger, 2008). Therefore, we need to adopt standard operating procedures 
so that monitoring systems yield comparable results and avoid confounding 
variables that may affect drug efficacy arising from different parasitological 
techniques.   
 ii. Interval of post-treatment follow-up: When evaluating drug efficacy, 
data for calculating this indicator should be collected no later than three weeks 
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after treatment. The optimal period is 7 to 14 days, as all dead worms and 
remaining eggs are eliminated during this interval. A follow-up during the pre-
patent period may also be indicative for efficacy against both adult and 
immature stages. However, the interval between pre- and post-treatment should 
be adapted to each parasite species and to the drugs used. For instance, for 
hookworms, a period of about two weeks is appropriate. A longer period would 
allow immature or even new infections to become patent, while a shorter one 
may overestimate efficacy, since some drugs temporarily suppress egg 
production without killing the worms (Geerts and Gryseels, 2000). Thus, 
monitoring after the pre-patent period is not recommended to avoid counting 
any possible cases of re-infection that may have occurred, and results are not 
indicative for efficacy.  
 iii. Baseline intensity levels: This is one of the parasite-related factors, 
whereby infection intensity and worm fecundity vary and may affect the efficacy 
of an anthelminthic drug. For instance, at a given dose, when the intensity of the 
infection is high, the indicator of efficacy might be reduced, affecting the final 
interpretation of the efficacy results. Drops in CR and FECR at high intensities of 
T. trichiura and hookworm infections have been demonstrated when the drug 
efficacy data were separately analysed by class of intensity (Bennett and Guyatt, 
2000). The WHO classification of intensity is shown in (Table 1.5). 
 
Table 1.5 Classes of infection intensity for soil-transmitted helminths 
(Montresor et al., 1999) 
 
Parasite Light-intensity 
infection 
Moderate-intensity 
infection 
Heavy-intensity 
infection 
A. lumbricoides 1-4,999 EPG  5,000-49,999 EPG >50,000 EPG 
T. trichiura     1-999 EPG 1,000-9,999 EPG >10,000 EPG 
Hookworms  1-1,999 EPG 2,000-3,999 EPG    >4,000 EPG 
EPG = eggs per gram of stools 
 Moreover, efficacy variation is further affected by the fact that egg counts 
are an inadequate measure of adult worm abundance in veterinary, and 
probably in human parasitic infections (Kopp et al., 2008; Kotze and Kopp, 
2008). For instance, in hookworms there is an inverse correlation between adult 
worm number and the fecundity of female worms. The fecundity of the 
remaining worms after drug administration increases, and hence thwarts the 
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interpretation of drug efficacy summarized by means of FECR (Kopp et al., 
2008). 
 iv. Sample size:  The different sample sizes employed by different 
investigators might have an influence on the power of the analysis, hence 
confounding the results. Keizer and Utzinger (2008) indicated in their systematic 
review and meta-analyses that the sample sizes in several of the trials they 
reviewed consisted of fewer than 50 individuals infected with a specific STH and 
treated with an anthelminthic drug. They concluded that such trials were likely 
underpowered, impeding comparison with efficacy trials in studies that used 
larger sample sizes. 
 v. Age group enrolled: The underlying distribution of parasite numbers per 
host (intensity) is central and it exhibits heterogeneity in different age groups. 
Moreover, changes in behaviour, exposure, immune responsiveness and/or 
physiology may cause a child’s worm burden to change markedly with age and 
therefore, from one year to the next. This will influence the baseline infection 
level; the proportional reduction in infection after chemotherapy; the rate of re-
infection; and the estimated impact of treatment. Moreover, the efficacy of BZ 
may depend on the main mechanism of action, and on their ability to reach high 
and sustained concentrations at the sites where parasites are located. This, in 
turn, depends on host-related pharmacokinetic, metabolic and tissue distribution 
factors (Lanusse and Prichard, 1993), which can all be affected by age. Thus, 
monitoring only in one age group/class may not provide robust measures of drug 
efficacy results. 
 vi. Quality of the drugs:  Drugs must be manufactured according to good 
manufacturing practice and be of sufficient quality to perform as required in 
control programmes. Nevertheless, variations between batches in the quantity of 
the active ingredient in a pharmaceutical formulation, its bioavailability, and 
degradation during storage/transport may result in inconsistent efficacy results. 
It is also acknowledged that there are many counterfeit drug products available 
on the market and that these may be used unconsciously in control programmes 
(Albonico et al., 1999). Thus, it is necessary to verify that the product is not 
counterfeit or sub-standard and actually contains the stated active compound. 
As well, it must meet the International Pharmacopoeia standard of dissolution 
and disintegration times, which may affect drug efficacy (Albonico et al., 2007). 
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 vii. Different treatment and dosing regimens:  Efficacy results may vary 
depending on the treatment regimens and dosing regimens. For example, ALB is 
effective in a single dose against A. lumbricoides, and it is also active against 
both species of hookworm, in contrast to MEB, which is principally active only 
against A. duodenale at single dose. There is, however, some evidence 
suggesting that very heavy infections with N. americanus may require more than 
one dose to achieve a complete cure. Moreover, dosing over three days may be 
required to cure heavier T. trichiura infections. Apart from affecting efficacy 
results, under-dosing selects for the development of anthelminthic resistance in 
target parasites, which may represent a major concern in human medicine 
(Horton, 2000). 
 viii. Diverse statistical measurements of intensity: Different investigators 
used either geometric or arithmetic means during the calculation of FECR to 
assess drug efficacy. However, there is evidence that geometric means provide a 
biased efficacy result when conducting a FECR (Dobson et al., 2009). Hence, 
lack of uniformity in the use of statistical measurements will present variable 
(either overestimating or underestimating) efficacy results.  
 ix. Other possible factors contributing to variable efficacy results may 
include: the possible presence of drug-resistant parasites, previous PC history, 
geographic differences among STH species, diet, health status of the child and 
level of immunity, rate of intestinal transit, episodes of vomiting during 
treatment, and faecal consistency.  
 The scale-up of chemotherapy programmes with BZ currently underway in 
various parts of Africa, Asia, South America will likely exert a drug pressure on 
the parasites, and this has the potential to select for parasite genotypes that can 
resist anthelminthics. However, it is important that reduced efficacy be 
differentiated from anthelminthic resistance, as many potential factors may 
affect the efficacy of an anthelminthic, and should first be excluded before 
anthelminthic resistance is assumed. Amusingly, many investigators have not 
seriously looked into the possible factors that might have contributed to and 
affected their efficacy trial endpoints. It is also important to note that all the 
aforementioned factors are not an exhaustive list, and many factors remain to 
be identified. 
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1.6 Benzimidazole drug efficacy studies in school-aged children in Africa 
 The following section summarizes a number of efficacy studies published 
from 1980 to 2011 on trials conducted to assess the efficacy of single-dose ALB 
and MEB against STH in children in Africa. For each trial the following aspects 
are reported (if available): the country in which the study was done, the year, 
the number of study subjects, the post-intervention time, and the CR and FECR 
for each STH covered by the study concerned. 
 The studies are summarized in Tables 1.6, 1.7 and 1.8 for ALB and Tables 
1.9, 1.10, and 1.11 for MEB. In general, most anthelminthic drug efficacy 
studies reported in Africa in the last three decades are limited to certain 
geographical areas/countries. Hence, the results are neither comprehensive nor 
representative of the whole continent, as the prevalence/intensity of STH 
infections may diverge strongly in different regions of Africa. Moreover, there is 
variation among the studies in terms of the duration of follow-up after 
treatment, statistical measurements, and to some extent, dosage and treatment 
regimens. Consequently, it is difficult to compare these studies, as they may be 
confounded in many ways.  
 
1.6.1 Albendazole  
 As indicated below (Tables 1.6, 1.7 and 1.8), very few studies have been 
conducted to evaluate the efficacy of ALB against the three main STHs in SAC in 
Africa: A. lumbricoides (7), T. trichiura) (10), hookworm (7).   
1.6.1.1 Ascaris lumbricoides  
 According to the seven studies identified, ALB has shown fair to excellent 
efficacy results against A. lumbricoides, both in terms of CR (91.3 to 100%) 
when the Kato-Katz diagnostic method was used, and FECR (>97%), regardless 
of the variation in length of post-treatment follow-up, except for one study that 
reported a very low FECR (52.2%) as evaluated 90 days post-treatment 
(Nkengazong et al., 2010). Since most of the studies used Kato-Katz, diagnostic 
method is not considered as factor explaining the variation in efficacy results in 
the present review. These findings– showing that ALB is efficacious against A. 
lumbricoides provided that post-treatment evaluation is done within three 
weeks–are consistent with those reported in the rest of the world, as 
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summarized in many published studies (Olsen, 2007; Reddy et al., 2007; Keiser 
and Utzinger, 2008). 
Table 1.6 Albendazole efficacy trials against Ascaris lumbricoides in school-
aged children in Africa 
 
 CR: Cure rate; FECR: reduction in faecal egg count; *FECR is based on 
geometric mean  
1.6.1.2 Trichuris trichiura 
 Of the ten studies done to evaluate the efficacy of ALB against T. trichiura, 
six are from the same country (Tanzania), representing only one confined 
geographical area. Nine studies used 400 mg ALB as a single dose, while one 
used 400 mg twice at an eight-hour interval (Namwanje et al., 2011). However, 
the length of post-treatment duration varies extremely (ranging from 7 to 120 
days). Equally, there was a huge variation in the size of the samples analysed 
among the trials and across the different countries, ranging from 66 to 1,942 
individuals.  
 
 
 
 
 
Country Year  Sample 
size 
Age-
range 
Dose 
(mg) 
Follow-up 
Interval  
(days) 
CR 
(%) 
FECR  
(%)* 
Reference 
Tanzania 1992 1,174 6-12 400  21 98.9 99.6 Albonico et al       
(1994) 
Tanzania 1992 377 6-12 400  21  99.9 Albonico et al 
(1995) 
  377 6-12 400  120  97.4  
Tanzania 2009 430 _ 400  14 98.2 97.0 Albonico et al 
(2011) 
Tanzania 2009 240 _ 400  21-35 91.3 99.9 Knopp et al 
(2011) 
Ethiopia 2003 130 6-19 400 21 99.9 99.9 Legesse et al 
(2004) 
Kenya 2004 1,942 4-18 400  60 100.
0 
100.0 Kihara et al 
(2007) 
Cameroon 2007 82 1-20 400 90 82.0 52.2 Nkengazong et al 
(2010) 
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Table 1.7 Albendazole efficacy trials against Trichuris trichiura in school-aged 
children in Africa 
 
CR: Cure rate; FECR: reduction in faecal egg count; *400 mg albendazole used 
two times at eight-hour interval. Note: most of the studies used Kato-Katz as a 
diagnostic method. 
 
 Overall, the CRs observed were below 20% for the majority of the studies 
when the efficacy evaluation was made between 14 and 21 days post-treatment, 
but the FECRs varied considerably among the trials even when evaluated during 
the same interval period. 
1.6.1.3 Hookworms 
 Of the seven studies done to evaluate the efficacy of ALB against 
hookworms, five indicated FECRs of >90% regardless of post-treatment interval 
Country Year  Sample 
size 
Age-
range 
Dose 
(mg) 
Follow-up 
Interval  
(days) 
CR 
(%) 
FECR  
(%)* 
Reference 
Tanzania 1992 377 6-12 400  21  57.8 Albonico et al 
(1995) 
Tanzania 1992 1174 6-12 400 21 73.3 99.6 Albonico et al 
(1994) 
Tanzania 2009 430 4-18 400  14   Albonico  et al 
(2011) 
    400  14    
Tanzania 2009 240  400  21-35 18.9 87.6 Knopp et al 
(2010) 
    400  21-35 9.7 80.7  
Tanzania 2009 140 >5 400 22-29 10.0 40.0 Knopp et al 
(2010) 
    400 14 2.1 23.7  
    400 21 6.0 37.3  
    400 28 15.4 54.9  
  96  400 * 7 50.0 94.8  
     14 10.3 51.6  
     21 17.7 66.2  
     28 43.4 89.3  
Ethiopia 2003 130 6-19 400  60 17.0 69.8 Legesse et al 
(2004) 
    400 120  61.5  
Kenya 2004 1942 4-18 400 60 14.3 45.0 Kihara et al 
(2007) 
Uganda 2005 66 6-15 400  7 8.0 89.0 Olsen et al 
( 2009) 
  67 6-15 400  14 0.0   
Uganda 2009 101 5-14 400 7 36.2 89.7 Namwanje et 
al (2011) 
Cameroon 2007 82 1-20 400 90 84.6 55.0 Nkengazong 
et al (2010) 
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variation (between 21 and 90 days). This is surprising if one considers the post-
treatment interval a possible factor affecting the efficacy results.  Seven of the 
studies evaluated the CR as well, and results varied from 56.8 to 97.8% as 
evaluated between 14 and 21 days post-treatment (Table 1.8). The lowest CR 
(56.8%) observed (Albonico et al., 1994) might be due to one or more of the 
factors identified above. One study evaluated the efficacy of using a dosage of 
200 mg ALB for three consecutive days and reported both a CR and FECR of 
100% (Nkengazong et al., 2010). 
 
Table 1.8 Albendazole efficacy trials against hookworms in school-aged 
children in Africa 
CR: Cure rate; FECR: reduction in faecal egg count; * 200 mg albendazole used 
for three days; Note: majority of the studies used Kato-Katz as diagnostic 
methods. 
 
 In general, it has been shown that repeated doses of 400 mg ALB, but not  
higher single doses, achieve much better efficacy against hookworms than the 
single 400 mg dose, whereas both increased single doses (such as 600 mg) and 
repeated doses of ALB 400 mg improve efficacy against T. trichiura (Horton, 
2000). This is also reflected in the African studies covered in this review, 
suggesting that a broader range of studies comparing different doses and 
regimens are still needed to identify optimal treatment for PC application 
strategies in Africa.  
Country Year Sample 
Size 
Age-
range 
Dose 
(mg) 
Follow-up 
Interval  
(days) 
CR 
(%) 
FECR 
(%)* 
Reference 
Tanzania 1992 377 6-12 400 21  97.7 Albonico et al 
(1995) 
Tanzania 1992 1,174 6-12 400 21 56.8 97.7 Albonico  et al 
(1994) 
Tanzania 2009 430  400 7   Albonico et al 
(2011) 
    400 14 97.8   
Tanzania 2009 240  400 21-35 61.2 89.9 Knopp et al 
(2011) 
    400 21-35 69.4 65.5  
Kenya 2004 1,942 4-18 400 60 95.1 96.0 Kihara et al 
(2007) 
Cameroon 2007 82 1-20 200* 90 100 100 Nkengazong  
et al (2010) 
Côted’Ivoire 2007 52 6-13 400 15-20 97.6  Scherrer et al 
(2009) 
     22-44 71.0   
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1.6.2. Mebendazole 
As indicated below (Tables 1.9, 1.10 and 1.11), even fewer studies have been 
done to evaluate the efficacy of MEB against the three main STH in SAC in 
Africa: A. lumbricoides (7), T. trichiura) (10), hookworm (4).   
1.6.2.1 Ascaris lumbricoides 
 The seven studies to evaluate MEB efficacy against A. lumbricoides were 
all conducted at 21 days post-treatment. Four out of the seven studies used 500 
mg MEB whereas three studies used 100 mg doses of three different brands of 
MEB twice a day for three consecutive days (Legesse et al., 2004). As indicated 
in Table 1.9, MEB has shown very good efficacy against A. lumbricoides: six 
studies showed CRs and FECRs of >96%; and one study indicated a relatively 
low CR of 93.0% (Legesse et al., 2004) and the authors concluded this could be 
due to the variation in quality among the different brands of MEB they used from 
different companies. 
 
Table 1.9 Mebendazole efficacy trials against Ascaris lumbricoides in school-
aged children in Africa 
 
CR: Cure rate; FECR: reduction in faecal egg count; *100 mg MEB twice a day for 
three days (Vermox, J &J); ** 100 mg MEB twice a day for three days (Unibios, 
India); *** 100 mg MEB twice a day for three days (East African Pharmaceutical)  
 
1.6.2.2 Trichuris trichiura 
 Eight of the ten studies evaluating the efficacy of MEB against T. trichiura 
were done in Tanzania. MEB 500 mg was used except in one study (100 mg); 
Country Year Sample 
Size 
Age-
range 
Dose 
(mg) 
Follow-up 
Interval  
(days) 
CR 
(%) 
FECR 
(%)* 
Reference 
Tanzania 1992 354 6-12 500  21  99.9 Albonico et al 
(1995) 
Tanzania 1992 1,120 6-12 500  21 99.9 97.7 Albonico et al 
(1994) 
Tanzania 1999 236  500  21 96.5 99.9 Albonico et al  
(2003) 
Tanzania 2000 448 6-9 500  21 98.0 96.1 Albonico et al 
(2002) 
Ethiopia 2003 138 6-19 100* 21 96.6 99.9 Legesse et al 
(2004) 
  123 6-19 100** 21 99.9 99.9  
  143 6-19 100*** 21 93.0 99.9  
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one study used 500 mg per day for three consecutive days and the rest, 500 mg 
as single one-time dose. When efficacy was evaluated at an interval of 14 to 21 
days post-treatment, the CR ranged from 10 to 20% and the FECR, from 45 to 
85%, regardless of single or repeated doses of 500 mg (Table 1.10).  
 
Table 1.10 Mebendazole efficacy trials against Trichuris trichiura in school-aged 
children in Africa 
 
CR: Cure rate; FECR: reduction in faecal egg count; *500 mg twice a day for 
three days ** 100 mg MEB twice a day for three days (Vermox, J &J)); *** 100 
mg MEB twice a day for three days (Unibios, India); **** 100 mg MEB twice a 
day for three days (East African Pharmaceutical)  
 
 The trials in which a  dose of 100 mg twice per day for three consecutive 
days was used showed a significant overall increase in CR (28.0 to 90.0%) and 
in FECR of over 88% (Albonico et al.,2002;Legesse et al., 2004). The most 
striking result in Legesse et al., 2004 study is the huge variation in CR (53.5 to 
90%) despite the fact that all other confounding factors seemed to be the same 
Country Year  Sample 
Size 
Age-
range 
Dose 
(mg) 
Follow-up 
Interval  
(days) 
  CR     
 (%) 
FECR 
(%) 
Reference 
Tanzania 1992 1120 6-12 500 21 14.2 81.6 Albonico et al 
(1994) 
Tanzania 1992 354 6-12 500  21  77.2 Albonico et al 
(1995) 
    500 120  50.8  
Tanzania 1999 236  500  21 22. 81.0 Albonico et al  
(2003) 
Tanzania 2000 448 6-9 500  21 25.2 83.6 Albonico et al 
(2002) 
  143 6-19 100**** 21 28.0 88.5  
Tanzania 2009 138 >5 500* 22-29 19.0 67.0 Knopp et al 
(2010) 
Ethiopia 2003 138 6-19 100** 21 90.0 90.0 Legesse et al 
(2004) 
  123 6-19 100*** 21 53.5 96.5  
Uganda 2009 105 5-14 500 7 25.6 84.7 Namwanje et 
al (2011) 
    500 14 7.6 45.4  
    500 21 11.4 54.9  
    500 28 20.4 66.7  
  108  500  7 31.9 90.3  
     14 14.0 63.6  
     21 10.6 57.2  
     28 41.9 90.2  
Chapter 1:  Control of Soil-Transmitted Helminthiasis: A Literature Review                                51 
   
(study site, study time, age group, parasitological technique, length of interval, 
statistical analysis, etc.) except the difference in the brands of the MEB used. 
Thus, one might attribute such variation to the quality of the drugs.  
 
1.6.2.3 Hookworms 
 The four studies evaluating the efficacy of MEB against hookworms were 
all done in Tanzania and involved a single 500 mg dose of MEB. The follow-up 
interval was at 21 days post-treatment in all except one case where it was 120 
days post-treatment (Table 1.11). There was a considerable variation both in 
CR, ranging from 7.6 to 85%, and in FECR, ranging from 52.1 to 87.6%.  
Table 1.11 Mebendazole efficacy trials against hookworms in school-aged 
children in Africa 
CR: Cure rate; FECR: reduction in faecal egg count 
 
1.6.3  Discussion  
 This review of BZ drug efficacy studies in school-aged children in Africa 
shows that there is a lack of consensus on the definition of efficacy or 
standardization of multiple indicators of morbidity in the evaluation of the impact 
of anthelminthic drugs in PC programmes. It points to the need for standardized 
methods and tools developedd for use in large-scale chemotherapy-based 
control programmes to better define and monitor the negative health 
consequences of helminth infections that may be reversed by treatment.  
 Overall, this review has noted the variation in the length of time between 
treatment and post-treatment follow-up as a major factor that vary across 
studies done so far in Africa. The other possible factors are: (i) differences in the 
brands of the drugs (might be a quality issue), (ii) lack of wide coverage (limited 
to very few geographical areas/countries) (iii) use of different sampling 
Country Year Sample 
Size 
Age-
range 
Dose 
(mg) 
Follow-up 
Interval  
(days) 
CR 
(%) 
FECR 
(%) 
Reference 
Tanzania 1992 354 6-12 500  21  83.0 Albonico et al 
(1995) 
     120  87.6  
Tanzania 1992 1120 6-12 500  21 22.4 82.4 Albonico et al 
(1994) 
Tanzania 1999 236  500  21 7.6 52.1 Albonico et al 
(2003) 
Tanzania 2000 448 6-9 500  21 85.0 67.0 Albonico et al 
(2002) 
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techniques (either two slides per sample or two samples per single subject) (iv) 
differences in FECR calculations (while most used a geometric mean, a few used 
an arithmetic mean), and (v) to some extent, differences in dose and treatment 
regimens. 
  All these variations in one way or another influence the endpoint, i.e., the 
CR and FECR, and in turn lead to the variable conclusions drawn from such 
studies. It should also be noted that a rigorous evaluation of the geographic 
variation in efficacy of these drugs against STH is lacking, and the available data 
may not reflect the real picture in Africa. Hence, the possible differences in allele 
frequency in populations across the continent that could contribute to differences 
in efficacy are totally unknown. 
1.7 Overall conclusions 
 Currently, drug administration in the form of PC is the stronghold strategy 
to control STH. BZ drugs are presently the drug of choice because of their 
relatively good efficacy for most STH species, safety, dosing (as they do not 
require weight-based dosing) and ease of administration in the treatment of 
individuals and/or whole communities. However, the present strategy of STH 
control through PC is not as straightforward and effective as might at first be 
anticipated. As revealed by this review of the literature, there are a number of 
gaps that need to be filled.  
 First, the frequency of PC is based on the prevalence of STH in a given 
affected community, yet still little is known about the demographic, socio-
economic and environmental determinants that explain variations in STH 
infections both within and across populations. This, in turn, might limit how 
national governments and international organizations define, and target 
resources to combat, the disease burden due to STH infection.  
 Second, the efficacy of the two commonly-used BZ drugs (ALB and MEB) 
varies across STH species. Factors accounting for such variations remain poorly 
defined. Among other factors under consideration is the contribution of baseline 
infection intensity, which requires in-depth investigation under varying 
epidemiological settings and infection-intensity levels.  
 Third, despite the global expansion of PC, standard operating procedures 
to monitor anthelminthic drug efficacy are lacking. Hence, standardizing clinical 
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trials, determining therapeutic efficacy thresholds, and identifying appropriate 
indicators of efficacy are crucial for future improvement of control programmes.  
 Fourth, there are a number of factors that affect and complicate the 
assessment of drug efficay (such as age group, drug resistant parassites, quality 
of drugs, previous history of PC, diet, etc). Those factors need to be further 
studied.  
 Fifth, healthcare decision-makers have a limited repertoire of strategies 
for rapid assessment of infection intensity and for checking drug-resistance 
development. Hence, searching for simplified fieldwork strategies for, and cost-
effective approaches to, screening a large population remains an important 
research topic in this era of PC programmes.  
 Overall, there are a limited number of alternative anthelminthic drugs 
available today, and this underscores the need for a well-designed research 
protocol that might address the concerns raised in the course of control 
programme implementation and drug efficacy monitoring. The present PhD 
thesis was formulated based on the paucity of the body of knowledge regarding 
these concerns, and is devoted to generating scientific evidence to allow us to 
close the existing gaps in our knowledge.  
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 The general objective of this PhD is to improve the control of soil-
transmitted helminthiasis in school-aged children in Jimma Town.  
 
Jimma is the capital of Jimma zone (one of the seventeen zones) in Oromia 
regional state of Ethiopia. It is situated about 350 kilometers (southwest) away 
from Addis Ababa. The zone has a total area of 19,293.5 square kilo meters 
(details of the study area is described in chapter 2).  
 
The four specific objectives are:  
 
1. To determine the seasonal prevalence and intensity of soil-transmitted 
helminth infections among school-aged children in schools in Jimma Town. 
 
2. To determine the efficacy of single dose albendazole and mebendazole against 
soil-transmitted helminths in school-aged children in Jimma Town. 
 
3. To determine the repeated doses of albendazole and mebendazole against 
Trichuris trichiura in school-aged children in Jimma Town 
 
4. To develop a rapid and cost effective diagnostic strategy to assess the 
infection intensity and efficacy of anthelminthics 
  
Chapter 2 
 
Assessment of Seasonality in Soil-
Transmitted Helminth Infections 
across 14 Schools in Jimma Town, 
Ethiopia: a Meta-Analysis 
 
 
 
 
Based on: 
Mekonnen Z, Bogers J, Vercruysse J, Levecke B (2014) Assessment of 
seasonality in soil-transmitted helminth infections across 14 schools in Jimma 
Town, Ethiopia: a meta-analysis (in preparation).  
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2.1 Introduction 
 Up to date, the mass drug administation (MDA) is the only strategy in 
control programmes targeting soil-transmitted helminths (STH). The frequency 
of these MDA is based on the overall STH prevalence, drugs being administered 
annually when the prevalence is at least 20% but less than 50% or bi-annually 
when the prevalence exceeds 50% (WHO, 2002, 2006; Montresor et al., 2012; 
see Table 1.2 of chapter 1). When the prevalence is less than 20%, it is 
recommended to provide a case-by-case (individual-based) treatment. However, 
the overall STH prevalence may be affected by climatic and/or seasonal changes. 
Adequate moisture and warm temperature are essential for egg/larval 
development in the soil (Brooker et al., 2006; Chen et al., 2008; Pullan and 
Brooker, 2012). For example, the eggs of of A. lumbricoides and T. trichiura will 
not embryonate at low humidity, whereas higher humidity is associated with 
faster development of eggs (Lorcan and Holland, 2000; Crompton, 2001), and 
hence influencing the transmission and eventually the prevalence estimates of 
STH. Furthermore, there is evidence that in rainy seasons, pre-parasitic stages 
of worms might survive in the environment, and subsequently increasing disease 
transmission. This is in contrast with dry climatic conditions, which negatively 
affect the infective stages on the soil surface, resulting in a drop in transmission 
(Weaver et al., 2010). 
 Overall, many epidemiology surveys revealed a correlation between the 
prevalence of parasitic infections, including STH, and the seasons of the year 
(Amaechi et al., 2013). It has been described that understanding of the seasonal 
changes of STH is essential to support public health decision-making to launch 
MDA programmes (Brooker et al., 2002; Weaver et al., 2010). For instance 
determining prevalence at times of the year when there is a low transmission of 
STH might underestimate the actual prevalence of infections. In addition, it is 
important to note that, administration of drugs at that time point when 
prevalence and/or infection intensity is at its highest might have a bigger impact 
on the morbidity caused by these worms. 
 In Ethiopia, and in Jimma Town (our study area) in particular, there is 
lack of up to date prevalence data that is required to determine the frequency of 
MDA. Moreover, season in Jimma Town are meteorogically different, and hence 
impact of MDA may vary across seasons. Therefore, the main objective of this 
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chapter was to describe the prevalence and infection intensity of any STH and 
the three species separately in two different seasons (dry vs. rainy season) in 
school across 14 primary schools in Jimma Town. 
2.2 Materials and methods  
2.2.1 Study sites and population 
 The study was conducted in Jimma Town (capital of Jimma Zone, 
Ethiopia), which is located approximately 350 km southwest of the capital Addis 
Ababa. The town has currently 174,000 inhabitants, and is situated at a latitude 
and longitude of 7° 40′ N 36° 50′ E, and at 1,720-2,010 m above sea level. It 
lies in a climatic zone locally known as Woina-dega, which is considered ideal for 
agriculture as well as human settlement. Like most of the subtropical (Woina-
dega) regions of Ethiopia, the Jimma Zone is known to have the four seasons in 
a year: spring [September-November (end of rainy season)], winter [December-
February (dry season)], autumn [March-May (beginning of rainy season)] and 
summer (June-August (rainy season)]. Of note, the term winter does not 
represent the characteristics of winter weather elsewhere. In average, the daily 
temperature equals 19 °C, but ranges from 12 to 30 °C. Maximum precipitation 
and heavy rain occurs between June and September (56.3% of the total 
rainfall), with minimum rainfall between October and February (17.5% of the 
total rainfall). In this study, for the sake of simplicity, the seasons were 
clustered into a rainy (June-November) and a dry season (December-May).  
 This study focused on school-aged children (SAC) from 5 to 18 years of 
age, covering all eight grades of primary school. In total, there were 24 primary 
schools hosting a total of 23,492 children. Figure 2.1a shows the map of Jimma 
Zone, and Figure 2.1b shows the schools studied in Jimma Town. The 
female/male ratio across the different schools was approximately 1:1 (Report 
Document 2011/2012 of Jimma Town Education Bureau). STH infections have 
been documented in Jimma Town, but at present, no control measures for STH 
in SAC have been implemented. The study was conducted in 14 out of 24 
schools, as they were hosting all eight grades. 
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(a) 
 
(b) 
Figure 2.1 Map of Jimma Zone (a) and map of Jimma Town indicating the 14 
schools included in the survey (b).  
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2.2.2 Study design 
 The assessment of prevalence and infection intensity of STH was carried 
out during the dry season (February-March, 2012) and at the end of rainy 
season (September-October, 2012) among 14 schools in Jimma, Ethiopia. For 
this study, a total of 1,680 schoolchildren (840 in each season) were included. 
The sample size was estimated based on varying epidemiological scenarios that 
at least 120 subjects per school (60 per season per school) were required for a 
cost-effective identification of regions in need of MDA (Sturrock et al., 2010).  
 To this end, all primary schools in Jimma Town hosting all eight grades of 
students were invited to participate. In each school, subjects were stratified into 
three age groups (5-9 years, 10-13 years, and 14-18 years). For each age group 
at least 20 subjects were selected on a voluntary basis, resulting in a total of at 
least 60 subjects per school. The subjects were asked to provide at least 3 g of 
stool. This quantity of stool was required to process and examine the samples 
individually using the McMaster egg counting method for detection and 
enumeration of STH eggs. Figure 2.2 illustrates the number of primary schools 
eligible, recruited, and included in the statistical analysis. 
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Figure 2.2 Flow chart illustrating the number of schools and stool samples for 
assessing the seasonality of prevalence and infection intensity and of soil-
transmitted helminths in Jimma (Ethiopia).a Eligibility criteria for schools was 
hosting grade 1-8 students (age from 5-18 years) and/or provision of 60 samples per 
school per season 
 
2.2.3 Parasitological examination 
 All stool samples were processed by the McMaster egg counting method. 
McMaster is a flotation technique that is commonly used in veterinary 
parasitology both to assess the intensity of gastro-intestinal parasite infections 
and to evaluate drug efficacy against these parasites. For the diagnosis and 
enumeration of STH in public health, it has been found to be user-friendly (vs. 
FLOTAC (Levecke et al., 2009) robust (vs. Kato-Katz thick smear (Levecke et al., 
2011) and accurate for enumeration of STH, but less sensitive when intensity of 
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infection is low (vs. Kato-Katz and FLOTAC (Levecke et al., 2009; Levecke et al., 
2011). The procedure for this method was done as previously described by 
Levecke et al., 2011. In short, two grams of stool was suspended in 30 ml of 
saturated salt solution (NaCl). The faecal suspension was poured three times 
through a wire mesh to remove large debris. Then, two chambers of a McMaster 
slide (Figure 2.3) were filled with this suspension. Both chambers were 
examined under a light microscope using a 100x magnification and faecal egg 
count (FEC) as eggs per gram of stool (EPG) for each helminth species were 
obtained by multiplying the total number of eggs by 50.  
A tutorial on how to perform the McMaster egg counting method can be found at 
http://www.youtube.com/watch?v=UZ8tzswA3tc, a tutorial on how to organize 
the staff in the laboratory to process a large number of stool samples can be 
found at: https://www.youtube.com/watch?v=q_yfdtE3TSE 
 
 
Figure 2.3 McMaster slide used to process and quantify the eggs of any soil-
transmitted helminths.  
 
2.2.4 Statistical analysis 
  The apparent prevalence (% of children excreting eggs) and the infection 
intensity (mean FEC) were calculated on STH species for the different schools, 
both sexes, three age groups (5-9 years, 10-13 years and 14-18 years) and two 
seasons (dry vs. rainy). A meta-analysis was performed to assess any 
differences in prevalence and infection intensity between the two seasons. To 
this end, random effect models were built at the school level based on the odds 
ratio and the difference in mean FEC (mean FEC in the rainy season-mean FEC 
in the dry season), respectively. The statistical analysis was performed in the 
statistical software R (The R Foundation for Statistical Computing, version 3.0). 
The meta-analysis was carried out using the ‘metafor’ package of the statistical 
software R. The level of significance was set at p <0.05.  
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2.3 Results 
2.3.1 Overall prevalence and infection intensity  
 Infections with any STH were observed in 824 out of the 1,680 subjects 
screened (49.0%). T. trichiura was the most prevalent (n=596, 35.5%), 
followed by A. lumbricoides (n = 394, 23.4%). Hookworm was observed in 166 
subjects (9.9%). STH infections were observed in all 14 schools, except for 
hookworms for which infections were absent in 2 schools. Overall, the mean FEC 
was 1,938 EPG, 207 EPG and 29 EPG for A. lumbricoides, T. trichiura and 
hookworm, respectively. The prevalence and infection intensity varied across 
schools and age groups, but not between sexes. Appendix 1.1 reports the 
prevalence and infection intensity of any STH and the three STH species 
separately for the 14 schools, 2 sexes, and three age groups, but these results 
will not be further discussed in detail. 
 
2.3.2 Seasonal differences in prevalence and infection intensity 
The prevalence and infection intensity of any STH and the three STH 
species across the two seasons is reported in Tables 2.1 and 2.2 respectively. 
STH infections were more prevalent in the dry season (52.4%) than in the rainy 
season (45.7%). This seasonality in prevalence was most pronounced for T. 
trichiura (39.2% vs. 31.8%), followed by hookworms (11.4% vs. 8.3%). For A. 
lumbricoides, the proportion of infections across seasons was comparable 
(23.9% vs. 23.0%). Intensity of all three STH infections was higher in the dry 
season. This seasonality in infection intensity was most pronounced for A. 
lumbricoides (2,411 EPG vs. 1,465 EPG), followed by T. trichiura (295 EPG vs. 
119 EPG) and hookworms (35 EPG vs. 23 EPG). 
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Table 2.1. The prevalence of any soil-transmitted helminth, Ascaris lumbricoides, Trichuris trichiura and hookworm 
infections at the school level for the rainy and the dry season.  
 
School Sample size 
(rainy/dry) 
STH  A. lumbricoides  T. Trichiura  Hookworm 
Rainy 
(%) 
Dry 
(%) 
 Rainy 
(%) 
Dry 
(%) 
 Rainy 
(%) 
Dry 
(%) 
 Rainy 
(%) 
Dry 
(%) 
1 60/60 26.7 31.7  10.0 15.9  20.0 20.0  0.0 0.0 
2 60/60 21.7 11.7  8.3 5.0  15.0 6.7  0.0 1.7 
3 60/60 60.0 55.0  33.3 26.7  46.7 35.0  10.0 8.3 
4 59/60 25.4 28.3  13.6 0.0  23.7 28.3  1.7 0.0 
5 60/60 55.0 70.0  33.3 38.3  38.3 46.7  20.0 21.7 
6 60/60 63.3 66.7  33.3 21.7  46.7 58.3  3.3 8.3 
7 60/60 56.7 51.7  31.7 13.3  33.3 41.7  10.0 15.0 
8 60/60 63.3 73.3  35.0 43.3  53.3 56.7  5.0 8.3 
9 60/60 56.7 63.3  26.7 40.0  30.0 38.3  26.7 30.0 
10 60/60 61.7 58.3  38.3 28.3  33.3 50.0  20.0 11.7 
11 60/60 45.0 58.3  21.7 31.7  25.0 51.7  8.3 6.7 
12 60/60 51.7 58.3  16.7 18.3  46.7 36.7  5.0 20.0 
13 61/60 37.7 73.3  16.4 41.7  21.3 48.3  6.6 28.3 
14 60/60 15.0 33.3  5.0 10.0  11.7 30.0  0.0 0.0 
Total 840/840 45.7 52.4  23.1 23.9  31.8 39.2  8.3 11.4 
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Table 2.2. The intensity of Ascaris lumbricoides, Trichuris trichiura and 
hookworm infections at the school level for the rainy and the dry season.  
 
School Sample size 
(rainy/dry) 
A. Lumbricoides  T. Trichiura  Hookworm 
 Rainy 
(EPG) 
Dry 
(EPG) 
 Rainy 
(EPG) 
Dry 
(EPG) 
 Rainy 
(EPG) 
Dry 
(EPG) 
1 60/60 158 952  62 64  0 0 
2 60/60 207 665  28 7  0 2 
3 60/60 1,792 2175  112 272  51 33 
4 59/60 639 0  104 51  10 0 
5 60/60 3,068 5,207  223 445  54 65 
6 60/60 1,659 2,450  214 851  40 34 
7 60/60 3,765 1,915  152 285  26 78 
8 60/60 3,188 3,295  235 289  10 11 
9 60/60 989 2,762  148 482  38 63 
10 60/60 2,366 7,486  146 303  72 14 
11 60/60 1,343 2,442  60 519  7 42 
12 60/60 610 799  128 189  8 61 
13 61/60 413 2,707  42 246  11 92 
14 60/60 317 907  12 131  0 0 
Total 840/840 1,465 2,411  119 295  23 35 
 
The intensity of infections is measured by the mean of individual faecal egg counts 
(expressed in eggs per gram of stool (EPG)) 
 
 Overall, any STH infection was less prevalent in the rainy season 
compared to the dry season, the odds of any STH infection is 0.74 (95% 
confidence interval [0.57-0.97], z = -2.19, p = 0.03) times smaller than the 
odds of any STH infection in the dry season (Figure 2.4).  
Chapter 2: Assessment of Seasonality in STH Infections in SAC in Jimma Town 75 
   
 
 
Figure 2.4 the odds ratio of any soil-transmitted helminth infection across 
seasons (95% confidence interval)  
 
 The odds ratio of infection and difference in infection intensity are 
reported separately for A. lumbricoides, T. trichiura and hookworm in Figures 
2.4, 2.5, and 2.6, respectively. An odds ratio significantly different from 1 was 
only observed for T. trichiura infections (Figure 2.5).  
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Figure 2.5 The odds ratio of infection and the difference in infection intensity 
for Trichuris trichiura across seasons 
 
  For this STH, the odds of infection in the rainy season were 0.71 ([0.53-
0.96], z = -2.26, p = 0.02) times smaller than those in the dry season. A 
comparable odds ratio (0.68 [0.68-1.06]) was observed for hookworms, 
however this ratio was not significantly different from 1 (z = -1.71, p = 0.06) 
(Figure 2.6).  
 
Figure 2.6 The odds ratio of infection and the difference in infection intensity 
for hookworm across seasons 
 
 For A. lumbricoides infections, the odds ratio equalled 1.00 [0.68-1.48] (z 
= 0.02, p = 0.98) (Figure 2.7). 
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Figure 2.7 The odds ratio of infection and the difference in infection intensity 
for Ascaris lumbricoides across seasons 
 A significant difference in infection intensity across seasons was observed 
for A. lumbricoides (Figure 2.7) and T. trichiura (Figure 2.5). For both STH 
species, infection intensities were lower in the rainy season compared to those in 
the dry season. The estimated difference infection intensity equalled 569 EPG 
([35-1104], z = -2.09, p = 0.04) for A. lumbricoides and 60 EPG ([1-120], z = -
1.98, p = 0.05) for T. trichiura.  For hookworms, there was no significant 
difference in infection intensity across seasons (= 10 EPG [-8-28], z = -1.11, p 
= 0.27). 
Table 2.3. summarizes the heterogeneity in effect size between the 
different schools for any STH and for the three STH species separately. With the 
exception for the model describing the odds ratios across seasons for 
hookworms, there was a statistical evidence of heterogeneity in effect size 
between schools (Q-statistic: 21.5-27.0, p: 0.01-0.03). The heterogeneity in 
effect size between schools accounted for at least 45% of the total variation in 
effect size. 
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Table 2.3. The heterogeneity in effect size for the random effect models 
describing the odds ratio and the difference in intensity of any STH, Ascaris 
lumbricoides, Trichuris trichiura and hookworm infections.   
 
 Odds ratio Difference in Infection 
intensity 
Q statistic  
p-value 
Total heterogeneity / 
total variability (%) 
Q statistic  
p-value 
Total heterogeneity / 
total variability (%) 
Any STH 23.2 
0.04 
40.5 NA NA 
A. lumbricoides 25.1 
0.02 
60.3 25.6 
0.02 
47.5 
T. trichiura 27.0 
0.01 
48.5 25.9 
0.02 
55.9 
Hookworm 14.9 
0.19 
34.4 21.5 
0.03 
70.4 
 
2.4 Discussion 
 Overall, the prevalence and intensity of any STH infection using the 
McMaster was high among SAC in Jimma Town. Although the overall prevalence 
in Jimma did not exceed the 50%, it is suggested to administer drugs twice a 
year. This is because the diagnostic method applied lacks sensitivity, and hence 
the true prevalence is underestimated.  
 This study indicates that, even within a well-defined geographic area 
located in less than 10 km radius (Figure 2.1), STH infections are not equally 
distributed. This finding supports results of recent studies revealing considerable 
and distinct spatial heterogeneity in STH infections (Stothard et al., 2008; Knopp 
et al., 2008). However, it remains unclear which demographic, socio-economic 
and environmental factors are causing these distributions. Although it has been 
documented that unhygienic sanitation, and inadequate water supply are 
contributing to disease transmission (Bethony et al., 2006; Ohta and Waikagul, 
2007), these are less likely to be the cause of the observed STH distribution. 
Aspects that need further attention are soil types of the specific study locations, 
as it has been shown that this may play a significant role in the transmission of 
STH (Brooker et al., 2003; 2004; Saathoff et al., 2005a, 2005). 
 School children were marginally more infected with T. trichiura and 
hookworms during dry season. The occurrence of A. lumbricoides infections was 
equally distributed across seasons. A significant difference in infection intensity 
across seasons was observed for both A. lumbricoides and T. trichiura, the 
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intensity of infections being significantly more pronounced in the dry season. For 
hookworms no significant difference was observed. This seasonality in STH 
infection can be explained by the washing effect during the rainy season, eggs 
being washed away from the soil after heavy rains. This hypothesis is supported 
by the findings of Nwoke and colleagues (2013). In this study, the highest 
number of eggs recovered from the soil were observed in the dry season 
(18.7%), whereas this was 12.0% in the rainy season. Nevertheless, it has been 
argued that although seasonal dynamics in transmission may occur, such 
fluctuations may be of little significance to the overall parasite equilibrium within 
communities (Anderson and May, 1991).  
 We conclude that STH infections are a public health problem in Jimma 
Town, and a biannually MDA is recommended. Given the seasonality in STH 
infections it is recommended to treat at least once in the dry season. The study 
also highlights once more the considerably variation among schools, even within 
small geographical area, which needs further attention.  
 
2.5 Ethics Statement  
 Ethical approval was obtained from Jimma University Institutional Review 
Board. The school authorities, teachers, parents, and the children were informed 
about the purpose and procedures of the study. The written consent form was 
prepared in two commonly used local languages (Afaan Oromo and Amharic) 
and handed over to the children’s parents/guardians. Only those children (i) who 
were willing to participate and (ii) whose parents or guardians signed the written 
informed consent form were included in the study. Following submission of stool 
sample, a single-oral dose of 400 mg albendazole was administered to all 
subjects. 
 
2.6 Acknowledgements 
 The authors are grateful to the schoolteachers, study subjects, and 
parents who allowed their children to participate. Additionally, we would like to 
thank the staff of Medical Laboratory Sciences, Jimma University (Mio Ayana, 
Ahmed Zeynudin, Dereje Atomisa, Mitiku Bajaro, Dereje Jirata, Nuredin 
Abduselam, Tesfaye Deme, and Mestawet Getachew) for processing stool sample 
80   Chapter 2 
samples and/ or technical/medical assistance in the field. Finally, we would like 
to thank the VLIR-IUC/JU for supporting financially this study. 
Chapter 2: Assessment of Seasonality in STH Infections in SAC in Jimma Town 81 
   
References 
Anderson RM, May RM (1991) Infectious diseases of humans: dynamics 
 and control. 1st ed. Oxford: Oxford University Press 
Amaechi EC, Ohaeri CC, Ukpai OM (2013) Prevalence of helminthiasis among 
 schoolchildren in some rural communities of Abia state, Nigeria. Anim 
 Rese Inter 10:1817-1825 
Bethony J, Brooker S, Albonico M, Geiger SM, Loukas A, Diemert D, Hotez PJ 
 (2006) Soil transmitted helminth infections: Ascariasis, trichuriasis and
 hookworm. Lancet 367:1521-1532 
Brooker S. Beasley M, Ndinaromtan M, Madjiouroum EM, Baboguel M, 
 Djenguinabe E, Hay SI, Bundy DA (2002) Use of remote sensing 
 and a geographical information system in a national helminth control 
 programme in Chad. Bull. World Health Organ 80:783–789 
Brooker S, Singhasivanon P, Waikagul J, Supavej S, Kojima S, Takeuchi T, 
 Luong TV, Looareesuwan S (2003)  Mapping soil-transmitted helminths in 
 Southeast Asia and implications for parasite control. Southeast Asian J 
 Trop Med Public Health 34:24–36. 
Brooker S, Bethony J, Hotez PJ (2004) Human hookworm infection in the 
 21st century. Adv Parasitol 58:197-288 
Brooker S, Clements A, Bundy DAP (2006) Global epidemiology, ecology 
 and control of soil-transmitted helminth infections. Adv Parasitol 
 62:223-265  
Chen YD, Tang LH, Xu LQ (2008) Current status of soil-transmitted  nematode 
 infection in   China. Biomed Environ Sci 21:173-179 
Crompton DW (2001) Ascaris and ascariasis. Adv Parasitol 48:285-375 
Knopp S, Mohammed KA, Khamis IS, Mgeni AF, Stothard JR, Rollinson D, 
 Marti H, Utzinger J (2008) Spatial distribution of soil-transmitted 
 helminths, including Strongyloides stercoralis, among children in 
 Zanzibar. Geospat Health 3:47-56 
Levecke B, De Wilde N, Vandenhoute E, Vercruysse J (2009) Field validity and 
 feasibility of four techniques for the detection of Trichuris in simians: a 
 model for monitoring drug efficacy in public health? PLoS Negl Trop Dis 3: 
 e366.Levecke B, Behnke JM, Ajjampur SS, Albonico M, Ame SM, Charlier 
J,Geiger  SM, Hoa NT, Kamwa Ngassam RL, Kotze AC, McCarthy JS, 
 Montresor A, Periago MV, rRy S, Tchuem Tchuente LA, Thach DT, 
 Vercruysse J (2011) A comparison of the sensitivity and fecal egg 
 counts of the McMaster egg counting and Kato-Katz thick smear  methods 
 for soil-transmitted helminths. PLoS Negl Trop Dis 5: e1201 
Lorcan PO, Holland CV (2000) The Public health importance of Ascaris 
 lumbricoides.  Parasitol 121:S51-71 
Montresor A, Crompton DWT, Gyorkos TW, Savioli L (2012) Helminth  control in 
 school-age children: a guide for managers of control programmes. 
 2nd Edition ed:WHO 
Nwoke EU, Ibiam GA, Odikamnoro OO, Umah OV, Ariom OT, Orji I (2013) 
 Examination of soil samples for the incidence of geohelminth parasites  in 
 Ebonyi north-central area of Ebonyi State, southeast of Nigeria. Arch 
 Appl Sci Res 5:41-48 
Ohta N, Waikagul J (2007) Disease burden and epidemiology of soil-
 transmitted helminthiasis and schistosomiasis in Asia: the Japanese 
 perspective. Trends Parasitol 23:30-35 
82   Chapter 2 
Pullan LR, Brooker SJ (2012) The global limits and population at risk of soil 
 transmitted helminth infections in 2010. Parasit Vectors 5:1-14 
Saathoff E, Olsen A, Sharp B, Kvalsvig J, Appleton CC, Kleinschmidt I (2005a)
 Ecologic covariates of hookworm infection and reinfection in rural 
 Kwazulu-Natal/South Africa: a geographic information system-based 
 study. Am J Trop Med Hyg 72:384-391 
Saathoff E, Olsen A, Kvalsvig JD, Appleton CC, Sharp B, Kleinschmidt I (2005) 
 Ecological covariates of Ascaris lumbricoides infection in schoolchildren 
 from rural KwaZulu-Natal, South Africa. Trop Med Int Health 10:412-422 
Stothard JR, Imison E, French MD, Sousa-Figueiredo JC, Khamis IS, Rollinson 
 D (2008) Soil-transmitted helminthiasis among mothers and their 
 pre-schoolchildren on Unguja Island, Zanzibar with emphasis upon 
 ascariasis. Parasitol 135:1447-1455 
Sturrock HJW, Gething PW, Clements ACA, Brooker S (2010) Optimal survey 
 designs for targeting chemotherapy against soil-transmitted helminths:  
 Effect of spatial heterogeneity and cost-Efficiency of sampling. Am J 
 Trop Med Hyg, 82:1079–1087 
Weaver HJ, Hawdon JM, Hoberg EP (2010) Soil-transmitted helminthiasis: 
 Implications of climate change and human behavior. Faculty publications 
 from the Harold W. Manter Laboratory of Parasitology. Paper 736 
World Health Organization (2002) Prevention and control of schistosomiasis 
 and soil-transmitted helminthiasis. Report of WHO Expert Committee. 
 WHO technical Report Series 912, WHO, Geneva, pp 1-29 
World Health Organization (2006) Preventive chemotherapy in human 
 helminthiasis: coordinated use of anthelminthic drugs in control 
 interventions: a manual for health professionals and programme 
 managers. World Health Organization, Geneva. 
                  
Chapter 2: Efficacy of ALB and MEB against STH in School Children                                                                                                   83 
 
  
   
Appendix 2.1. The prevalence and infection intensity by means of faecal egg counts across 14 schools in Jimma Town, 
Ethiopia, 2 sexes, 3 age groups and 2 seasons. 
 
 
 
 
 
 
 
 
 
  N STH 
(%) 
A. lumbricoides T. trichiura Hookworms 
Prevalence 
(%) 
Mean FEC 
(EPG) 
Prevalence 
(%) 
Mean FEC 
(EPG) 
Prevalence 
(%) 
Mean FEC 
(EPG) 
School         
 1 120 29.2 12.5 555 20.0 63 0 0 
 2 120 16.7 6.7 436 10.8 18 0.8 1 
 3 120 57.5 30.0 1,983 40.8 192 9.2 42 
 4 119 26.9 6.7 317 26.1 77 0.8 5 
 5 120 62.5 35.8 4,138 42.5 334 20.8 60 
 6 120 65.0 27.5 2,055 52.5 532 5.8 37 
 7 120 54.2 22.5 2,840 37.5 218 12.5 52 
 8 120 68.3 39.2 3,242 55.0 262 6.7 10 
 9 120 60.0 33.3 1,875 34.2 315 28.3 50 
 10 120 60.0 33.3 4,926 41.7 225 15.8 43 
 11 120 51.7 26.7 1,892 38.3 290 7.5 25 
 12 120 55.0 17.5 705 41.7 158 12.5 35 
 13 121 55.4 28.9 1,550 34.7 143 17.4 51 
 14 120 24.2 7.5 612 20.8 72 0 0 
Sex         
 Female 782 50.0 23.3 1,908 34.5 199 10.1 31 
 Male 898 48.2 23.6 1,968 36.3 214 9.7 28 
Age group         
 5-9 yrs 539 47.7 26.0 2,884 37.1 305 5.8 17 
 10-13 yrs 603 47.6 21.2 1,727 35.2 177 10.1 31 
 14-18 yrs 538 52.0 23.4 1,228 34.2 143 13.8 40 
Total 1,680 49.0 23.5 1,938 35.5 207 9.9 29.0 
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Guillard B, Nguyen T, Kang G, Kattula D, Kotze AC, McCarthy JS, Mekonnen Z, 
Montresor A, Periago M, Sumo L, Tchuente LA, Dang TC, Zeynudin A, Levecke B (2011) 
Assessment of the anthelminthic efficacy of albendazole in schoolchildren in seven 
countries where soil-transmitted helminths are endemic. PLoS Negl Trop Dis 5:e948 
 
Levecke B, Montresor A, Albonico M, Ame SM, Behnke JM, Bethony JM, Noumedem CD, 
Engels D, Guillard B, Kotze A, Krolewiecki AJ, McCarthy JS, Mekonnen Z, Periago MV, 
Sopheak H, Tchuem Tchuenté LA, Duong TT, Huong NT, Zeynudin A, Vercruysse J. 
(2014) Anthelminthic efficacy of single-oral dose 500 mg mebendazole in schoolchildren 
in six countries where soil-transmitted helminths are endemic: a meta-analysis. PLoS 
Negl Trop Dis 8(10): e3204. 
Note: MZ was the principal investigator of the trial in Ethiopia. 
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3.1 Introduction  
  To control the burden of soil-transmitted helminths (STH) on public health 
the World Health Organization (WHO) recommends the implementation of 
preventive chemotherapy (PC) programmes, in which a single oral dose of 
albendazole (ALB, 400 mg) or mebendazole (MEB, 500 mg) are periodically 
administered to preschool-aged (preSAC) and school-aged children (SAC) (WHO, 
2006, 2010, 2011). These PC programmes have recently received increased 
political and scientific attention (WHO, 2012; Gabrielli et al., 2011). The WHO 
has devised a roadmap to guide implementation of the policies and strategies 
set out in a global plan to combat neglected tropical diseases (NTD, period 
2008-2015). More than 70 pharmaceutical companies, governments, and global 
health organizations committed to support this roadmap (WHO, 2011) in the 
London Declaration on NTD in January 2012 by sustaining or expanding drug 
donation programmes (Uniting to Combat NTDs, 2013).  
 These pledges of drug donations are now in place. However, we are 
relying only on two drugs with the same mode of action, and hence the 
emergence of anthelminthic resistance (AR) as drug donations expand, as 
substantiated in veterinary medicine, is likely (Geerts and Gryseels, 2001; van 
Wyk, 2001; Wolstenholme et al., 2004). This would particularly become a 
problem when there is a paucity of alternative drugs (Awasthi et al., 2003; 
Olliaro et al., 2011). As a consequence of this, it is imperative that monitoring 
systems are designed to detect any change in drug efficacy due to emerging 
resistance of the parasites against these benzimidazole (BZ) drugs (Geerts and 
Gryseels, 2001; Albonico M, 2004). 
 Currently, the assessment of eggs in stool following drug administration 
by means of cure rate (CR) and reduction in faecal egg counts (FECR) is the 
most commonly applied assay for monitoring the efficacy of anthelminthic drugs 
against STH (Keiser and Utzinger, 2008; see Chapter 1). In contrast to other 
available assays, it allows for the assessment of drug efficacy against all three 
STH (vs. in vitro assays and molecular assays) with a minimum of laboratory 
equipment (vs. molecular assays) (Smout et al., 2010; Kotze et al., 2011; 
Diawara et al., 2013). However, interpretation of the results from the stool 
assay remains difficult, since reliable reference efficacy values of BZ drugs 
against each of the STH are still lacking. In a systematic review and meta-
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analysis of published efficacy trials targeting STH, Keiser and Utzinger (2008) 
highlighted recently that there is a lack of high quality trials to determine these 
reference values. Available efficacy data are obtained through a variety of study 
protocols, including variation in diagnostic methods, follow-up periods, origin of 
drugs and statistical analyses (see also Chapter 1).  
 The objective of the present work was therefore to assess the efficacy of a 
single oral dose ALB (400 mg) and a single oral dose MEB (500 mg) against STH 
infections in SAC based on a protocol standardized in terms of diagnostic method 
(McMaster egg counting method), follow-up period (approximately 14 days), 
origin of the drugs (ALB: Zentel, GlaxoKlineSmith, batch N° L298; MEB: Vermox, 
Janssen-Cilag, Latina, Italy, batch N° BCL2F00) and statistical analysis of CR and 
different formulae of FECR. To give the study wide relevance, the study was 
conducted in seven populations of SAC in Brazil, Cameroon, Cambodia, Ethiopia, 
India, Tanzania and Vietnam. In the present Chapter, we will present the results 
obtained in Ethiopia. In the discussion, we will put these results obtained in 
Ethiopia more in perspective by comparing the results with results obtained in 
other countries.  
3.2 Materials and methods  
3.2.1 Study Area and Study Population 
 Both the ALB and the MEB trial were conducted in Jimma Town. The ALB 
trial was conducted in school 9 in May 2009. The MEB trial was conducted in 
school 6 and school 9 in December 2011. For details on the epidemiology of STH 
in these two schools, we refer the reader to Chapter 2.  
 
3.2.2 Study design 
  A standardized protocol was applied for both trials. In short, during the 
baseline survey, school children aged 5 to 18 at the different study sites (Brazil, 
Cameroon, Cambodia, Ethiopia, India, Tanzania and Vietnam) were asked to 
provide a stool sample. For the initial sampling, the aim was to enrol at least 
250 infected children with a minimum of 150 eggs per gram of stool (EPG) for at 
least one of the STH.  
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 This sample size was selected based on statistical analysis of study power, 
using random simulations of correlated over-dispersed faecal egg count (FEC) 
data reflecting the variance-covariance structure in a selection of real FEC data 
sets. This analysis suggested that a sample size of up to 200 individuals (alpha 
= 0.05, power = 80%) was required to detect a 10 percentage point drop from a 
null efficacy of 80% (mean percentage FEC difference per individual) over a wide 
range of infection scenarios. Standard power analyses for proportions also 
indicated that the detection of a 10% point drop from a null CR required sample 
sizes up to 200 (the largest samples being required to detect departures from 
null efficacies of around 50%). Given an anticipated non-compliance rate of 
25%, a sample of 250 individuals with 150 EPG pre-treatment was therefore 
considered necessary.  
 All children providing stool samples were treated under vision with a 
single oral dose ALB (400 mg, Zentel, GlaxoKlineSmith, batch N° L298) or a 
single oral dose MEB (500 mg, Vermox, Janssen-Cilag, Latina, Italy, batch N° 
BCL2F00) under supervision (chewing + water). No placebo control subjects 
were included in the trial for ethical and operational reasons. Approximately 7 to 
15 days (but exactly 14 days for the site of Ethiopia) after the baseline survey, 
stool samples were collected from the treated subjects. All samples were 
processed using the McMaster egg counting method within the same day of 
collection (see Chapter 2). None of the samples were preserved. Subjects who 
were unable to provide a stool sample at follow-up, or were experiencing a 
severe concurrent medical condition or had diarrhoea at time of the first 
sampling, were excluded from the study.  
 The participation, the occurrence of STH and sample submission 
compliance at baseline and follow-up surveys in the ALB and MEB trial conducted 
in Ethiopia are summarized in Figure 3.1. The participation, the occurrence of 
STH and sample submission compliance for baseline and follow-up surveys for 
the remaining sites involved are reported elsewhere (Vercruysse et al., 2011 for 
ALB and Levecke et al., 2014 for MEB).  
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Figure 3.1 The enrolment of school-aged children, occurrence of soil-
transmitted helminths and sample submission compliance at baseline and 
follow-up surveys. Subjects who were not able to provide a sample for the follow-up, 
or who were experiencing a severe current medical condition or had diarrhoea at the 
time of the first sampling were excluded from the trial. 
 
3.2.3 Statistical analysis  
 The efficacy of the treatment for each of the three STH was evaluated 
qualitatively based on the reduction in infected children (CR) and quantitatively 
based on the FECR. The outcome of the FECR was calculated using three 
formulae. The first two formulae were based on the mean (arithmetic/geometric) 
of the baseline and follow-up intervention FEC largely ignoring the individual 
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variability, whereas the third formula represented the mean of the reduction in 
the FEC per subject.  
 
 
 
 
3.3 Results  
3.3.1 Cure rate 
 Table 3.1 summarizes the CR for ALB and MEB. Overall, the CR of ALB 
was the highest for A. lumbricoides (99.3%), followed by hookworm (98.9%). 
The lowest CR was observed for T. trichiura (85.7%). For MEB, a similar trend 
was observed, highest CR results observed for A. lumbricoides and lowest for T. 
trichiura, however MEB resulted in lower CR results compared to ALB. Overall, 
the efficacy of MEB by means of CR was 90.3% for A. lumbricoides, 58.0% for 
hookworm and 50.9% for T. trichiura.  
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Table 3.1 Efficacy measured by means of cure rate and reduction in faecal egg 
counts of a single oral dose albendazole (400 mg) and a single oral dose 
mebendazole (500 mg) against Ascaris lumbricoides, Trichuris trichiura and 
hookworm infections in school children in Jimma Town, Ethiopia  
 
 
 ALB  MEB 
School 9  School 6 School 9 School 6+9 
 
A. lumbricoides 
 
N = 151 
  
N = 133 
 
N = 146 
 
N = 279 
 CR (%) 99.3  87.2 93.1 90.3 
 FECR (1) (%) >99.9  97.6 99.4 98.6 
 FECR (2) (%) >99.9  >99.9 >99.9 >99.9 
 FECR (3) (%) >99.9  92.5 93.0 92.7 
       
T. trichiura N = 105  N = 197 N = 129 N = 326 
 CR (%) 85.7  47.2 56.6 50.9 
 FECR (1) (%) 92.4  67.7 60.5 65.9 
 FECR (2) (%) 99.5  95.1 95.3 95.1 
 FECR (3) (%) 93.0  57.6 13.2 40.0 
       
Hookworm N = 91  N = 18 N = 82 N = 100 
 CR (%) 98.9  61.1 57.3 58.0 
 FECR (1) (%) 99.7  51.9 67.7 65.4 
 FECR (2) (%) >99.9  94.9 95.3 95.3 
 FECR (3) (%) 99.9  68.9 66.1 66.6 
 
3.3.2 Faecal egg count reduction rate 
 Figure 3.2 indicates the pre-intervention FEC for A. lumbricoides, T. 
trichiura and hookworm for the ALB and MEB trial, respectively. The pre-
intervention FEC in the ALB trial ranged from 50 to 62,500 EPG for A. 
lumbricoides (arithmetic mean = 3,443 EPG), from 50 to 5,200 EPG for T. 
trichiura (arithmetic mean = 420 EPG) and from 50 to 1,650 EPG for hookworm 
(arithmetic mean = 326 EPG). In the MEB trial the pre-intervention FEC ranged 
from 50 to 60,950 EPG for A. lumbricoides (arithmetic mean = 6,497 EPG), from 
50 to 11,750 EPG for T. trichiura (arithmetic mean = 653 EPG) and from 50 to 
1,450 EPG for hookworm (arithmetic mean = 266 EPG). As illustrated in Figures 
3.2 pre-intervention FEC were highly aggregated, majority of the eggs being 
excreted by a minority of the subjects.  
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Figure 3.2. The distribution of pre-intervention faecal egg counts for Ascaris 
lumbricoides (top row graphs), Trichuris trichiura (middle row graphs) and 
hookworm (bottom row graphs) for the albendazole (left column) and 
mebendazole trial (right column). 
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 The FECR calculated using all three formulae (based on FECR (1)-(3)) for 
both ALB and MEB in turn for A. lumbricoides, T. trichiura and hookworms are 
summarized in Table 3.1. Overall, FECR (1) for ALB was the highest for A. 
lumbricoides (>99.9%), followed by hookworm (99.7%) and T. trichiura 
(92.4%). Compared to ALB, MEB resulted in lower FECR (1) results for both 
hookworm (65.4%) and T. trichiura (65.4%). Efficacy results for A. lumbricoides 
for MEB (98.6%) were comparable to that of ALB. 
 Compared to FECR (1), FECR (2) gave higher efficacy results. Of the 12 
estimates of drug efficacy based on FECR (1) summarized in Table 3.1, FECR (2) 
provided higher efficacy results in 11 cases. The most pronounced differences 
between FECR formulae were observed in the MEB trial. In this trial the 
difference ranged from 27.4 (school 6) to 34.8% (school 9) for T. trichiura and 
from 27.6% (school 9) to 43.0% (school 6) for hookworm. For the remaining 
estimates, the difference did not exceed 7.1% (T. trichiura ALB trial). Overall, 
FECR (3) resulted in lower efficacy results in 6 out of 12 cases, with a difference 
ranging from 5.1% (MEB, school 6, A. lumbricoides) to 43.1% (MEB trial, school 
9, T. trichiura). In 5 cases, the difference between efficacy summarized by FECR 
(1) and FECR (3) was less than <2%. In the remaining cases (MEB, school 6, 
hookworm), the FECR (3) resulted in higher efficacy results (68.9% vs. 61.1%). 
 
3.4 Discussions  
 Overall, the results in Ethiopia support previous reports indicating (i) that 
a single dose of both ALB and MEB is most effective for infection with A. 
lumbricoides, (ii) that ALB is more effective against hookworm infections 
compared to MEB and (iii) that MEB has a poor efficacy for T. trichiura infections 
(Bennet and Guyatt, 2000; Keiser and Utzinger 2008, Chapter 1). However, the 
results did not confirm a poor efficacy of ALB against T. trichiura for which a 3-
day dose schedule of ALB has been shown to be necessary to achieve acceptable 
therapeutic efficacy (Bennet and Guyatt, 2000). In addition to this, the results 
highlight that different metrics of drug efficacy (CR and FECR formulae) rarely 
provide comparable results, and hence impede readily interpretation/comparison 
of drug efficacy results.  
 To put the efficacy results of both ALB and MEB obtained in Ethiopia in 
perspective, this section will now discuss the findings obtained from the 
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combined data sets. Further analysis on the combined data set indicated that CR 
should not be the recommended parameter, as it is sensitive to variation in the 
intensity of infection before treatment. In addition, it can be affected by the 
sensitivity of the diagnostic methods used. The CR of ALB declined in all three 
STH with increasing intensity of infection (FEC) at the pre-intervention survey 
(Figure 3.3), including Ethiopia. Hence, comparison between populations (e.g., 
countries, villages, schools) differing in pre-intervention FEC are guaranteed to 
arrive at different conclusions about drug efficacy.  
 Differences in the outputs of calculations based on processing quantitative 
data in different ways also showed variation that requires careful review if 
standard operating procedures for data processing are to be adopted. The 
observation that therapeutic efficacies based on arithmetic means were mostly 
lower than those based on geometric means is in agreement with another study 
(Dobson et al., 2009), and arises because the arithmetic means captures the 
variation more effectively, while the geometric means compress the data such 
that efficacies are highly overestimated.  
 
Figure 3.3 The factors affecting the cure rate of Ascaris lumbricoides (A), 
Trichuris trichiura (B) and hookworms (C). Generalized linear models (binomial 
error) were built with the test result (infected /uninfected) as the outcome, ‘trial’ (7 
levels: trials in Brazil, Cambodia, Cameroon, Ethiopia, India, Tanzania and Vietnam) and 
‘sex’ (2 levels: female and male) as factors, and ‘age’ and the log transformed pre-
intervention FEC as covariates. Full factorial models were evaluated by the backward 
selection procedure using the likelihood ratio test of χ2. The level of significance was set 
at p<0.05. Finally, the CR for each of the observed values of the covariate and factor 
was calculated based on these models (The R Foundation for Statistical Computing, 
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version 2.10.0). Only 3 ages (9, 10 and 11) were considered in the graph A, as they 
represent 50% of the total study population.  
 
 An additional exploratory analysis of different statistical approaches for 
analyzing data also indicates that FECR based on individuals was highly affected 
by excluding subjects with pre-intervention FEC below 150 EPG (Table 3.2). 
Therefore, this finding conclude that the group-based formula using an 
arithmetic mean is the best summary statistic to employ in analysis of 
therapeutic efficacy in future large-scale drug administration trials, since it 
represents a robust indicator that is sensitive to changes in drug efficacy. 
 Although it can be argued that the application of a diagnostic method with 
poor sensitivity, such as the McMaster (Levecke et al., 2011), may result in 
biased efficacy results, there is a growing literature suggesting that the 
sensitivity of the diagnostic method has little impact on assessment of drug 
efficacy estimates as it is summarized using FECR (1) (Albonico et al., 2012, 
Levecke et al., 2014).  
Table 3.2 Faecal egg count reduction (FECR (1)) for Trichuris trichiura across 7 
countries based on all subjects excreting eggs at pre-intervention and based 
subjects that are at least excreting less 150 eggs per gram of stool. 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
FEC: faecal egg count, EPG: eggs per gram of stool; FECR: reduction in faecal egg 
counts; FECR (1): group based and arithmetic mean; FECR (2): group based and 
geometric mean; FECR (3): individual based and arithmetic. 
*Due to the low number of infected subjects (<50), the trials conducted in these countries were 
excluded from further analysis. 
Baseline intervention FEC >0 EPG 
Country N FECR (1) 
(%) 
FECR (2) 
(%) 
FECR (3) 
(%) 
 
Brazil 1* 100.0 98.0 100.0 
Cambodia 2* 100.0 92.2 100.0 
Cameroon 386 39.2 93.0 34.7 
Ethiopia 105 92.4 99.1 93.1 
India 18* 74.5 98.9 92.1 
Tanzania 396 52.0 82.6 -36.2 
Vietnam 138 92.3 98.8 86.4 
Baseline intervention FEC ≥150 EPG 
Brazil 0* - - - 
Cambodia 1 100.0 99.7 100.0 
Cameroon 233 39.9 93.4 50.4 
Ethiopia 72 92.3 99.2 92.6 
India 11* 72.0 99.1 87.0 
Tanzania 325 58.3 86.6 36.4 
Vietnam 71 93.1 99.2 88.0 
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 A meta-analysis of the outcome of the different trials showed that the 
estimated efficacy [95% confidence interval] of MEB was highest for A. 
lumbricoides (97.6% [95.8; 99.5]), followed by hookworms (79.6% [71.0; 
88.3]). For T. trichiura, the estimated efficacy was 63.1% [51.6; 74.6]. 
Compared to MEB, ALB was significantly more effective against hookworm 
(96.2% [91.1; 101.2], p = 0.0001) and to a lesser extent against A. 
lumbricoides infections (99.9% [99.0; 100]), but equally effective for T. trichiura 
infections (64.5% [44.4; 84.7]). In addition to this, the efficacies of both ALB 
and MEB were dependent on infection intensity in both A. lumbricoides and T. 
trichiura, decreasing in both cases with increasing infection intensity (Figure 
3.4). However, the magnitude of this loss of efficacy as a function of increasing 
infection intensity differed between both BZ drugs and the STH. Between BZ 
drugs, the change in drug efficacy was more pronounced for MEB with A. 
lumbricoides, whereas for T. trichiura the decrease was more pronounced for 
ALB. Between STH, the overall impact of infection intensity on treatment with BZ 
was pronounced for T. trichiura (1.2-7.8% per 100 EPG), but almost negligible 
for A. lumbricoides (0.4% per 1000 EPG).  
 For hookworm the efficacy did not depend on the infection intensity. This 
could be explained by either a true constant efficacy across infection intensity or 
a low number of moderate and high infection intensities in these trials. The 
bases of these differences in efficacy between the BZ drugs and their effects on 
STH remain unclear, mainly due to the paucity of detailed pharmacokinetic and 
pharmacodynamics studies in pediatric populations in STH endemic countries 
(Horton, 2000; Dayan, 2003; Utzinger and Keiser, 2004).  
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Figure 3.4 The efficacy of a single oral dose albendazole (400 mg) and a single 
oral dose of mebendazole (500 mg) as a function of infection intensity at pre-
intervention survey. The estimated efficacy (straight line) and 95% confidence 
intervals (dashed line) of a single oral dose of 400 mg ALB (black) and a single oral dose 
of 500 mg MEB (red) as a function of infection intensity at the pre-intervention survey 
(arithmetic mean of FEC) for Ascaris lumbricoides and Trichuris trichiura. To assess the 
impact of infection intensity on drug efficacy, generalized mixed effect models were 
fitted for each of the three STH species with FECR at the trial level as the dependent 
variable, and BZ drug (two levels: ALB and MEB) and mean FEC at the pre-intervention 
survey as covariates, and the interaction between these covariates. The meta-analysis 
was carried out using the ‘metafor’ package of the statistical software R. The level of 
significance was set at p <0.05. 
 
 These findings emphasize a need to adhere to strict standard operating 
procedures (SOP) and methodologies, and to change the WHO recommended 
threshold levels for the efficacy of BZ (WHO, 1999) where a FEC reduction rate 
below 70% in the case of A. lumbricoides or below 50% for the hookworms are 
the currently accepted thresholds. Thus, it is recommended that in future 
monitoring of single-dose ALB-dependent control programmes a minimum FEC 
reduction rate (based on arithmetic means) of 95% for A. lumbricoides and 90% 
for hookworms and 50% for T. trichiura are appropriate thresholds, and that 
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efficacy levels below this should raise concern. For a single oral dose MEB, we 
propose 95%, 70% and 50%, respectively. 
 In conclusion, the present study is the first to evaluate drug efficacy of a 
single oral dose of ALB (400 mg) and MEB (500 mg) in Jimma Town (Ethiopia) 
as part of a multi-national trial representing such a large scale across three 
continents. The results confirm the therapeutic efficacy of these treatments 
against A. lumbricoides, the superior efficacy of ALB against hookworm 
infections, and the low efficacy against T. trichiura. The efficacy widely varied 
across the seven different trials, and infection intensity is thought to be an 
important confounding factor. The FEC reduction rate based on arithmetic means 
is the best available indicator of drug efficacy, and should be adopted in future 
monitoring and evaluation studies of PC programmes. Finally, these findings 
emphasize the need to revise the WHO recommended efficacy thresholds for a 
single oral dose ALB treatments.  
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Infections in School Children in 
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albendazole and mebendazole regimens against heavy-intensity Trichuris trichiura 
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4.1 Introduction 
 As illustrated in Chapter 3, a single dose of benzimidazole (BZ) drugs 
shows poor efficacy against Trichuris trichiura. For this, multiple dose regimens 
are likely to be more efficacious (Bennett and Guyatt, 2000; Keiser and 
Utzinger, 2008). Moreover, the results from Chapter 3 also indicate that the 
efficacy of BZ drugs may vary across infection intensity, the efficacy of a single 
oral dose albendazole (ALB) decreasing against T. trichiura when the mean 
faecal egg counts (FEC) at baseline increases (Levecke et al., 2012; Chapter 3). 
Hence, the infection intensity should be considered as an important determinant 
of drug efficacy. 
 The objective of this study was to determine the efficacy of different 
regimens of ALB and mebendazole (MEB) administered to school children in 
Jimma Town, Ethiopia with heavy-intensity of T. trichiura infections. 
4.2 Materials and methods 
4.2.1 Study area and study populations 
 This study was conducted in school 6 in Jimma Town, Ethiopia (see 
Chapter 2). 
 
4.2.2 Study design  
 The study was designed as a randomized multi-arm efficacy trial utilizing 
four arms for the treatment of T. trichiura. In total, 605 school children (age 5 to 
18 years) attending grade 1 to 8 were recruited at baseline and asked to provide 
one stool sample. All together, 425 school children excreting eggs of T. trichiura 
were randomly assigned to one of the four treatment arms stratifying for 
baseline FEC. To this end, baseline FEC were stratified into three strata based on 
the 33rd and 66th percentile. Subsequently, subjects within each stratum were 
randomly assigned to one of the four treatment arms using the ‘rand’ function in 
xls. The treatment arms included were (i) a single dose of ALB 400 mg (Zentel, 
GlaxoSmithKline Pharmaceuticals Ltd, India) for one day (1xALB), (ii) a single 
dose ALB 400 mg for two consecutive days (2xALB), (iii) a single dose of MEB 
500 mg (Vermox, Johnson & Johnson) for one day (1xMEB), and (iv) a single 
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dose of 500 mg MEB for two consecutive days (2xMEB). The study subjects 
enrolled, randomized, followed-up and analyzed were summarized in Figure 4.1.  
 
 
Figure 4.1 Flowchart showing total number of subjects enrolled, randomizated, 
follow-up and included in the statistical analysis: comparing the four treatment 
groups with albendazole for 1 and 2 days and mebendazole for 1day and 2 days, against 
Trichuris trichiura in children from school 6 in Jimma, Ethiopia, end of 2010. 
Legend: 1xALB = albendazole 400 mg single day. 2xALB = albendazole 400 mg/day for 
two consecutive days. 1xMEB = mebendazole 500mg for single day. 2xMEB = 
mebendazole 500 mg/day for two consecutive days 
  
 Fourteen days after the first treatment, a single stool sample of 385 was 
collected and screened for the presence of STH eggs. All stool samples (both at 
baseline and at follow-up) were processed with the McMaster egg counting 
method as described by (Levecke et al., 2011; see Chapter 2). 
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 Subjects who were unable to provide a stool sample at baseline, 
experiencing a severe concurrent medical condition, had diarrhoea at time of the 
first sampling, had known history of allergic reaction to BZ drugs or were 
pregnant were excluded from the study. 
4.2.3 Statistical Analysis 
 The efficacy of the different treatment arms were reported by means of 
reduction in faecal egg counts (FECR), using the formula below: 
 
baseline)at  (FEC mean arithmetic
up)follow at  (FEC mean arithmetic - baseline)at  (FEC mean arithmeticx  100%FECR =  
 The 95% confidence intervals (95% CI) for age, sex ratio (females 
/males) and FECR were determined by bootstrap analysis (10,000 iterations).  
Permutation tests and Bonferonni post-hoc corrections were performed to do a 
pairwise comparison of age, sex ratio and FECR in the different treatment arms 
(6 pair-wise comparisons). For each pair-wise comparison, the permutations test 
consisted of 2 consecutive steps. First, the permutation distribution under the 
null hypothesis that in average there was no difference in age, sex ratio, 
baseline FEC and FECR between two treatment arms was generated. To this end, 
all individuals of both trials were randomly re-assigned to one of the treatment 
arms (the number of individuals in each treatment arm remained unchanged). 
The new mean age, sex ratio, baseline FEC and FECR for each of the two 
treatment arms was determined, and the absolute value of the difference in age, 
sex ratio, baseline FEC and FECR between treatment arms was calculated. Next, 
this procedure was repeated 10,000 times. The distribution of these 10,000 
permutated age, sex ratio, baseline FEC and FECR differences represented the 
permutation distribution when the null hypothesis is true. Second, the 
probability of finding a value at least equal to the absolute value of the observed 
difference in age, sex ratio, baseline FEC and FECR between the two treatment 
arms in this permutation distribution was determined (= p-value). The level of 
significance was set at p <0.05. 
 
4.3 Results  
 In total, 385 subjects received the assigned treatment regimen and 
provided a stool sample at follow-up (compliance rate of 90.6%) who had 
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completed the trial. The baseline characteristics for each of the four treatment 
arms are reported in Table 4.1. Overall the mean age and proportion of males of 
the subjects included in the final analysis ranged from 10.8 years (MEBx2) to 
11.1 years (MEBx1) and from 36.7% (ALBx2) to 48.9 (MEBx2). The mean FEC of 
T. trichiura ranged from 1,075 EPG in MEBx1 to 1,262 EPG in ALBx2. These 
parameters did not significantly differ between the four treatment arms. 
 
Table 4.1 Baseline characteristics of the children who completed the efficacy 
trial against Trichuris trichiura in school 6 of Jimma Town (Ethiopia) 
 
Parameter  (95% 
CI) 
      1xALB 
      n = 102 
2xALB 
n = 90 
1xMEB 
n = 103 
2xMEB 
n = 90 
Mean age 
   (years) 
11.0 
(10.6-11.3) 
11.1 
(10.9-11.4) 
11.1 
(10.9-11.4) 
10.8 
(10.5-11.1) 
Proportion of males     
      (%) 
45.1 
(38.3-51.7) 
36.7 
(29.8-43.3) 
40.0 
(32.8-46.8) 
48.9 
(41.8-55.7) 
Mean FEC of T. trichiura 
    (EPG) 
1193 
(867-1590) 
1262 
(977-1578) 
1075 
(863-1305) 
1122 
(899-1371) 
 
1xALB: a single dose albendazole 400 mg; 2xALB: a repeated single dose albendazole 
400 mg across 2 consecutive days; 1xMEB: a single dose mebendazole 500 mg; 2xMEB: 
a repeated single dose mebendazole 500 mg across 2 consecutive days; 95% CI: 95% 
confidence interval; EPG: eggs per gram stool; n: number of subjects. 
 
 The efficacy of the four treatment regimens is summarized in Table 4.2. In 
general, MEB treatment arms were more efficacious than ALB arms (MEBx1: 
60.0% vs. ALBX1: 29.3% and MEBx2: 87.1% vs. ALBx2: 73.5%) and repeated 
doses were more efficacious than single dose arms (ALBx1: 29.3% vs. ALBX2: 
73.5% and MEBx1: 60.0% vs. 87.1%). However, this difference in efficacy 
between treatment arms was not significant for pairwise comparison of 1xALB-
1xMEB (p = 0.21) and ALBx2-MEBx1 (p = 0.29).  
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Table 4.2 Reduction in faecal egg counts of four treatment arms against 
Trichuris trichiura in School 6 of Jimma Town (Ethiopia) 
 
 N FECR (%) 
(95% CI) 
Significant pairwise 
comparison 
 
ALBx1 
 
102 
 
29.3 
(-9.9-56.2)  
  
2xALB, 2xMEB 
MEBx1 103 60.0 
(48.5-70.9) 
  2xMEB 
ALBx2 
 
90 73.5 
(64.2-81.3) 
  1xALB 2xMEB 
MEBx2 90 87.1 
(81.4-91.2) 
  1xALB, 1xMEB 
 
1xALB: a single dose albendazole 400 mg; 2xALB: a repeated single dose albendazole 
400 mg across 2 consecutive days; 1xMEB: a single dose mebendazole 500 mg; 2xMEB: 
a repeated single dose mebendazole 500 mg across 2 consecutive days; 95% CI: 95% 
confidence interval; EPG: eggs per gram stool; n: number of subjects 
 
4.4 Discussions 
 In agreement with a previous review (Bennett and Guyatt, 2000), both 
drugs show limited efficacy against T. trichiura and repeated doses of MEB are 
the most efficacious. However, administering multiple doses has some important 
logistic implications in PC programmes. Compared to a previous study which was 
conducted by our group under comparable demographic (mean (95% CI) age = 
11.1 years (10.7-11.5); sex ratio = 1.1 (0.75-1.63)), environmental (Jimma 
Town, December, 2009) and research conditions (McMaster egg counting 
method, same lot no of ALB), but including light-intensity T. trichiura infection 
(mean baseline FEC = 420 EPG) (Chapter 3, Vercruysse et al., 2011), a single 
dose ALB was significantly less efficacious (92.4% (88.1;95.9) vs. 29.3% (-9.9; 
56.2)).  
 This finding (a negative correlation between infection intensity and drug 
efficacy) may be attributed to different factors, including (i) increased intestinal 
transit (due to heavy infections that cause irritation of the intestines and will 
subsequently increase the excretion of ALB), (ii) density dependent fecundity 
(following chemotherapy may not always yield a reduction in FEC, due to an 
increase in fecundity among the small residual worm population) and (iii) the 
bioavailability of single-dose ALB per adult worm may decrease with increasing 
infection levels (Albonico, 2003). Although these are all credible hypotheses, it 
remains unclear why such a large variation in efficacy was not observed for A. 
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lumbricoides and hookworms, despite the large variation in baseline FEC (see 
Chapter 2). These observations warranted a further research to test these 
hypotheses. More importantly, it is essential existing or new compounds against 
T. trichiura should be assessed under varying levels of infection intensity.  
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5.1 Introduction 
 Over the past few decades, significant progress has been made in the 
control of soil-transmitted helminths (STH) through preventive chemotherapy 
(PC), and a worldwide scale-up of these large-scale programmes is underway in 
various parts of Africa, Asia and South-America (Neglected Tropical Diseases 
(NTD) Partner Website, 2012). Although these pledges of drug donations are in 
place, there are two factors that have received little attention but which might 
affect the success of these programmes. First, the therapeutic efficacy of the two 
benzimidazoles (BZ) differs across STH species (Chapter 3 and 4). Both are 
highly efficacious against A. lumbricoides, but ALB is more efficacious against 
hookworm, whereas both drugs are unsatisfactory when used as single dose 
against T. trichiura infections (Chapter 3 and 4). Moreover, therapeutic efficacy 
may change across the level of infection intensity (Chapter 3 and 4). Second, we 
only rely on two drugs with the same mode of action, and hence the emergence 
of anthelminthic resistance (AR) as drug donations are expanding, as 
substantiated in veterinary medicine, is likely (Geerts and Gryseels, 2001; van 
Wyk, 2001; Wolstenholme et al., 2004). Hence, it is important to seek for 
alternative strategies (i) to ensure appropriate choice of drug and regimen, (ii) 
to monitor AR, and (iii) to assess the long-term impact of MDA programmes. 
 Traditionally, the assessment of both infection intensity and drug efficacy 
is based on the examination of individual stool samples. However, this strategy 
impedes an up-scale of epidemiological surveys that are required to support 
health care decision makers to further maximize the efficiency of PC at the level 
of the countries. An alternative to individual stool examination could be the 
examination of pooled stool samples. The validity of pooling samples (e.g., stool, 
serum, and urine) of the same individual has been found valuable for diagnosis 
of various pathogens, including Giardia (Wahlquist et al., 1991), HIV 
(Verstraeten et al., 1998), Salmonella (Randall et al., 2006) and Chlamydia 
(Shipitsyna et al., 2007). Studies validating a pooling strategy for human STH 
are lacking. In animal health it has been shown that pooling stool samples allows 
for a rapid assessment of both infection intensity and drug efficacy. Pools of up 
to 10 animals provided comparable estimates of intensity of helminth infections 
by means of faecal egg counts (FEC) (Morgan et al., 2005; Eysker et al., 2008). 
They also highlight that the accuracy of these estimates may be thwarted as 
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infections become more aggregated. The effect of the number of samples to pool 
has not yet been examined. 
 The main objective of the present study was therefore to develop and to 
evaluate a sampling strategy based on pooling of stool samples. To this end, we 
assessed intensity of STH infections across varying epidemiological settings and 
drug efficacy of a single dose mebendazole (MEB, 500 mg) on both individual 
samples and pooled samples (pool sizes of 10, 20, and 60 individual stool 
samples). 
5.2 Materials and Methods 
5.2.1 Study Area and study population 
 The study was conducted in Jimma Town (see Chapter 2 for the details of 
the study site). Our study focused on school children from age 5 (grade 1) to 
age 18 (grade 8), and the study was conducted in 14 schools (Chapter 2). 
5.2.2 Study Design  
5.2.2.1 Assessing Infection Intensity 
 The assessment of infection intensity of STH was part of an 
epidemiological survey in Jimma Town (Chapter 2) that aimed to assess (i) STH 
prevalence in order to determine frequency of PC, and (ii) to assess seasonal 
differences in STH prevalence and infection intensity (rainy vs. dry season). The 
present study assessed the intensity of STH infections in the dry season between 
February and March 2012.  
 To this end, all primary schools in Jimma Town hosting grade 1 to grade 8 
students were invited to participate. In each school subjects were stratified 
according to three age groups (age 5-9 years, age 10-13 years, and age 14-18 
years). For each age class at least 20 subjects were selected on a voluntary 
basis, resulting in a total of at least 60 subjects per school. The subjects were 
asked to provide at least 5 g of stool. This quantity of stool was required to 
examine the samples individually (2 g) and to pool individual stool samples (1 
g). All samples were processed with the McMaster egg counting method within 
the same day of collection (see Chapter 2; Levecke et al., 2011) for detection 
and enumeration of STH eggs. Figure 5.1 illustrates the number of primary 
schools eligible, recruited, and included in the statistical analysis.  
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Figure 5.1 Number of schools and stool samples for assessing infection 
intensity of soil-transmitted helminths in Jimma Town (Ethiopia). aEligibility 
criteria for the schools was hosting grade 1 to 8 (age 518 years); bExcluded from 
analysis since <60 stool samples were provided. 
 
5.2.2.2 Monitoring Drug Efficacy  
 In December 2011, the efficacy of a single dose of MEB (500 mg) against 
STH based on a standard protocol for ALB (Chapter 3, Vercruysse et al., 2011) 
was evaluated both on individual and pooled samples. This study was part of a 
multi-country trial designed to assess the efficacy of a single dose of MEB (see 
Chapter 3). In short, schoolchildren aged 5 to 18 years at different study sites 
were asked to provide a stool sample during the pre-intervention survey. A 
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single dose of MEB 500 mg was administered to all subjects, regardless of the 
infection status of STH. Stool samples were processed using the McMaster egg 
counting method for the detection and the enumeration of STH infections. 
Fourteen days post-treatment, stool samples were again collected and processed 
by the McMaster egg counting method (Chapter 2). 
This Ethiopian trial was conducted in two schools (school 6 and 9) in Jimma 
Town. Subjects who were unable to provide a stool sample at baseline, 
experienced a severe concurrent medical condition, had diarrhoea at time of the 
first sampling, had a known history of allergic reaction to MEB, or were pregnant 
were excluded from the study. Pregnancy was ruled out based on the following 
criteria: (i) date of last menstrual period, (ii) sexual intercourse after the last 
menstrual period, and (iii) correct use of a reliable contraceptive method. Figure 
5.2 summarizes the study subjects enrolled, and followed-up, and the sample 
submission compliance and the number of pooled samples (both at baseline and 
follow-up) included in the analysis. 
 
5.2.3 Parasitological Examination 
 All stool samples were individually processed with the McMaster egg 
counting method, as described in Chapter 2. 
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Figure 5.2 Participation and compliance for assessing drug efficacy against soil-
transmitted helminths in school children in Jimma Town (Ethiopia). At follow-up 
pooling of exactly up to 10, 20, or 60 stool samples were not always possible: * pool10 
includes: pools of 9 (n = 12) and pools of 10 (n = 36) samples; ** pool20 includes: pools 
of 18 (n = 5), pools of 19 (n = 2) and pools of 20 (n = 17) samples; and *** pool60 
includes: pools of 55 (n = 1), 56 (n = 1), 58 (n = 1) and 59 (n = 1) and pools of 60 (n 
= 4) samples 
 
In addition, a subset of the stool samples was pooled in pools of 10, 20, 
and 60 individual stool samples, and this in both studies. We considered pooling 
as a rapid alternative for individual stool examination if at least 10 samples were 
pooled. Pools of 60 individual samples allowed for pooling all stool samples of 
one school in the study assessing infection intensity. For uniformity across the 
two studies, pooling of 60 stool samples was also applied for the evaluation of 
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the drug efficacy. Pools of 20 samples were considered as an intermediate of 
pools of 10 and 60. The procedure to pool individual samples is illustrated in 
Figure 5.3, and will be discussed more in detail below. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3 Procedure to obtain pools of 10, 20, and 60 individual stool samples. 
Sixty individual stool samples were arranged in 6 rows with each row consisting of 10 
individual samples, subsequently 6 pools of 10; 3 pools of 20; and 1 pool of 60 individual 
stool samples, resulting in total of 10 pooled stool samples per school. 
  
 At first, 60 individual samples were randomly organized in 6 rows of 10 
individual stool samples. From each row 1 g of each of the 10 individual stool 
samples was transferred into a new pre-labelled plastic beaker (resulting in a 
total of 6 pools of 10 individual stool samples). After homogenization, 5 g from 2 
plastic beakers representing pools of 10 individual samples were transferred into 
another new pre-labelled plastic beaker, resulting in a total of 3 pools of 20 
individual samples. Next, 3.33 g was transferred from the 3 beakers of pools 20 
into new pre-labelled plastic beaker, resulting in 1 pool of 60 individual stool 
samples. Finally, each of the pools was processed using the McMaster egg 
counting method as done for individual samples. A detailed tutorial on how to 
pool stool samples can be found on 
http://www.youtube.com/watch?v=UZ8tzswA3tc.  
 This pooling procedure has two important advantages. First, the cascade 
procedure applied (e.g. we pooled pools of 10 to make pools of 20) allowed for 
1g each 
1g each 
1g each 
1g each 
5g each 
5g each 3.33g  
3.33g  
3.33g  
Individual Samples 
Pools of 10  
Pools of 20  
5g each 
1g each 
1g each 
Pools of 60  
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pooling samples into different pool sizes with only 1 g per individual sample. 
Second, it avoids the homogenization of too large quantities of stool. For 
example, for pools of 60 we only had to homogenize 10 g of stools (3.33 g of 
three pools of 20 individual stool samples), whereas this would have been 60 g if 
we had pooled 60 times 1 g of individual samples.  
 For the assessment of infection intensity, samples were randomized 
according age group (2 rows of 10 samples per age group). For the efficacy trial, 
small deviations from the aforementioned procedure should be noted. Samples 
were randomly pooled both at baseline and at follow-up. However, due to 
unforeseen dropout, pools at baseline did not always match pools at follow-up 
and at follow-up pooling of exactly 10, 20, or 60 samples was not always 
possible. In addition, not all subjects were included at both baseline and follow-
up. 
 Quality of the parasitological examination was ensured by (i) analyzing 
the samples within an average of 4 hr, (ii) verification of density of the sodium 
chloride solution (NaCl), (iii) sensitivity of the scale to weigh stool, (iv) 
supervision of the procedure of the McMaster and pooling, and (v) re-
examination of 10% of the McMaster slides by a senior researcher. The total 
numbers of the individual samples and pooled samples across the assessment of 
the infection intensity and the efficacy trial are provided in Figures 5.1 and 5.2, 
respectively. 
 
5.2.4 Statistical Analysis 
5.2.4.1 Assessing Infection Intensity 
 The infection intensity was determined for A. lumbricoides, T. trichiura 
and hookworm, and expressed as eggs per gram of stool (EPG) for each 
individual and pooled sample. A total of 140 pools (84 pools of 10, 42 pools of 
20, and 14 pools of 60) consisting a total of 840 individual samples were pooled. 
Subsequently, the agreement in mean FEC based on the examination of 
individual samples and the FEC based on the examination of the pooled sample 
was evaluated by the Spearman rank correlation coefficient (SAS 9.3 SAS 
Institute Inc.; Cary, NC, USA). In addition, a permutation test was applied to 
test for differences in mean FEC between examination of individual and pooled 
samples. This permutation test consisted of 2 consecutive steps. First, the 
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permutation distribution under the null hypothesis that in average there was no 
difference between the mean FEC of individual stool samples and its 
corresponding FEC of pooled stool sample was generated. To this end, the sign 
of the observed difference in mean FEC of the individual stool sample and its 
corresponding FEC of the pooled sample was randomly changed with a 
probability of 0.5, and the absolute value of the mean of this new permutated 
difference in FEC was calculated. Next, this procedure was repeated 10,000 
times. The distribution of these 10,000 permutated differences represents the 
permutation distribution when the null hypothesis is true. Second, the 
probability of finding a value at least equal to the absolute value of the observed 
mean difference in FEC between individual and pooled stool samples in this 
permutation distribution was determined (= p-value). The level of significance 
was set at p <0.05.  
5.2.4.2 Monitoring Drug Efficacy 
The efficacy of single dose of MEB (500 mg) treatment regimen was 
evaluated quantitatively based on the faecal egg count reduction (FECR), using 
the following formula: 
baseline)at  (FEC mean arithmetic
up)follow at  (FEC mean arithmetic - baseline)at  (FEC mean arithmeticx  100%FECR =  
 
 At baseline a total of 600 individual samples were pooled into 60 pools of 
10, 30 of 20 and 10 of 60 individual samples. Whereas at follow-up 468 
individual samples were pooled into 80 pools. As highlighted above, the pool size 
did not always include the anticipated number of individual stool samples (see 
also Figure 5.2). FECR was calculated for the three STH separately for each of 
the three pool sizes. A permutation test was applied to test for differences in 
FECR based on individual and on pooled samples. This permutation test 
consisted of 2 consecutive steps. First, the permutation distribution under the 
null hypothesis that in average there was no difference between the FECR based 
on the examination of individual stool samples with the FECR based on 
examination of pooled stool samples. To this end, the observed mean FEC of the 
individual FEC at baseline and follow-up were swapped with the FEC of the 
corresponding pooled sample at baseline and follow-up with a probability of 0.5. 
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The new permutated FECR for both the examination of individual and pooled 
samples was calculated, and the absolute value of difference in FECR was 
calculated. Next, this procedure was repeated 10,000 times. The distribution of 
these 10,000 permutated FECR differences represents the permutation 
distribution when the null hypothesis is true. Second, the probability of finding a 
value at least equal to the absolute value of the observed difference in FECR 
between individual and pooled stool samples in this permutation distribution was 
determined (= p-value). The level of significance was set at p <0.05. The level 
of significance was set at p <0.05. 
 
5.3 Results 
5.3.1 Correlation in infection intensity 
 Overall, there was a significant positive correlation between mean FEC of 
individual samples and the FEC of the pooled samples for each of the three STH 
species (RsA. lumbricoides = 0.91, p <0.001; RsT. trichiura = 0.82, p <0.001; Rshookworm 
= 0.68, p <0.001). As illustrated in Figure 5.4, these correlation coefficients 
were more or less consistent across the different pools of individual samples (A. 
lumbricoides:  Rs = 0.91-0.98, p <0.001; T. trichiura: 0.75-0.85, p <0.001; 
hookworm: Rs = 0.62-0.92, p <0.001). 
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Figure 5.4 The agreement in faecal egg counts of soil-transmitted helminths between individual and pooled samples.  
Each of the 9 scatter plots represents the agreement in mean individual FEC and pooled FEC of stool samples. The plots in column A, B 
and C represent A. lumbricoides, T. trichiura, and hookworm, respectively. The plots in top, middle and bottom row represent pool sizes 
of 10, 20 and 60, respectively. The magnitude of correlation for each plot is based on the Spearmann correlation coefficient (Rs). 
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5.3.2 Difference in infection intensity 
 Table 5.1 summarizes the mean FEC for both individual and pooled 
samples. Overall, there were no significant differences in FEC between individual 
and pooled samples across the three STH. Only for A. lumbricoides a significant 
difference in FEC was observed when pool size increased up to 60 samples, 
resulting in higher FECs (FEC60 = 3,321 EPG vs. FECindividual = 2,411 EPG, p = 
0.007). For the remaining two STH, no significant difference across pool sizes 
was observed (p > 0.05).  
 
Table 5.1 Mean faecal egg counts for soil-transmitted helminths based on 
individual and pooled samples.  
FEC, faecal egg count; EPG, eggs per gram of stool  
 
5.3.3 Monitoring Drug Efficacy 
 The mean FEC and FECR for each of the STH based on examination of 
individual and pooled samples are described in Table 5.2. Based on individual 
samples, FECR was high for A. lumbricoides (97.2%), but only moderate for T. 
trichiura (60.9%) and low for hookworm (44.2%). Pooled samples provided 
comparable FECR results for A. lumbricoides and T. trichiura, however, for 
hookworm, a significant statistical difference was found for pools of 10 (p = 
0.027) and 60 individual samples (p = 0.015).  
Pool 
size 
Sample 
size 
A. lumbricoides T. trichiura Hookworm 
   Mean FEC 
(EPG) 
p value Mean FEC 
(EPG) 
p value Mean FEC 
(EPG) 
p value 
1 840 2,411  295  35  
10 84 2,604 0.19 289 0.97 36 0.45 
20 42 2,842 0.17 312 0.55 27 0.09 
60 14 3,321 0.006 428 0.10 64 0.10 
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Table 5.2 Faecal egg count reduction of mebendazole for soil-transmitted helminths assessed by individual and pooled 
samples.  
 
 
 
 
 
 
 
 
 
 
At follow-up pooling of exactly up to 10, 20, or 60 samples were not always possible: * pool10 includes: pools of 9 (n = 12) and pools of 
10 (n = 36) samples;  ** pool20 includes: pools of 18 (n = 5), pools of 19 (n = 2) and pools of 20 (n = 17)  samples; and*** pool60 
includes: pools of 55 (n = 1), 56 (n = 1), 58 (n = 1) and 59 (n = 1) and pools of 60 (n = 4)  samples. FECR, faecal egg count reduction; 
FEC, faecal egg count; EPG, eggs per gram of stool 
 
 
Pool 
size 
Sample size 
at baseline/ 
follow-up 
A. lumbricoides T. trichiura Hookworm 
   Mean FEC 
at baseline 
 (EPG) 
FECR 
(%) 
p-value Mean FEC 
at baseline 
(EPG) 
FECR 
(%) 
p -value Mean FEC at 
baseline 
(EPG) 
FECR 
(%) 
 
p-value 
 
1 
 
600/468 
 
3,091 
 
97.2 
  
320 
 
60.9 
  
43 
 
44.2 
 
10 60/48* 3,354 96.8 0.74 338 53.2 0.39 60 68.8 0.027 
20 30/24** 4,965 96.8 0.80 607 77.7 0.62 67 65.6 0.26 
60 10/8*** 4,020 96.1 0.24 305 57.7 0.44 50 87.5 0.015 
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5.4 Discussion 
 Given the upcoming pledges of drug donations, and hence prospects of an 
increasing drug pressure on parasite populations, cost-effective tools to guide 
health care decision makers on how to optimize treatment strategies and on how 
to monitor the control of STH are urgently needed. In analogy with studies 
conducted in animal health, our results show that pooling stool samples, also 
holds promise as a rapid strategy in public health (i) to assess infection 
intensity, (ii) to ensure appropriate choice of drug and regimen, (iii) to monitor 
AR, and (iv) to assess the long-term impact of the upcoming PC programmes to 
control STH.  
 However, before we can provide specific recommendations further 
research is required to gain more insights on how and when to apply this pooling 
strategy. First, it is essential to assess the effect of pool size, sample size 
(number of pools), detection limit of the FEC method, and level of aggregation 
and intensity of infections on the precision and the accuracy of FEC and FECR 
results. This is in particular when level of infection and aggregation of STH 
infections change across different rounds of PC, and hence demanding a 
different pool and sample size and FEC method. This became already apparent in 
the present study where pooling samples to assess drug efficacy worked for A. 
lumbricoides and T. trichiura, but not for hookworm for which the level of FEC 
was low and FEC were highly aggregated. Because it is impossible to thoroughly 
evaluate the impact of each of these 5 aforementioned factors by field or 
laboratory experiments, a simulation study, as recently initiated in both animal 
(Morgan et al., 2005) and public health (Levecke et al., 2011), is at place.  
 Second, a detailed cost-effectiveness analysis is highly recommended 
(Speich et al., 2010). Examination strategies resulting in a comparable level of 
accuracy or precision on FEC or FECR may still require a different level of 
technical and financial support. The present study was not designed to verify the 
cost-effectiveness of our pooling strategy. However, from the current results 
conducted in a region endemic to STH; pooling samples is most likely cost-
effective. For example, in the present study we are able to reduce the samples 
examined with a tenfold without a significant loss in accuracy of the FEC results 
(only for A. lumbricoides a significant difference in FEC was observed between 
examination of individual and pools of 60). We estimate that processing and 
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reading a McMaster requires approximately 5 min (Levecke et al., 2009). With 
pooling 10 individual samples we would have won 270 min per day (= 60 
individual samples * 5 min – 6 pools of 10 * 5 min). Of course, pooling samples 
requires some additional time, and pooling will be hard to justify as being cost-
effective when the pooling procedure requires more than 270 min. In the current 
strategy we had to weigh a certain quantity of stool 60 times (60 individual 
samples to make 6 pools of 10) and to homogenize 6 pools. If we assume that 
homogenization of 1 pool demands 5 min (this way too much), the pooling 
strategy will still be cost-effective when the quantity of stools could be measured 
within 240 minutes (270 – 6 pools of 10 x 5 min) or 4 min per step of measuring 
stool (240/60). Given that McMaster can be applied in 5 min and comprises 
weighing of 2 grams of stool, homogenization in a flotation solution, filling and 
reading of the McMaster slide, it is clear that the 4 min available to transfer a 
fixed quantity too is quite conservative.  
 Third, various strategies to pool stool samples should be evaluated. In the 
present study, we pooled samples in a cascade: pools of 10 were made by 
pooling individual samples, but rather than repeating this procedure of pooling 
individual samples for the other pool sizes, we used the pools of 10 to make 
pools of 20, subsequently the pools of 20 to make the pools of 60. This 
procedure provided an equal amount of stool pooled for each pool, in casu 10 g, 
and an elegant way to assess different pool sizes without too much additional 
work. However, it remains uncertain whether this procedure itself does not 
introduce any bias, particularly when the contribution of each subject decreased 
over pool size. For pools of 10, each individual contributed 1 g, whereas this was 
0.5 g and 0.15 g for pools of 20 and 60, respectively. Moreover, pools were 
homogenized by simple stirring. Homogenization in a liquid phase prior to 
examination, however, should be recommended, as it facilitates homogenization 
of pools. This is in particular when eggs are not equally distributed among stool 
samples. Therefore, homogenization of stool remains a crucial step in the most 
important FEC methods applied in veterinary parasitology, including McMaster, 
FECPAK (www.fecpak.com) and (mini-)FLOTAC (Cringoli et al., 2010)). In 
addition to this, homogenization will prevent drying of the stool while pooling 
samples. Due to our cascade procedure larger pool sizes were made at the end. 
However, this probably resulted in an increase of evaporation of water from the 
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stool samples. As a consequence of this the mass of the stool decreased over 
time whereas the number of eggs in the stool remained unchanged, and hence 
resulting in the observed trend of increasing FEC over pool sizes. This could have 
been overcome by homogenizing the pools immediately in the flotation solution. 
Finally, to simplify procedures under field conditions, it would be worth to 
evaluate pooling based on a fixed volume rather than pooling a fixed amount of 
faeces.  
 Fourth, assessing drug efficacy based on pooled samples remains delicate, 
and this despite the comparable FECR results between individual and pooled 
stool samples for A. lumbricoides and T. trichiura. Subjects who are not infected 
(truly or apparent) at baseline cannot be excluded from the analysis and there is 
no perfect match of pools before and after drug administration due to drop out. 
Therefore, both analysis need to be validated independently.  
 Fifth, we only focused on STH infections, but since the advocacy to 
integrate NTD control measures, this pooling strategy should also be validated 
for the other NTD, such as Schistosoma. Finally, although pooling samples does 
not provide prevalence data, various models have been developed for other 
pathogens to estimate prevalence based on pooled samples. Validation of these 
models for STH is required (Speybroeck et al., 2012).  
 In conclusion, this study highlights that pooling stool samples is a rapid 
strategy that holds promise as a cost-effective strategy to assess intensity of 
STH infection and to monitor PC programmes. However, further research is 
required (i) to gain more insights into the impact of pool size, sample size, 
detection limit of the FEC method, intensity and aggregation of infections on the 
validity of pooling stool samples, (ii) to verify the cost-effectiveness of pooling, 
(iii) to optimize the methodology of pooling stool samples, and (iv) to validate 
models to estimate prevalence based on pooled samples. 
 
5.5 Ethics Statement  
 Ethical approval was obtained from Ghent University (2011/374), 
Belgium, and Jimma University (RPGC/09/2011), Ethiopia. The efficacy trial was 
registered under Clinical Trials.gov identifier B670201111554. The school 
authorities, teachers, parents, and the children were informed about the purpose 
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and procedures of the study. The written consent form was prepared in two 
commonly spoken local languages (Afaan Oromo and Amharic) and handed-over 
to the children parents/guardians. Only those children (i) who were willing to 
participate and (ii) from whom the parents or guardian signed written informed 
consent form were included in the study. Moreover, an additional separate 
written informed consent form for children older than 12 years was prepared, 
read, and handed-over to them and obtained their additional written informed 
consent.  
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6.1 Introduction 
 The overall objective of this thesis was to improve the control of soil-
transmitted helminths (STH) in school-aged children (SAC) in Jimma Town. To 
do this, we assessed STH infections in SAC in 14 primary schools across 
seasons, assessed the efficacy of different drugs and drug regimens against STH 
and validated new diagnostic strategies to reduce both financial and technical 
resources to assess infection intensity and to monitor the efficacy of the drugs 
administered. The studies performed indicated that STH are highly prevalent in 
children going to primary schools, but that STH infections in terms of prevalence 
and intensity vary both among schools and between seasons (Chapter 2). The 
assessment of efficacy of a single oral dose of albendazole (ALB) and 
mebendazole (MEB) pointed out that both drugs are highly efficacious against A. 
lumbricoides infections, but show poor efficacy against T. trichiura infections. For 
hookworms, ALB was more efficacious. In addition, the expected efficacy values 
for each drug and STH species were established. Any efficacy below these values 
should warrant further investigation for the potential development of 
anthelminthic resistance (AR) (Chapter 3). To further improve the control of T. 
trichiura a single oral dose needs to be administered over consecutive days 
(Chapter 4). Finally, the findings emphasize that the pooling of stool samples 
holds promise as a rapid diagnostic tool to assess both infection intensity of STH 
and drug efficacy (Chapter 5).  
 Overall, these results provide insight into different aspects related to the 
control and monitoring of mass drug administration (MDA) programmes. The 
objective of this chapter is to combine all insights and propose a plan on how to 
further improve the control of STH in children and how to monitor MDA 
programmes in Jimma Town (Ethiopia). To this end, we will first describe the 
current control measures for STH in Jimma Town. Second, we will provide 
concrete suggestions on how to improve current control measures through MDA, 
WASH (water, sanitation and hygiene) and health education. Third, we will 
outline a concrete plan to monitor MDA programmes. Finally, we will make some 
suggestions for future research.  
6.2 Current control measures in Jimma Town 
Current measures to control STH in Jimma Town are based on MDA only. 
However, these measures remain limited and scattered. Since 2008, a single 
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oral dose of ALB has biannually been administered to preschool-aged children 
(preSAC, <5 years of age) in Jimma Zone (Jimma Town is the capital of Jimma 
Zone). However, other population groups who are also at risk of morbidity 
caused by STH, such as SAC and women of childbearing age, have not been 
included. For preSAC, although it is claimed that MDA has been applied twice a 
year for the last 5 years, there is no complete report that indicates (i) in which 
months of the year it was applied, (ii) how the MDA was organized (e.g., 
whether drugs were distributed at kindergartens or health institutions or from 
house-to-house), and (iii) how many preSAC were covered. Moreover, there is 
no regular supply of drugs. Drugs were donated by United Nations 
Children's Fund (UNICEF) and channelled through the Pharmaceuticals Fund and 
Supply Agency (PFSA) of Ethiopia. Subsequently, the drugs were forwarded to 
the Oromia Regional Health Bureau, which sent it to Jimma Zone Health Bureau.  
Although the Health Bureau estimated that about 80% of the preSAC were 
covered at zonal and national level, the data from Jimma Town shows a 
coverage of about 70% of the total population of preSAC. As highlighted in 
Chapter 2, besides the claimed relatively high coverage of MDA the prevalence 
of any STH remains high in the study area. These measures seem to have little 
impact on the re-infections of STH unless MDA is supplemented with other 
control measures like health education, improving environmental sanitation and 
personal hygiene to break the transmission cycle in the long run. In this Figure 
6.1, we report the distribution of STH infections in children (1 to 18 years) as a 
function of age. The data for children aged 6 to 18 (SAC) are derived from the 
survey presented in Chapter 2. The data from children aged 1 to 4 were 
obtained during an additional survey that was designed to assess STH infections 
in preSAC in 12 kindergartens in Jimma Town (Dana et al., 2014). The data for 
children aged 5 were obtained from both surveys. The prevalence of any STH in 
SAC does not drop below 40% at any point in their childhood, and hence 
suggesting that, although the morbidity caused by STH will be reduced in 
preSAC, children remain exposed to infections and re-infections and vulnerable 
to the morbidity caused by these worms during the majority of their childhood. 
Moreover, this Figure also illustrates the high prevalence of any STH in preSAC, 
and this despite the ongoing MDA for the last 5 years. The estimated prevalence 
of any STH in preSAC was 46.6%. We did not observe the high coverage of 
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preSAC reported by the Health Bureau. Less than a third of the preSAC screened 
received a tablet during the last round of MDA.  
 
 
Figure 6.1 Distribution of any soil-transmitted helminth infection in children 
aged 1 to 18 in Jimma Town. 
 
6.3. How to improve the control of soil-transmitted helminths in Jimma 
Town 
 Control of STH in Jimma Town will have to rely on three pillars, namely 
MDA, WASH and health education. We will discuss their applicability and 
feasibility in Jimma Town separately, with the ultimate goal that the results of 
this thesis will be of relevance for the STH control programme in Jimma Town 
and might find application at a broader level in Ethiopia. 
 
6.3.1 Mass drug administration  
 Although it is generally recommended to include both preSAC and SAC, 
MDA programmes are mainly focussing on SAC (Awasthi et al., 2003; Hotez et 
al., 2005; Bundy et al., 2005). In contrast to SAC who can be largely reached 
through schools, preSAC usually stay at home, and hence are difficult to reach. 
This difference in accessibility may have contributed to the increasing MDA 
coverage in SAC worldwide over the last three years (from 28% in 2010 to 36% 
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in 2012), but the decreasing coverage in preSAC over the same period (from 
37% in 2010 to 25% in 2012) (WHO, 2014). We will include both preSAC and 
SAC in our plan for MDA in Jimma Town. Our plan for MDA in Jimma Town is 
graphically illustrated in Figure 6.2.  
 
 
Figure 6.2 Flow chart indicating the proposed framework of implementing mass 
drug administration in Jimma Town. 
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6.3.1.1. Coverage 
 Clearly, the coverage of children in Jimma Town is currently insufficient 
for preSAC and nil for SAC, despite the well organized health and education 
system in Jimma Town, allowing increasing the coverage while minimizing both 
technical and financial resources. In Jimma Town there are 24 registered 
primary schools (either public or private), hosting a total of 23,492 children. In 
addition, the Ethiopian Federal Ministry of Education is increasingly encouraging 
parents to send their preSAC to kindergartens to prepare them for formal 
schooling. Consequently, the number of kindergartens has tripled in the last 10 
years. There are currently 44 (either public or private) kindergartens in Jimma 
Town, in which 5,491 preSAC are enrolled (= 20.2% of the total population of 
preSAC, Jimma Town Education Bureau, August 2014). Moreover, the majority 
of these kindergartens, especially the public ones, are often included in the 
compounds of the primary schools, and hence this allows reaching both preSAC 
and SAC with a minimum of additional efforts. Nevertheless, it has to be kept in 
mind that if we succeed to cover all preSAC and SAC attending kindergartens 
and schools, we will only cover 51.8% of all children in Jimma Town (see Table 
6.1). This coverage is still about 25% below the 75%-target proposed by WHO 
to be reached by 2020.  
 
Table 6.1. The proportion of the total population of preschool-aged and school-
aged children who are attending kindergartens or schools in Jimma Town.  
 
 Number of children  
attending 
kindergarten/school 
Proportion of the total  
population (%) 
PreSAC 5,491 20.2 
SAC 23,492 81.5 
Total 28,983 51.8 
 
 In response to these challenges, we will first look for an alternative 
strategy to reach the preSAC and SAC that do not attend kindergartens or 
schools. Such means include strengthening the collaborative work with different 
stakeholders and utilizing the existing Health Service Extension Programmes and 
Health Extension Workers (details will be found in the subsequent sections). In 
addition, we will practise the philosophy of Jimma University, which has as a 
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motto 'we are in the community'. For instance, the postgraduate students of 
the university (clinical pharmacists, medical parasitologists and public health 
students) are taking community-based training courses as part of their 
curriculum. During these courses, they spend at least 2 months in the 
community, forming an additional platform to give health education, to trace 
children who are not enrolled in kindergartens or schools, and even to distribute 
drugs during rounds of MDA. This, we will not only improve the control of STH, it 
will also decrease the burden involving MDA on the Jimma Town Health Bureau. 
Finally, in collaboration with the Jimma Town Health Bureau and political 
administrations, we will propose a special day that will be named 'Deworming 
Day', which will be publically announced (the communication with the concerned 
governmental bodies has already been initiated). This 'Deworming Day’ will be 
taken as an excellent opportunity to treat all children at a specified place, which 
could be health centres or a stadium or school compounds, and to to give health 
education through postgraduate students and schoolteachers.  
 
6.3.1.2 Choice of frequency of mass drug administration, period, drug, and drug 
regimen  
 Although the overall prevalence in Jimma did not exceed the 50% in both 
preSAC (46.6%; Dana et al., 2014) and SAC (49.0%, Chapter 2), we suggest 
administering drugs twice a year (we used a diagnostic method that lacks 
sensitivity, and hence the true prevalence is underestimated). Due to seasonal 
variation in STH infections, we would administer drugs in well-chosen periods 
(Chapter 2). Although this may be scientifically grounded, the implementation of 
such a timed MDA is bound to important logistic issues in the field (e.g. school 
holidays and term exam schedules). We therefore suggest starting the first 
round of MDA in September (towards the end of the rainy season), and a second 
one 6 months later in March (towards the end of the dry season). September is 
probably the most ideal time of the year to initiate MDA. In this month, another 
school year starts, and hence MDA can easily be promoted as a boost of school 
performance. For this, it is important that the MDA receives the necessary media 
attention to further leverage the coverage and to increase the sustainability of 
the MDA programme (see also ‘Deworming Day’ and the sections below).  
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 Given the relatively high prevalence of T. trichiura compared to 
hookworms, we would opt for a single oral dose of mebendazole (MEB, 500 mg). 
To further improve the control of T. trichiura, we would apply single-dose of MEB 
at two consecutive days (Chapter 2 and 3) in kindergartens / schools were the 
intensity of infection is high (mean FEC >800 EPG, see Chapter 3 for proposed 
thresholds). Although it can be argued that multiple doses are impractical in a 
MDA application, there are various opportunities that may facilitate the 
administration of drugs over consecutive days, including the philosophy of 
Jimma University, the availability of postgraduate students and the presence of 
the Health Service Extension Programme. However, it is worth to note that our 
plan might not fit perfectly into the plan at the national level. When this thesis 
was forwarded for publication, it was communicated that Ethiopia will soon start 
a nationwide MDA programme to control STH. It is anticipated that both drugs 
will be distributed, and that the frequency of MDA will vary among and within 
regional states depending on the recent nationwide STH prevalence results.  
6.3.1.3 Delivery of the drugs 
 To effectively deliver the planned MDA to preSAC and SAC, we will use the 
advantage of the unique health service system of Ethiopia. The main features of 
this service include a focus on decentralization and encouraging partnerships as 
well as the participation of the whole community in health activities. It expands 
healthcare service at the grass roots level through the implementation of the 
Health Service Extension Programme (HSEP). HSEP is an innovative, 
community-based (‘kebele’-based) programme that was first introduced in 
Ethiopia in 2003. The primary aim of HSEP is to bring health service to the rural 
community at household level. This programme receives due political 
commitment from the government that has led to the construction of more than 
14,000 Health Posts (the smallest health service unit within the health service 
system hierarchy, Figure 6.3), the employment and training of 30,000 Health 
Extension Workers (HEW, 2 HEW per Health Post), and the organizational 
structure of Health Development Arms (HDA).  
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Figure 6.3. The hierarchy of health service system of Ethiopia (source: FMoH 
Quarterly Health Bulletin 2014). 
 
 HEW are females, trained for one year with special training emphasizing 
on disease prevention measures (see Box 6.1). By means of basic curative and 
preventive health services, they help the community in acquiring the knowledge 
and skills required to ensure health in the community. 
 
 
 
 
 
 
Primary level health 
care (PHCU) 
General Hospital- serving 
(1 - 1.5 million) people 
Primary Hospital- serving 
(60,000- 100,000) people 
Specialized Hospital 
(3.5 - 5.0 million) people 
Health Center- serving 
(15,000- 25,000) people 
Health Post- serving 
(3,000- 5,000) people 
Tertiary level health care 
Secondary level health 
care 
Operational center of HEW under the supervision of 
woreda Health Bureau, kebele administration and 
technical support from the nearest Health center    
Box 6.1  Elements of Primary Health Care where Health Extension Workers 
play a crucial role 
1. Education on health problems and how to prevent and control them. 
2. Development of effective food supply and proper nutrition.  
3. Maternal and child healthcare, including family planning. 
4. Adequate and safe water supply and basic sanitation. 
5. Immunization against major infectious diseases. 
6. Local endemic diseases control. 
7. Appropriate treatment of common diseases and injuries. 
8. Provision of essential basic medication.  
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 Currently, like any part of Ethiopia, every household in Jimma Town is 
organized into what is called HDA. These HDA consists of representatives of 5 
neighbouring households (one representative per household) who meet on a 
regular basis to discuss various issues at the household level, including health. 
One of these household representatives will take responsibility to organize these 
meetings. He/she will also be the contact person for the HEW to identify those 
children that are not enrolled in kindergartens or schools. Thus, for the delivery 
of drug we will closely work with both HEW and HAD, as they will facilitate the 
administration of drugs to children and health education. 
6.3.1.4 Training 
 As described in the above section, HEW and HDA will be our primary 
working partners to administer drugs, to trace children who are not enrolled in 
kindergartens or schools and to give health education. Hence, considering their 
limited knowledge on STH, we will organize a series of trainings. These trainings 
will focus on (i) STH and their burden on the community, (ii) the role of MDA as 
a measure to control STH, (iii) the importance of WASH and health education in 
the fight against STH, (iv) how to organize rounds of MDA, including how to 
administer drugs and how to trace children not attending kindergartens or 
schools. Moreover, this training will not only be limited to HEW or HAD, 
depending on the necessity they can also be extended to schoolteachers and 
concerned stakeholders depending on necessities. 
6.3.1.5 Increase the participation of the community 
 Participation of the community is of vital importance for the success of 
any control programme. During this PhD thesis we paid attention on how we 
could increase the participation of the community. We therefore presented our 
data from each of the different chapters to the schools and the communities 
involved, and invited school representatives to the laboratory to demonstrate 
the diagnosis of STH. To further disseminate our findings we discussed the 
magnitude of STH problem in the school community, the potential risk factors 
and the way forward to the control of STH in Jimma Town on the local radio 
station. Finally, we also wrote policy letters to the Educational and Health 
Bureau of Jimma Town, FMoH and other stakeholders.  
Although it is difficult to measure the impact of these measures on the 
participation of the communities, we experienced an improved cooperation of 
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both schools and the parents/guardians to take part in our studies, an increased 
rate of SAC taking the drugs, and a positive feedback of stakeholders. Figure 6.4 
illustrates some of awareness creation sessions at schools. 
 
 
Figure 6.4 An example of an awareness creation session at school 9 in Jimma 
Town, Jimma, Ethiopia. 
 
6.3.2 Water, sanitation and hygiene 
 MDA alone will not be effective to eliminate STH infections on the long-
term in the absence of  clean water, sanitation and hygiene (Ziegelbauer et al., 
2012). Thus, whenever resources allow we shall supplement the MDA 
programme with improved access to clean water together with adequate 
sanitation and hygiene (WHO, 2010; Ziegelbauer et al., 2012). However, in our 
opinion, this will not be possible in a short time of period in Jimma Town. This 
will require a long-term commitment of the different partners, such as 
politicians, city administrators and health sectors, to change the overall living 
standard of the community, which in our opinion is not present and not within 
our reach. Alternatively, as outlined in the following section we will focus on 
health education.  
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6.3.3 Health education 
 Health education is the principal component of most of the control and 
elimination programmes. Health education and information campaigns aim to 
enhance knowledge on how the disease can be treated and prevented, and 
hence reducing the transmission of STH (Albonico et al., 1999; WHO 2002). 
Health education and information can be given in different ways, such as formal 
trainings, production of different educational tools (e.g., posters, games, 
leaflets) or via mass media in form of news, policy letters or songs.  
 Besides our ongoing efforts to increase the participation of the community 
through e.g. seminars, workshops, and radio sessions (see section above), we 
have started working on some of these educational materials. For example, at 
the time this thesis was send for publication, we finalized a 14 page (script and 
illustrations) for a drama at the level of SAC (Figure 6.5). In this script, we 
discuss details of the life cycle of STH, the role and the effect of MDA, 
importance of WASH through the daily life of a boy called 'Chuchu' (the name of 
the boy who plays a key role in the drama). At this stage, we have transformed 
the script into an audio-drama, which we would like to make radio-born at the 
first round of MDA in Jimma Town. Eventually, we would like to film this drama, 
and broadcast it through the national TV (Figure 6.5). In this play, the key 
actors will be selected from SAC, teachers, HEWs, community leaders and 
representatives of the scientific community. It will be our plan to produce 
different educational materials (e.g., leaflets and posters) to further improve 
STH control in Jimma Town and making it as a model for the rest of the regions, 
and Ethiopia at large.  
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Figure 6.5 Our strategic plan to make our script air- and TV-borne through 
mass media 
 
 
Figure 6.6 Interactive discussions with students after the expulsion of Ascaris 
lumbricoides adult worm from one of the students, school 6, Jimma Ethiopia.  
 
6.4 How to monitor mass drug administration programmes in Jimma 
Town 
 Monitoring MDA programmes is of vital importance to detect emerging AR 
(short term impact) and to determine whether the MDA programme progresses 
as anticipated (long term impact). Therefore, a monitoring system will be set up 
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in Jimma Town to verify whether the drugs administered are still efficacious and 
whether the programme has an impact on prevalence/infection intensity (~ 
morbidity). In addition to this, we will give special attention to standardization of 
protocols and capacity building / strengthening of the laboratories. Figure 6.7 
illustrates the proposed monitoring system.  
6.4.1 Detection of emerging drug efficacy 
6.4.1.1 Assessment of drug efficacy 
 In accordance with WHO guidelines (WHO, 2013), we will evaluate the 
efficacy of the administered drugs every 4 years. To evaluate this we will select 
25% of the schools (= 6 schools out of 24). The selection will be based on the 
prevalence and intensity of STH infections, with special attention for T. trichiura. 
Schools that we consider to include are Schools 3, 5, 7, 8, 12 and 13 (see also 
Figure 2.1 in Chapter 2). At each school, at least 60 infected children (aged 5-
18) per STH species will be requited (WHO recommends a minimum of 50). 
Subsequently, we will compare the efficacy results with the thresholds recently 
set by WHO (Chapter 3). 
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Figure 6.7 Flow chart indicating the proposed framework of monitoring mass 
drug administration in Jimma Town. 
How to Monitor MDA in Jimma 
Short 
term 
impact 
Long 
term 
impact 
MDA application to all schools 
• Biannual 
 
Selected schools:  
• High intensity/prevalence 
• Six schools 
• 60 infected pupils/selected 
schools 
•  
 Drug efficacy trial: 
• Efficacy difference 
across STH species 
• Efficacy difference 
between drugs 
Educational tools: 
• Videos 
• Leaflet 
• Mass media 
WASH 
Evaluate efficacy indicator: 
• FECR 
 
Follow up: 
• Parasitological 
survey 
• Prevalence/intensity 
Preserving 
Stool Samples 
 
Cost effective strategies 
• Pooling   
Evaluating re-
infection status 
Molecular analysis for possible 
anthelminthic resistance gene 
like ß - tubulin 
• Strengthen molecular 
biology & NTD labs. 
• Laboratory net works 
• Continues operational 
researches 
Diagnostic techniques 
• Sensitivity 
Field / laboratory organization 
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6.4.1.2 Monitoring emergence of drug resistance 
 It has been well argued that frequent administration of drugs will exert 
pressure on the parasites, and might give rise to resistant parasites (Albonico et 
al., 2004; Humphries et al., 2012). Thus, as it is clearly indicated in Figure 6.7, 
it is our plan to preserve a portion of the positive stool samples (10%) for 
further molecular analysis each time we assess drug efficacy. If at some point 
during the course of monitoring, the drug efficacy becomes suspected or reduced 
we will further analyse the preserved samples for possible anthelminthic 
resistance gene (for instance for any change in mutations in the β-tubulin gene). 
6.4.1.3 Assessment of prevalence and infection intensity 
 We will re-assess the prevalence and the intensity of STH infections in the 
6 schools selected for assessment of drug efficacy. The obtained prevalence data 
will allow us to accordingly adapt the frequency of MDA (Jia et al., 2012; see 
Chapter 1 Figure 1.3).  
 
6.4.2 Application / development of standardized operating procedures 
 Despite the global expansion of MDA programmes, standard operating 
procedures (SOP) to monitor anthelminthic drug efficacy are lacking. As shown 
in Chapter 3, the research conducted by the STH research team at Jimma 
University (as part of the seven countries study all over the world) has been 
instrumental in generating new SOP to monitor anthelminthic drug efficacy 
(Chapter 3). These SOP have contributed significantly in the standardization and 
adaptation of existing monitoring drug efficacy tools and development of new 
therapeutic efficacy thresholds. Moreover, the use of such SOP will be of 
paramount importance in enormously minimizing the confounding factors listed 
in the literature such as the use of different diagnostic techniques, the time 
interval for follow-up, treatment and dosing of drug, and statistical approach) 
thought to affect the drug efficacy results (Keiser and Utzinger, 2008; Chapter 
1). We will effectively apply those SOP during the launch of MDA and subsequent 
monitoring efforts (Figure 6.8 and 6.9). 
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Figure 6.8 Standard operating procedures adapted/ developed by our group 
detailing field organization to laboratory analysis for tutorial and quick 
references. (https://www.youtube.com/watch?v=q_yfdtE3TSE) 
 
 In chapter 2, we described a huge difference in the prevalence and 
intensity of infection among schools located in Jimma Town. The challenge will 
be when this monitoring system is expanded to larger geographical areas such 
as Jimma Zone. An alternative approach is pooling of samples (Chapter 5), but 
this requires further validation and optimization. Thus, we will also continue 
validating and standardizing the pooling strategies during the aforementioned 
surveys. 
6.4.3 Capacity building/strengthening of research institutions 
6.4.3.1. training 
 Experience gained in the early days of this PhD work made the STH 
research team of Jimma University realize that capacity building for health 
research is a prerequisite for developing a lasting research tradition and for 
ensuring that the research outcomes are translated into practical 
recommendations for the health decision makers. During this PhD staff from the 
laboratory have been trained in a wide range of areas such as how to perform 
laboratory techniques applied for the detection and quantification of STH, how to 
organize the laboratory and field, how to preserve stool samples and how to 
manage data (Figure 6.9). 
 In addition to these onsite trainings, we have developed video clips of the 
different operational procedures. These clips, seven in total, have been made 
publically available on YouTube (https://www.youtube.com/ 
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watch?v=q_yfdtE3TSE, Figure 6.8 above), hoping they will serve not only for 
local people but also for a wider scientific community. Since we have put them 
on YouTube in October 2013, they have been viewed more than 4,500 times. 
Currently, they have also been embedded in different internationally recognized 
websites (Global Atlas of Helminth Infection, Schistosomiasis Control Initiatives, 
and Children without worms). 
 
Figure 6.9 Some pictures illustrating training given, field and laboratory 
organizations, in the Jimma Neglected Tropical Diseases (NTD) Laboratory, 
Jimma University, Ethiopia. 
 
6.4.3.2 Capacity building /strengthening of the laboratories  
 We have established both the NTD Laboratory and the Molecular Biology 
Laboratory. These two laboratories are the result of the capacity building efforts 
within the frame of this PhD work in collaboration with our partners (Laboratory 
of Prof. Dr. Jozef Vercruysse, Ghent University). Taking the experience and 
expertise of our partners, we have managed to transfer different coprological 
techniques to the Jimma University-NTD laboratory (e.g., McMaster method, 
FLOTAC/mini-FLOTAC, and FECPACKG2), and different molecular techniques in 
the Molecular Biology Laboratory. At present our laboratories have the expertise 
on all diagnostics methods.  
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Figure 6.10 Some pictures illustrating the work on FECPACKG2 diagnostic 
methods in the neglected tropical diseases (NTD) Laboratory (left column) and 
the extraction of DNA from stool samples and agarose gel displaying the PCR 
result in the Molecular Biology Laboratory (right column). 
 
 In addition, we have agreed with the Ethiopian Public Health Institute 
(EPHI) to make these laboratories one of the reference centres in south-western 
region of Ethiopia. We will be involved in organizing workshops on a wide range 
of operational procedures involved in MDA. For example, we have proposed a 
national workshop on STH and schistosomiasis to be hosted in Jimma in summer 
2015. During this workshop we expect participation of national and international 
stakeholders and experts. Moreover, we are striving to maximize and 
standardize these laboratories with the ultimate goal of making them one of the  
reference laboratories for monitoring MDA programmes against STH in Africa. 
6.5 Implications for future research 
 Our group would like to continue working on the following areas: 
1. Re-infection status studies: This study indicated that STH are highly 
prevalent in children (Chapter 2, Dana et al., 2014). Although MDA remains the 
global strategy to control STH, MDA must be repeated regularly because of the 
high re-infection rates. However, it is important to elucidate how frequently the 
re-infection occurs and to identify factors that contribute most to re-infection. 
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Thus, our future work will focus on the role of local risk factors, such as soil-
composition and moisture, as well as socioeconomic discrepancies and 
differences in sanitation, hygiene and health seeking behaviour, which are 
thought to sustain helminth transmission.  
2. Genetic and/or molecular studies: Firstly, the molecular characterization 
of the STH species will be optimized. Secondly, we will explore the genetic 
variability among STH species (both from human and animal sources) to rule out 
the possibility of zoonotic transmissions. We will extend this genetic variability 
studies to other zoonotic parasites such as Giardia, Cryptosporidium and 
Entamoeba. Finally, genetic/molecular studies will be carried out to detect the 
possible emergence of drug resistance.  
3. Efficacy trials on the combination of different drugs against T. 
trichiura: a single-dose of ALB and MEB have poor efficacy against this parasite. 
Currently there is a paucity of new drugs in the pipeline. Therefore, it would be a 
wise approach to look for possible new combinations of 'old' well-known drugs. 
For example, the combination of pyrantel (PYR) and oxantel (OX) has shown 
broad-spectrum anthelminthic activity (Rim et al., 1975) and might offer a 
valuable alternative to ALB and MEB treatments for the control of intestinal 
nematode including Trichuris infections (Albonico et al., 2002; keiser et al., 
2013). Moreover, this drug combination has a different mode of action, and 
hence providing a back-up plan would AR against ALB and MEB arise. Thus, we 
plan to evaluate the efficacy of PYR and OX combination.  
6.6 Conclusions  
 MDA-based STH control programmes have been implemented in different 
parts of the world since the mid-1990s. However, the control of STH in Ethiopia 
is yet to start. Ethiopia has launched a "National Master Plan for Integrated 
Control of NTD" in June 2013 and completed the mapping of NTD. Preliminary 
result of this mapping was released June 2014. (Figure 6.11). It is anticipated 
that the first nationwide round of MDA will take place early next year. We 
strongly believe that the existing health service system will play a key role in 
rolling out and sustaining this MDA, but that the expertise and universities and 
research institutions, such as Jimma University, should also be duly consulted.  
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Figure 6.11 Flow chart indicating the summary of proposed roadmap and 
available human resources in implementing mass drug administration in Jimma. 
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 Soil-transmitted helminths (STH), including Ascaris lumbricoides 
(roundworm), Trichuris trichiura (whipworm) and Ancylostoma duodenale and 
Necator americanus (hookworms) pose the highest burden of all neglected 
tropical diseases. They affect the most socio-economically deprived populations 
in both subtropical and tropical countries, children and women being at the 
highest risk of morbidity caused by these worms. To fight these worms mass 
drug administration (MDA) programmes are implemented. However, despite the 
high prevalence of STH, and its enormous burden on public health, the measures 
to control STH in Ethiopia are limited. The overall objective of this thesis was to 
improve the control of STH in children in Jimma Town, Ethiopia. 
  In chapter 1, we reviewed (i) the current available and recommended 
control strategies for STH infections, (ii) the World Health Organization (WHO) 
recommended anthelminthic drugs, (iii) the ways of monitoring drug efficacy, 
(iv) the factors affecting drug efficacy, and (v) the efficacy trials performed in 
the last three decades in Africa. This review indicates that MDA programmes 
remain the stronghold strategy to control STH, the benzimidazole drugs 
(albendazole (ALB) and mebendazole (MEB)) being the drugs of choice. They are 
relative efficacious, safe, and easy to administer (dosing is not based on 
bodyweight). However, the present strategy of STH control through MDA may 
not be optimal and can be further improved. First, the frequency of MDA is 
based on the prevalence of STH, but little is known about the demographic, 
socio-economic and environmental factors that contribute to these infections. 
Second, efficacy of ALB and MEB varies across the different STH species, and 
hence the choice of drug may depend on the geographical distribution of STH. 
Third, despite the global expansion of MDA, standard operating procedures to 
monitor anthelminthic drug efficacy are lacking. Fourth, there are a number of 
factors that may affect the efficacy of drugs. Fifth, there is a lack of strategies 
that allow health decision makers to rapidly assess the infection intensity and 
monitor the development of drug resistance.  
  In chapter 2, the infection intensity and prevalence of STH was assessed 
during the dry season (February-March) and end of the rainy season 
(September-October) across 14 primary schools in Jimma Town, Ethiopia. A total 
of 1,680 school children (840 in each season; and 60 children/school) were 
included. All stool samples were processed using the McMaster egg counting 
method. A meta-analysis was performed to assess any differences in prevalence 
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and infection intensity between the two seasons. Infections with any STH were 
observed in 49.0% (824/1,680) of the subjects. T. trichiura was the most 
prevalent (35.5%), followed by A. lumbricoides (23.4%) and hookworm (9.9%). 
Among the schools there was a considerable variation in prevalence, ranging 
from 16.7% to 68.3% for any STH, 6.7% to 39.2% for A. lumbricoides, 10.8% 
to 55.0% for T. trichiura and 0 % to 28.3% for hookworms. Overall, any STH 
infection was significantly less prevalent in the rainy season compared to the dry 
season. A significant difference in prevalence across seasons for the three STH 
species separately was only observed for T. trichiura infections. A significant 
difference in infection intensity across seasons was observed for A. lumbricoides 
and T. trichiura. For both STH species, infection intensities were lower in the 
rainy season compared to those in the dry season. Our results indicate that STH 
infections are highly prevalent in Jimma Town and that biannually MDA is 
recommended to control the morbidity caused by these worms. In addition, they 
suggest that MDA in the dry season may have a higher impact compared to MDA 
in the rainy season, as prevalence and intensity of STH infections is highest in 
the dry season. Finally, the large variation in both prevalence and intensity of 
infections observed in Jimma Town warrant further research to identify factors 
that explain the observed variation. 
 In chapter 3, we report the results of a drug efficacy trial in Jimma Town. 
This trial was part of a multi-national efficacy trial that was performed in 
different STH endemic countries in Asia, Africa and Latin-America to assess the 
efficacy of a single oral dose of ALB (400 mg) and MEB (500 mg) against STH 
infections in school-aged children. In each country the same protocol was 
applied. This protocol was standardized in terms of diagnostic method (McMaster 
egg counting method), follow-up period (approximately 14 days), origin of the 
drugs and statistical analysis (cure rate (CR) and different formulae for faecal 
egg reduction rate (FECR; (1), (2), (3)). The first two formulae were based on 
the mean (arithmetic/geometric) of the pre- and post-intervention faecal egg 
counts (FEC) largely ignoring the individual variability, whereas the third formula 
represented the mean of the reduction in the FEC per subject). In Ethiopia, the 
CR of ALB was the highest for A. lumbricoides (99.3%), followed by hookworm 
(98.9%). The lowest CR was observed for T. trichiura (85.7%). For MEB, a 
similar trend was observed, highest CR results observed for A. lumbricoides and 
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lowest for T. trichiura, however MEB resulted in lower CR results compared to 
ALB. Overall, the efficacy of MEB by means of CR was 90.3% for A. lumbricoides, 
58.0% for hookworm and 50.9% for T. trichiura. The FECR (1) for ALB was the 
highest for A. lumbricoides (>99.9%), followed by hookworm (99.7%) and T. 
trichiura (92.4%). Compared to ALB, MEB resulted in lower FECR (1) results for 
both hookworm (65.4%) and T. trichiura (65.4%). Efficacy results for A. 
lumbricoides for MEB (98.6%) were comparable to that of ALB. Compared to 
FECR (1), FECR (2) gave higher efficacy results. The combined results obtained 
in the different countries involved confirmed the therapeutic efficacy of these 
treatments against A. lumbricoides, the superior efficacy of ALB against 
hookworm infections, and the low efficacy against T. trichiura. Efficacy varied 
widely across the seven different trials, and infection intensity was an important 
confounding factor. The FECR rate based on arithmetic means (FECR (1)) was 
the best available indicator of drug efficacy, and should be adopted in future 
monitoring and evaluation studies of MDA programmes. Finally, our findings 
emphasize the need to revise the WHO recommended efficacy thresholds for a 
single oral dose ALB treatments. 
 In chapter 4, a randomized multi-arm efficacy trial was conducted to 
assess the efficacy of ALB and MEB administered for 1 (ALBx1 and MEBx1) or 2 
consecutive days (ALBx2 and MEBx2) against heavy-intensity trichuriasis (mean 
FEC >1000 eggs per gram of stool (EPG)) in 385 school-aged children in Jimma 
Town. The efficacy (95% confidence intervals) by means of FECR (1) was 29.3% 
(29.9–56.2), 60.0% (48.5–70.9), 73.5% (64.2–81.3), and 87.1% (81.4–91.2) 
for ALBx1, MEBx1, ALBx2, and MEBx2, respectively. MEB treatment arms were 
more efficacious than ALB arms and repeated doses were more efficacious than 
single dose arms. These observations highlight that assessment of the 
anthelminthic efficacy of existing or new compounds against T. trichiura should 
be assessed under varying levels of infection intensity. 
 In chapter 5, we developed and evaluated a pooling strategy to assess 
the intensity of STH infections and drug efficacy. Stool samples from 840 
children attending 14 primary schools in Jimma Town were pooled into different 
pool sizes (pool sizes of 10, 20, and 60 individual stool samples) to evaluate the 
infection intensity of STH. In addition, the efficacy of a single dose of MEB (500 
mg) by means of FECR (1) was evaluated in 600 children from two of the 14 
schools. Individual and pooled samples were examined with the McMaster egg 
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counting method. For each of the three STH, we found a significant positive 
correlation between the mean FEC of individual stool samples and the FEC of 
pooled stool samples, ranging from 0.62 to 0.98. Only for A. lumbricoides was 
any significant difference in mean FEC of the individual and pooled samples 
found. For this STH species, pools of 60 samples resulted in significantly higher 
FECs. FECR for the different number of samples pooled was comparable in all 
pool sizes, except for hookworm. For this parasite, pools of 10 and 60 samples 
provided significantly higher FECR results. This study highlights that pooling 
stool samples holds promise as a strategy for rapidly assessing infection 
intensity and the efficacy of administered drugs in programmes to control human 
STH. However, further research is required to determine when and how pooling 
of stool samples can be cost-effectively applied along a control programme, and 
to verify whether this approach is also applicable to other neglected tropical 
diseases. 
 In chapter 6, we combined all insights from the previous chapters and 
propose a plan on how to further improve the control of STH in children and how 
to monitor MDA programmes in Jimma Town. To this end, we describe the 
current control measures for STH in Jimma Town. Second, we provide concrete 
suggestions on how to improve current control measures through MDA, WASH 
(water, sanitation and hygiene) and education. Third, we outline a concrete plan 
to monitor MDA programmes. Finally, we make some suggestions for future 
research topics.  
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 Worminfecties veroorzaakt door Ascaris lumbricoides (rondworm), 
Trichuris trichiura (zweepworm), en Ancylostoma duodenale en Necator 
americanus (haakwormen) beïnvloeden in grote mate de volksgezondheid in 
zowel subtropische als tropische landen. De impact van deze worminfecties is 
vooral uitgesproken bij kinderen en vrouwen. Om deze wormen te bestrijden 
werden grootschalige ontwormingsprogramma’s ingevoerd. Maar ondanks de 
hoge prevalentie van worminfecties in Ethiopië, staan maatregelen om deze 
wormen te bestrijden in de kinderschoenen. De algemene doelstelling van dit 
proefschrift is daarom het verbeteren van de controle van worminfecties bij 
kinderen in Jimma, Ethiopië.  
 In hoofdstuk 1 geven we een overzicht van de literatuur over (i) de 
huidige beschikbare en aanbevolen controlestrategieën voor worminfecties, (ii) 
de ontwormingsmiddelen aanbevolen door de Wereldgezondheidsorganisatie, 
(iii) de manieren om de effectiviteit van de ontwormingsmiddelen op te volgen, 
(iv) de factoren die de effectiviteit van geneesmiddelen kunnen beïnvloeden, en 
(v) de studies die de effectiviteit van ontwormingsmiddelen evalueerden in 
Afrika in de laatste 3 decennia. Dit overzicht toont aan dat grootschalige 
toediening van ontwormingsmiddelen de belangrijkste strategie is, en 
albendazole (ALB) en mebendazole (MEB) zijn hierbij de eerste keus 
ontwormingsmiddelen.  Ze zijn relatief effectief, veilig en gemakkelijk toe te 
dienen (dosering is niet gebaseerd op lichaamsgewicht). De huidige strategie 
kan echter verbeterd worden. Allereerst is de frequentie van het toedienen van 
ontwormingsmiddelen gebaseerd op prevalentie, maar het is niet geweten welke 
demografische, socio-economische en ecologische factoren bijdragen tot infectie. 
Ten tweede, de werkzaamheid van ALB en MEB is verschillend voor de 
verschillende wormsoorten, dus de keuze van ontwormingsmiddel zal afhangen 
van de lokale epidemiologie van de individuele wormsoorten. Ten derde, 
ondanks de wereldwijde uitbreiding van de ontwormingsprogramma’s, zijn er 
geen richtlijnen om de effectiviteit van de ontwormingsmiddelen te evalueren. 
Ten vierde, zijn er een aantal factoren die de effectiviteit van 
ontwormingsmiddelen beïnvloeden. Ten vijfde, er is een tekort aan strategieën 
voor een snelle beoordeling van de intensiteit van infecties en voor het opsporen 
van resistentie-ontwikkeling in de wormen. 
 In hoofdstuk 2 werd de intensiteit en prevalentie van worminfecties 
nagegaan in 14 scholen in Jimma (Ethiopië) tijdens het droog- (februari-maart) 
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en regenseizoen (september-oktober). Een totaal van 1.680 schoolgaande 
kinderen werden onderzocht (840 in elk seizoen, 60 kinderen / school). Iedere 
stoelgang werd onderzocht met de McMaster techniek. Een meta-analyse werd 
uitgevoerd om verschillen in prevalentie en infectie-intensiteit tussen de twee 
seizoenen te evalueren. In 49.0% (824/1680) van de kinderen werd minstens 1 
van de wormsoorten opgespoord. Infecties met T. trichiura kwamen het meest 
voor (35,5%), gevolgd door A. lumbricoides (23,4%) en haakwormen (9,9%). 
Tussen de scholen was er een enorme variatie in prevalentie, variërend van 
16,7% tot 68,3% voor worminfecties, 6,7% tot 39,2% voor A. lumbricoides, 
10,8% tot 55,0% voor T. trichiura en 0% tot 28,3% voor haakwormen. 
Worminfecties kwamen significant minder voor in het regenseizoen. Een 
significant verschil in prevalentie tussen seizoenen voor de drie wormsoorten 
afzonderlijk werd alleen waargenomen voor T. trichiura. Een significant verschil 
in infectie-intensiteit tussen seizoenen werd waargenomen voor A. lumbricoides 
en T. trichiura. Voor beide wormen werd een lagere graad van intensiteit 
waargenomen in het regenseizoen. Onze resultaten geven aan dat worminfecties 
wijd verspreid zijn in Jimma en dat tweejaarlijks toediening van een 
ontwormingsmiddel aanbevolen is voor de controle van deze wormen. Ze 
suggeren ook dat ontworming in het droog seizoen een grotere impact zal 
hebben op worminfecties dan wanneer ontworming in het regenseizoen gebeurt. 
De grote waargenomen variatie in zowel prevalentie en infectie-intensiteit in de 
scholen in Jimma rechtvaardigen verder onderzoek om na te gaan welke 
factoren deze variatie verklaren. 
In hoofdstuk 3 beschrijven we de effectiviteit van geneesmiddelen tegen 
worminfecties in schoolkinderen in Jimma (Ethiopië). Dit onderzoek maakte deel 
uit van een studie waarin de effectiviteit van een enkelvoudige orale toediening 
van ALB (400 mg) en MEB (500 mg) tegen wominfecties in schoolkinderen werd 
onderzocht in Azië, Afrika en Latijns-Amerika. Deze multinationale studie werd 
gestandaardiseerd op het gebied van diagnostische techniek (McMaster), 
opvolgperiode (ongeveer 14 dagen), de herkomst van de ontwormingsmiddelen 
en statistische analyse (percentage van kinderen dat geneest (CR) en 3 formules 
voor het bepalen van de reductie in ei-uitscheiding (FECR (1), (2) en (3); de 
eerste twee formules zijn gebaseerd op het groepsgemiddelde (rekenkundig / 
geometrisch) van de ei-uitscheiding vóór en na behandeling, de derde formule 
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geeft het gemiddelde van de reductie in ei-uitscheiding per kind weer). De CR 
van ALB was het hoogst voor A. lumbricoides (99,3%), gevolgd door 
haakwormen (98.9%). De laagste CR werd waargenomen voor T. trichiura 
(85,7%). Voor MEB werd een gelijkaardige trend waargenomen: de hoogste CR 
resultaten werden waargenomen voor A. lumbricoides en de laagste voor T. 
trichiura. MEB resulteerde echter in lagere CR resultaten vergeleken met ALB. 
Wanneer de effectiviteit van MEB werd samengevat in CR was de effectiviteit 
90,3% voor A. lumbricoides, 58,0% voor haakwormen en 50,9% voor T. 
trichiura. De FECR (1) voor ALB was het hoogst voor A. lumbricoides (>99,9%). 
De FECR (1) voor haakwormen was 99.7%, en 92.4% voor T. trichiura. 
Vergeleken met ALB, resulteerde MEB in lagere FECR (1) resultaten voor zowel 
haakwormen (65,4%) en T. trichiura (65,4%). De werkzaamheid voor MEB 
tegen A. lumbricoides (98,6%) was vergelijkbaar met die van ALB. Vergeleken 
met FECR (1), gaf FECR (2) hogere waarden. De gecombineerde resultaten 
bekomen in de verschillende landen die betrokken waren in deze studie 
bevestigden de therapeutische werkzaamheid van deze behandelingen tegen A. 
lumbricoides, de superieure werkzaamheid van ALB tegen haakworminfecties, en 
de lage werkzaamheid tegen T. trichiura. FECR (1) varieerde sterk tussen de 
verschillende landen, en intensiteit van de infecties was een belangrijke 
verklarende factor. De reductie in ei-uitscheiding op basis van het rekenkundig 
groepsgemiddelde (FECR (1)) was de beste indicator voor het evalueren van de 
effectiviteit van ontwormingsmiddelen, en moet de standaard statistiek worden 
voor studies die effectiviteit van geneesmiddelen in ontwormingsprogramma’s 
evalueren. Tot slot, de resultaten benadrukken de noodzaak om de door 
Wereldgezondheidsorganisatie vooropgestelde minima voor effectiviteit van ALB 
en MEB moeten worden herzien.  
 In hoofdstuk 4 evalueerden we de effectiviteit van ALB en MEB 
toegediend gedurende 1 dag (ALBx1 en MEBx1) of 2 opeenvolgende dagen 
(ALBx2 en MEBx2) tegen T. trichiura infecties van hoge intensiteit (gemiddelde 
ei-uitscheiding >1000 eieren per gram stoelgang) in schoolgaande kinderen in 
Jimma. De effectiviteit (95% betrouwbaarheidsinterval) gemeten aan de hand 
van FECR(1) was respectievelijk 29,3% (29,9-56,2), 60,0% (48,5-70,9), 73,5% 
(64,2-81,3), en 87.1% (81.4- 91,2) voor ALBx1, MEBx1, ALBx2 en MEBx2. MEB 
was effectiever dan ALB, en een herhaalde toediening was effectiever dan een 
enkelvoudige toediening. Deze resultaten benadrukken dat de beoordeling van 
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de efficiëntie van bestaande of nieuwe ontwormingsmiddelen tegen T. trichiura 
onder verschillende niveaus van infectie-intensiteit moeten worden beoordeeld.  
 In hoofdstuk 5 ontwikkelden en evalueerden we een strategie om 
stoelgang te mengen voor het bepalen van de intensiteit van worminfecties en 
de effectiviteit van ontwormingsmiddelen. De intensiteit van worminfecties werd 
bepaald voor 840 kinderen in 14 basisscholen in Jimma. De effectiviteit van een 
enkelvoudige dosis MEB (500 mg) werd bepaald bij 600 kinderen in 2 scholen en 
dit door middel van FECR (1). Stoelgang van 10, 20 en 60 kinderen werd 
gemengd tot 1 mengstaal. Individuele en mengstalen werden onderzocht met de 
McMaster techniek. Voor elk van de drie wormsoorten vonden we een 
significante positieve correlatie tussen de gemiddelde individuele ei-uitscheiding 
(FEC) en de FEC van het mengstaal, variërend van 0,62 tot 0,98. Alleen voor A. 
lumbricoides was er een significant verschil in ei-uitscheiding: mengstalen van 
60 individuen gaven een significant hogere FEC. FECR (1) resultaten waren 
vergelijkbaar, behalve voor haakwormen. Voor deze wormen gaven mengstalen 
van 10 en 60 individuen een significant hoger FECR (1) resultaat. Deze studie 
benadrukt dat het mengen van stoelgang een potentiële strategie is voor het 
snel beoordelen van de infectie-intensiteit van worminfecties en de effectiviteit 
van de toegediende ontwormingsmiddelen. Er is echter meer onderzoek nodig 
om te bepalen wanneer en hoe het mengen van stoelgang kosteneffectief is, en 
om na te gaan of deze aanpak ook toepasbaar is op andere tropische ziekten.  
 In hoofdstuk 6, combineren we alle inzichten uit de voorgaande 
hoofdstukken en stellen op basis van de huidige controle maatregelen een plan 
op om de controle van worminfecties in kinderen van Jimma te verbeteren. We 
bieden ook concrete suggesties aan voor het opvolgen van deze 
ontwormingsprogramma’s. Tot slot geven we enkele suggesties voor 
toekomstige onderzoeksonderwerpen. 
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